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Abstract 
The emergence of multiple-antibiotic resistance among clinical pathogens has 
created an urgent requirement for the development of new antibiotics. The 
current lack of new antibiotics has not only renewed interest in traditional 
natural product screening approaches, but also prompted efforts to develop 
alternate antimicrobial strategies. 
Antisense RNA based silencing provides a strategy for developing whole cell 
screening assays, whereby antisense RNA induction leads to target protein 
depletion and subsequently the increased sensitivity of test organisms to target 
specific inhibitors. The development of synthetic derivatives to expressed 
antisense RNA such as peptide Nucleic Acids (PNA), has also been explored 
for use as bacterial inhibitors. This thesis aims to examine two novel 
antimicrobial strategies, firstly by comparing mRNA and protein based 
techniques to evaluate essential gene requirement in bacteria, to identify novel 
targets for antibiotic screening assays. Secondly, to evaluate the potential use 
of peptide peptide-PNA’s as antimicrobials capable of targeting individual 
bacterial species. 
To successfully develop either approach requires the identification and 
validation of suitable gene encoded molecular targets. Essential genes may 
provide potential candidates, yet a suitable system is necessary for 
characterisation to enable genes to be ranked, so that the most suitable targets 
can be prioritized. A disproportionate growth requirement (stringency) is known 
to exist among essential genes, which provides a means to delineate between 
essentially required targets, yet is based upon the measurement of mRNA 
abundance. Due to post-transcription and translation mechanisms, mRNA does 
not provide a reliable indicator of expressed protein, which represents the 
ultimate output of gene expression. 
This study demonstrates the use of a quantitative proteomics strategy for 
evaluating essential gene stringency at the protein level, using the E.coli gene 
fabI. Using expressed antisense RNA silencing to deplete target protein 
concentration and to reduce normal growth rate to 50%, absolute protein 
determinations were used to define a Minimum Protein Level (MPL50), for the 
quantitative characterisation of essential gene stringency. To support the 
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justification of evaluating gene stringency using expressed protein abundance, 
the stringency of operon based genes fusA and rplE using antisense RNA 
silencing was investigated and revealed transcript profiles that contradict the 
use of Minimum Transcript Level (MTL50) previously used to define gene 
stringency. 
Finally, to demonstrate a potential application that would benefit from the 
characterisation of essential gene stringency, the species-specificity of a 
peptide-PNA targeting the essential gene ftsZ was evaluated. Exposing a mixed 
culture of S.typhimurium and E.coli to a peptide-PNA conjugate, incorporating a 
2 base pair mismatch demonstrated the capacity to inhibit translation of ftsZ in 
S.typhimurium but not E.coli. 
This study highlights how characterising essential genes using the MPL50 can 
be used to delineate stringently required gene targets to support antimicrobial 
screening and the development of species specific antimicrobials. Furthermore 
the applications of evaluating gene stringency may be extended further, to 
provide a tool for standardising genetic components in synthetic biology 
approaches. 
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Chapter 1 Introduction 
1.1 Antibiotics overview 
1.1.1 Antibiotic origins, function & resistance 
The discovery and derivatization of antibiotics from natural products has 
provided the foundations of modern chemotherapy, while pioneering techniques 
in isolation, characterisation, purification and systematic screening have 
contributed to the development of the modern pharmaceutical industry. The 
study and elucidation of antibiotic modes of action on bacterial physiology, has 
not only advanced the understanding of cellular mechanisms underlying 
replication, transcription and translation, but also provided selection tools for 
cloning strategies (Fabbretti et al., 2011). 
The origins of naturally derived antibiotics can be traced to organisms within the 
plant and animal kingdoms, primarily unicellular bacteria and eukaryotic fungi. 
Of particular interest are the filamentous gram-positive bacteria belonging to the 
order Actinomycetales (Lechevalier and Lechevalier, 1967),  typified by the 
genera  Streptomyces, which exist ubiquitously within the terrestrial 
environment, fulfilling  a saprophytic role  (Goodfellow and Williams, 1983). 
Streptomyces are among the most prolific producers of naturally derived 
antibiotics that have entered clinical practice, with a speculative capability of 
producing up to 100,000 potential antimicrobial compounds (Watve et al., 
2001).  
Antibiotics are characterized as low molecular weight compounds (MW<3000) 
which are synthesized via complex secondary metabolic pathways, divorced 
from the primary metabolic functions concerned with cell growth (Bérdy, 2005). 
Secondary metabolic pathways are a consequence of distinct biosynthetic gene 
clusters that encode metabolic  enzymes, regulatory genes and resistance 
mechanisms, implying functional evolution as a unit (Maplestone et al., 1992). 
The secondary metabolites produced, possess intricate molecular scaffolds with 
unique functional group configurations (Silver, 2008). These properties enable 
specific interactions with molecular targets (cellular components or enzymes) 
(Figure 1.1),  through specific binding sites either on the target surface, or at 
sites that are exposed following structural re-arrangement, when the target is 
assembled as part of a macromolecular complex with other cellular constituents 
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(Lange et al., 2007). The subsequent binding alters the ordered structure of the 
target causing impairment or complete abolition of normal function. Essential 
cellular function is subsequently effected, which depending on the degree of 
target inhibition, is characterized as either inhibitory (bacteriostatic) or capable 
of initiating cell death (bactericidal) (Walsh, 2003).  
Impaired cellular function and cell death can also occur via a secondary 
pathway that is activated  following primary antibiotic target binding, which 
initiates a universal mechanism of cell death through oxidative damage 
(Kohanski et al., 2010). Interaction between the antibiotic and respective cellular 
target, alters metabolic feedback to the Tricarboxylic Acid Cycle (TCA), through 
increased oxidation of the reduced form of the co-enzyme nicotinamide adenine 
dinucleotide (NADH). Hyper-activation of the electron transport chain ensues, 
causing an increase in the formation of superoxide (O2-), hydrogen peroxide 
(H2O2) and hydroxyl (OH) free radicals, which react readily with enzymes 
containing iron complexes. Iron is subsequently lost following oxidation and 
becomes freely available to interact with H2O2 via the Fenton reaction to 
produce OH radicals, which are highly reactive and capable of readily oxidising 
DNA and proteins (Imlay, 2003). 
The role of antibiotics was deemed to be an evolved survival strategy in the 
guise of a chemical defence mechanism, for minimising competition from other 
bacteria (Fajardo et al., 2009)  and providing protection against bacterivorous 
predators such as protozoa and nematodes (Jousset, 2012). This concept was 
supported by widespread antibiotic production among organisms subject to 
Darwinian competition, in addition to the structural complexity of natural 
products encoded by a significant proportion of the genomes of Actinomycetes 
and the sophisticated interaction between the antibiotic and it’s cognate 
receptor (Williams et al., 1989).  More recently it has been suggested that, 
antibiotics may fulfil a role as autoregulators in intracellular communication, 
since they are known to induce secondary metabolism and aerial mycelium 
formation in Actinomycetes, in addition to cellular differentiation in other species 
(Beppu, 1992). The dual role of defence and communication has been 
suggested to be concentration dependant, with antibiotics behaving as 
autologous signals at low concentrations, whereas at high concentrations they 
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act in the traditional sense of inhibiting bacterial growth (Fajardo and Martinez, 
2008).  
1.1.2 Antibiotic mode of action 
Antibiotics are broadly grouped according to the cellular pathways and targets 
they affect (Table 1.1) peptidoglycan assembly in cell wall synthesis, disruption 
of the outer cytoplasmic membranes, protein synthesis machinery such as the 
ribosome and associated elongation factors, enzymes responsible for 
replication and transcription and the biosynthesis of folate, tRNA and fatty acids 
(Lange et al., 2007) . 
 
 
Figure 1.1. Cellular targets of current antibiotics in clinical use (adapted from Walsh, 
2003).
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Table 1.1. The targets and inhibitory modes of action of antibiotics in clinical use 
Pathway Antibiotic class Primary Target Mechanism of action 
Cell wall 
synthesis 
β-Lactams and derivatives: 
Cephalosporins Carbenems 
Monobactems 
DD-transpeptidases 
(penicillin binding proteins) 
Pencilioyation of the penicillin binding protein active site, 
preventing the catalysis of peptide bond formation between 
peptidoglycan units. 
 Glycopeptide Peptidoglycan units Binds peptidoglycan units (at D-alanyl-D-alanine-dipeptide), 
thereby Inhibiting transglycolase activity and preventing 
cross linking of peptidoglycan. 
DNA 
replication 
Quinolones/fluoroquinolones A-subunit of DNA gyrase or  
A-subunit of Toposiomerase 
IV 
Interferes with the maintenance of chromosome topology, 
through the Inhibition of strand cleavage and re-joining, 
resulting in double strand breaks and replication fork arrest. 
Protein 
synthesis 
Aminoglycosides 16S rRNA 30S ribosome tRNA mismatching resulting in mistranslation. 
 Tetracyclines 30S ribosome Blocks access of aminoacyrl t-RNA to the ribosome. 
 Macrolides 50S ribosome Inhibiting the initiation phase of translation and translocation 
of peptidyl tRNA. 
Transcription Rifamycins Β-subunit of  DNA-
dependent RNA polymerase 
Stable binding to the DNA/RNA tunnel of the Β-subunit 
subsequently blocks RNA elongation. 
Folate 
biosynthesis 
Sulfonamide Dihydropteroate synthase Acts as a competitively inhibitor  
 Trimethoprim Dihyrdofolate reductase Prevents recycling of folate coenzymes 7,8 dihydrofolate 
(DHF) to 5,6,7,8-tetrahydrofolate (THF) 
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1.1.3 The emergence of antibiotic resistance 
Decades of anthropogenic activity in biopharmaceuticals, medicine and 
agriculture, have been speculated to increase the capacity for bacterial 
evolution. Antibiotic exposure promotes a transient increase in rates of 
mutation, recombination and Horizontal Gene Transfer (HGT), which underlie 
genetic diversity. Over time lineages displaying higher mutation rates 
predominate, leading to the directional selection of antibiotic resistance among 
bacteria (Gillings and Stokes, 2012). Although the probability of antibiotic 
resistance developing was initially thought to be low, subsequent advances in in 
microbial genetics have increased understanding regarding the precursors to 
resistance and it’s dissemination amongst other species (Davies, 1994). Within 
a clinical context, persistent antibiotic use has prompted the emergence of three 
predominant classes of resistant pathogens; gram positive organisms such as 
Methicillin Resistant Staphylococcus aureus (MRSA), and gram negative 
organisms such as multidrug resistant (MDR) Escherichia coli, Enterococcus 
faecium, Enterobacter cloacae, Extended-spectrum β-lactamases (ESBL) 
Klebsiella pneumoniae, MDR Actinetobacter baumanii and Pseudomonas 
aeruginosa. In addition a third class consisting of multidrug resistant (XDR) 
Mycobacterrium tuberculosis has also been observed (Fischbach and Walsh, 
2009). It is now accepted that antibiotic exposure creates a Darwinian selection 
pressure which promotes an adaptive response,  through the development of 
survival mechanisms that enable continued growth in cytotoxic antibiotic 
concentrations (Wright, 2007). Those microorganisms best adapted for survival 
persist with the capability of disseminating resistance traits amongst other 
species (Allen et al., 2010).  
Antibiotic resistance mechanisms are considered artefacts arising from a 
comprehensive and evolving natural reservoir of resistance genes, among 
pathogenic and environmental bacteria. This compendium encompasses cryptic 
resistance elements within chromosomes and precursor genes encoding 
proteins with alternate functions, that serve as prototypes to bona fide 
resistance mechanisms, collectively referred to as the antibiotic resistome 
(Wright, 2007). The resistome is thought to have originated from the co-
evolution of proteins with alternate biochemical function which undergo 
convergence, whereby a single functional transcriptional unit develops from the 
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merging of contiguous genes sets coding for structural, regulatory and 
resistance elements into a single bio-synthetic cluster (Fischbach, 2009). The 
source of antibiotic resistance mechanisms has been attributed to 
Actinomycetes, which require a resistance strategy to compensate for antibiotic 
production. Indeed antibiotic resistance in Actinomycetes is known to increase 
in conjunction with synthesis.  In Streptomyces coelicolor, elucidation of the 
production of the antibiotic actinorhordin, revealed a coupling between 
biosynthesis and intracellular export. Pathway intermediates were identified and 
found to be capable of binding to a transcriptional repressor (ActR), responsible 
for regulating the expression of a trans-membrane efflux pump (actA). As a 
result of this mechanism, S.coelicolor was primed in preparation for the toxic 
build-up of antibiotic (Tahlan et al., 2007). 
Resistance mechanisms may be classified as either active (stimulated by an 
evolutionary selective pressure) or passive (a consequence of innate cell 
function or general adaptive process) (Wright, 2005). In these cases, the 
expression of intrinsic resistance mechanisms can arise following spontaneous 
chromosomal mutation or a series of cooperative mutations within genes that 
dictate the synthesis and structural assembly of the antibiotic target. Mutations 
may cause structural re-orientation of the active site (target structural 
mutations), enhance access to the target (target access mutations), or shield 
the target from antibiotic action (target protection mutations) (Martinez and 
Baquero, 2000). 
A prerequisite for spontaneous mutation is pre-mutagenic damage to 
chromosomal DNA as a consequence of native replication errors following DNA 
synthesis, characterised as base substitution, frame-shift, or sequence 
substitutions. Alternatively, mutations may arise from DNA lesions caused by 
adverse chemical reactions (Oxidation, methylation, depurination, deamination 
and hydrolytic decomposition of nucleotide bases), in conjunction with  failures 
in cell repair mechanisms (Maki, 2002). The probability of a spontaneous 
mutation event creating resistant phenotypes (mutability) is dependent on gene 
structure, length and surrounding sequences, which may be prone to genetic 
alteration. Environmental cues such as nutrient limitation are also known to 
increase the rate of mutation by initiating an adaptive response, involving the 
expression of contingency genes, linked to the SOS response (Martinez et al., 
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2009).  Such factors underlie the conditions for mutator phenotypes to arise 
within bacterial populations, which provide a survival mechanism for bacteria to 
adapt and respond to environmental changes. Alternatively resistance genes 
may be acquired from other species through horizontal gene transfer (Mazodier 
and Davies, 1991), encompassing the transmission of mobile genetic elements 
from bacteriophages (transduction), plasmids and conjugative transposons 
(conjugation) and integration of exogenous DNA within chromosomal DNA 
(transformation) (Alekshun and Levy, 2007). Ultimately such mutations support 
the development of common resistance mechanisms enabling mutant bacteria 
to compete with wild-type counterparts. The outcome is subject to the relative 
fitness conveyed by the mutation, which may present a significant biological 
cost in terms of additional metabolic requirements, arising from the expression 
and maintenance of resistance genes (Andersson and Levin, 1999). Although 
resistance is often viewed as reducing fitness, it can be compensated by 
additional mutations in other chromosomal loci, restoring fitness equivalent to 
wild-type strains (Martinez and Baquero, 2000). 
Despite the extensive documentation of emerging resistance mutations, only 
three new classes of antibiotic have been developed in the last few decades, 
consisting of mutilins, lipopetides and oxazolidinones (Fischbach and Walsh, 
2009). Efforts at reversing resistance within a clinical context, through reducing 
antibiotic treatments have had limited effects (Andersson and Hughes, 2010). 
The primary means to treat resistant strains may lie in the discovery of 
antibiotics possessing novel modes of action capable of negating established 
resistance mechanisms. 
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Table 1.2. Resistance mechanisms associated with current antibiotics. 
Resistance 
Mechanism 
Mode of action Antibiotic 
example 
Mutation description 
Structural 
modification of the 
molecular target  
Alterations in target structure 
reduce interactions / disrupt 
recognition sites for 
antibiotic binding 
Quinolones 
 
Mutations in gyrA  (Ser83 – Leu), gyrB  (Asp426-Asn), which 
encode the subunits of DNA gryase  and subunit of topisomerase 
IV  encoded by parC (Ser80-Arg)  
Aminoglycosides Mutation in nucleotide A1408G of Helix 44 of decoding site of 30S 
subunit 
Alteration in cell 
membrane 
permeability   
Restricts entry of the 
antibiotic  to intracellular 
targets  
Vancomycin 
Polymyxin 
Thickened cell wall in S.aureus 
Modification of lipopolysaccharide and lipid A composition in 
S.enterica by 2 component regulatory system PmrAB 
Expression of 
active efflux 
pumps  
Removes antibiotic from the 
cytoplasm and across inner 
and outer membrane of the 
cell envelope 
Tetracycline 
 
Tet transmembrane efflux transmembrane proteins A-E (gram-) 
and K, L (gram+) protein 
Macrolides MsrA ATP binding cassette (ABC) efflux protein 
Expression of 
enzymes   
Enzymatic modification or 
degradation of antibiotic 
structure rendering it 
inactive 
Aminoglycosides Acetyltransferase(AAC), Nucleotidyltransferases(ANT), 
Phosphotransferases (APH) 
Overproduction of  
molecular target  
Excess target saturates 
antibiotic levels, increasing  
Isoniazid Mutations in the promoter region of inhA encoding enoyl 
transferase in M.tuberculosis 
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1.1.4 The antibiotic discovery paradigm 
The paradigm of antibiotic discovery can be traced to the convergence of two 
separate approaches; systematic chemical synthesis and natural product 
discovery. Systematic chemical synthesis aimed to utilise reaction mechanisms 
to generate variant chemical structures with antibacterial properties. This 
culminated in the development of the first true antibacterial prontisil rubrum, 
which demonstrated in vivo activity against streptococcal infection. Further 
investigation attributed antibacterial activity to the metabolite sulfonilamide, 
which heralded the process of rational design and screening of antimetabolites 
leading to the development of antifolates. The origins of natural product 
discovery began with the serendipitous observation and subsequent isolation of 
penicillin from the mould Penicillium notatum. This was followed by the 
discovery of streptomycin, which provided a template for the screening 
fermentation broths derived from soil Actinomycetes. This became the 
prevailing  approach which facilitated the discovery of the majority of antibiotic 
classes, referred to as  “golden age of antibiotics” (Silver, 2012).  
Over recent decades traditional discovery programs within the pharmaceutical 
industry have declined, due to a loss in profitability associated with developing 
new antibiotics. This has been attributed to the short duration of antibiotic 
therapy which generates a lower return on capital invested in comparison to 
other treatments (e.g.: hypertensives). Profitability has been further exacerbated 
by the conservative pricing of antibiotics  and efforts to limit their prescribing to  
minimise resistance (Tillotson, 2008).  A substantial proportion of the economic 
costs incurred, have been attributed to the reliability of natural sources and the 
characterisation necessary to identify active components in often complex 
extracts (Li and Vederas, 2009). The most significant factor in the decline of 
traditional antibacterial discovery occurred following the introduction of 
combinational chemistry. Combichem refers to the systematic assembly of 
diverse chemical structures by the connection of individual components, 
through biological, chemical or biosynthetic means (Gallop et al., 1994). Using 
this approach it is possible to construct  structurally diverse compounds through 
the addition of functional groups to a primary scaffold element, often derived 
from a natural product template (Koehn and Carter, 2005).  Unlike traditional 
natural product libraries, sufficient quantities can be synthesized economically 
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and undesirable chemical properties that may cause unwanted side effects can 
be avoided at the design stage. 
The introduction of combichem subsequently  prompted a paradigm shift in 
screening strategies that saw empirical screening from natural sources, 
superseded by High Throughput Screening (HTS) using synthetic libraries (Li 
and Vederas, 2009). Yet despite extensive efforts, synthetic libraries have failed 
to make a significant impact. The evidence for this limited  success has been 
exemplified by the screening of synthetic polyketides libraries, which have 
demonstrated a hit rate of <0.001% compared to a 0.3% hit rate achieved with 
natural product libraries (Weissman and Leadlay, 2005). Even the use of 
genomics to identify and select essential genes for target based screening has 
failed to deliver new antibiotic entities.  In a landmark study, a genomics based 
approach was used to identify 70 essential genes, which proceeded to generate 
only 5 leads from subsequent HTS campaigns (Payne et al., 2007). Similar 
results were identified in 127 antibacterial screening programs covering 69 
essential targets (Chan et al., 2004).  
Conclusions drawn from these studies revealed the limitations of synthetic 
libraries, specifically an inherent lack of chemical diversity in terms of steric 
complexity, unique functional groups, chiral centres, and broad molecular 
properties associated with natural products. Furthermore, synthetic compounds 
often lack evolved target specificity, often against subtle features such as 
protein domains and binding motifs (Koehn and Carter, 2005). The lack of 
chemical diversity may have  arisen from an inherent bias towards compounds 
that fulfil Lipinski’s rule of 5, a set of parameters associated with solubility and 
permeability,  in terms of molecular weight, Log p and number of hydrogen 
acceptors and donors (Lipinski et al., 2012). In comparison natural products 
typically display higher MW and polarity compared to other drug classes 
(O'Shea and Moser, 2008). With increasing rates of antibiotic resistance and a 
lack of novel antibiotics in development, there has been a renaissance in 
natural product discovery.  
1.1.5 Possibilities to exploit new sources of antibiotics 
Current efforts in natural product discovery have focused on identifying new 
antibiotic producing microorganisms on the rationale that taxonomic diversity is 
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a proxy for  the  chemical scaffold diversity, associated with natural products 
(Bull et al., 2000). New microorganisms have been sought by surveying 
previously unexplored geographical locations, where extreme environmental 
conditions of temperature pH and salinity are encountered.  Considerable focus 
has been expended on the marine environment including sea ice, the ocean 
subsurface, hydrothermal vents and the ocean floor (Keller and Zengler, 2004).  
Marine sediments in particular have shown large diversity of microorganisms in 
particular Actinomycetes (Stach and Bull, 2005; Pathom-aree et al., 2006). 
Currently members covering 50 genera of Actinomycetes have been isolated 
and cultured from marine habitats including the discovery of new genera; 
Demequina, Lamia, Marinactinospora, Marisediminicola, Miniimonas, 
Paraoerskovia, Phycicococcus, Phycicola, Salinibacterium, Salinispora, 
Aciscionella and Serinicoccus (Goodfellow and Fiedler, 2010). Akin with their 
terrestrial counterparts, marine Actinomycetes possess a significant coding 
capacity reserved for numerous biosynthetic clusters encoding secondary 
metabolites (Baltz, 2008). Evidence has emerged suggesting that marine 
secondary metabolites are synthesised via unique halogenation mechanisms, 
absent in terrestrial Actinomycetes (Butler, 1998). Marine halogenated 
metabolites are speculated to possess novel  properties which arise from the 
incorporation of halogen atoms within aromatic, heterocyclic rings and carbon 
centres, that  influence steric effects and electrophilic reactivity  of the antibiotic 
scaffold, thereby dictating biological activity (Vaillancourt et al., 2006). Recently 
a novel enzymatic pathway that utilises vanadium-dependant haloperoxidases 
was identified within the biosynthetic gene cluster of a marine Streptomyces 
(Lane and Moore, 2011). Consequently, natural products derived from rare 
marine Actinomycetes display desirable characteristics that may be exploited to 
treat antibiotic resistant pathogens. Screening for such products is therefore a 
priority for antibiotic discovery programs. 
The search for Actinomycete derived natural products has been supported by 
advances in genomics and chemical biology, which have aided the elucidation 
of biosynthesis mechanisms, and subsequently defined  new biodiscovery 
approaches (Kurtboke, 2012). The exploitation of whole Actinomycete genomes 
such as Streptomyces avermitlis (Omura et al., 2001) and use of bioinformatic 
analyses to interrogate sequences, has provided the basis for numerous 
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genome mining strategies (Van Lanen and Shen, 2006; Zerikly and Challis, 
2009). 
One such strategy has been founded on manipulating the synthesis of novel 
secondary metabolites such as polyketides (PK) and non-ribosomal proteins 
(NRP).  It is known that the synthesis of PK and NRP antibiotics proceeds in an 
assembly line sequence, where the construction of unique scaffolds arises from 
the coordinate assembly of monomer units by multi-modular enzymes encoded 
in biosynthetic clusters. The structural organization of the multimodular protein 
domains function as a template to direct the order of monomer units within a 
linear oligomer, while catalytic domains govern the activation and incorporation 
via covalent tethering (Fischbach and Walsh, 2006).  Using experimentally 
derived data, it has been possible to ascribe product structure to subunit 
composition thereby enabling characterization of individual subunits (McDaniel 
et al., 1995). Functional information for individual subunits can be utilized in 
predicting metabolic products, including their putative physiochemical 
properties, as exemplified by the polyene marolactam Salinilactam A from 
Salinispora tropica (Udwary et al., 2007). The re-arrangement of monomer units 
within the assembly sequence can also enable the synthesis of novel metabolic 
products. In one example the loading module of Avermectin polyketide synthase 
was substituted with a cyclohexanecarboxylic loading module, enabling the 
synthesis of the novel analogue doramectin (Wang et al., 2011).  
Alternative genome mining approaches have combined bioinformatics analysis 
with assay guided fractionation in a genomisotopic approach. Analysis of the 
genome of Pseudomonas fluorescens Pf-5 revealed three unknown biosynthetic 
clusters for non-ribosomal peptide synthases, the nucleotide sequence of which 
enabled the prediction of amino acid assembly of the product. By using a 
isotopically labelled amino acid, incorporation into the unknown product could 
be identified by NMR, resulting in the discovery of the novel lipopeptide 
orfamide A (Gross et al., 2007). 
Biosynthetic clusters may also be isolated and expressed in host organisms 
followed by the purification of proteins, which are then incubated with co–factors 
in an in vitro reconstitution approach, as performed with the  biosynthetic cluster 
of lantibiotic haloduracin produced by Bacillus halodurans C-125 (McClerren et 
al., 2006). In cases where biosynthetic gene clusters are not constitutively 
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expressed or dictated by specific environmental conditions, expression may be 
induced by modulating transcriptional regulatory factors. In one example, 
overexpression of the transcriptional activator apdR under an inducible 
promoter in Aspergillus nidulans lead to the identification of aspyridones A and 
B (Bergmann et al., 2007). Alternatively cryptic biosynthetic clusters can be 
cloned and expressed in laboratory and industrial strains of Streptomyces with 
characterized metabolomes (Baltz, 2010).  
 An alternative biodiscovery perspective is to examine microbial communities 
directly within their ecological habitats in order to provide an assessment of 
functional diversity. This has been achieved using metagenomics whereby DNA 
is isolated directly from environmental sources and cloned into a model 
organism such as E.coli. Transformants are  then screened for functional 
activity in  a high-throughput assay, in order to assess metabolic potential 
(Handelsman et al., 1998).  The comparison of metagenomic data from 
microbial communities can not only reveal trends that suggest functional 
diversity, but also reveal spatio-temporal characteristics. Metagenomic data can 
therefore reflect  environmental factors that promote the distribution and 
evolution of antibiotic biosynthetic gene clusters that contribute towards 
speciation and diversification (Kurtboke, 2012). The detection of rare 
Actinomycetes can also be pursued using taxonomical studies to devise 
selective isolation procedures. Refinements of Actinomycetes systematics and 
the development of selective isolation techniques within  culture dependant bio-
prospecting strategies have also been investigated (Goodfellow and Fiedler, 
2010).   
In addition to the identification of new taxa, existing Actinomycetes can be 
evaluated with greater scrutiny to reveal their secondary metabolite producing 
capacity. It has been documented that a discrepancy exists between the 
number of compounds produced and potential synthesis capability of many 
Actinomycetes. An attempt to  explore this facet is  exemplified by the One 
Strain Many Compounds (OSMAC) approach, whereby cultivation conditions 
are systematically modified to influence key steps in biosynthesis and thereby  
generate diverse metabolic profiles (Bode et al., 2002). Successful bio-
discovery requires not only consideration of ecological habitat, selective 
isolation procedures and bacterial systematics for the identification of rare 
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Actinomycetes, but also the  implementation of an appropriate screening 
strategy to assess the bioactivity of secondary metabolites that are synthesized 
(Kurtboke, 2012). 
1.1.6 Antibiotic screening approaches  
A key requirement for an antibacterial screening assay is the capacity to 
discriminate between known antibiotics and novel undiscovered compounds.  
Within the terrestrial biosphere, antibiotic biosynthetic clusters are not 
distributed uniformly.  Random genome sampling has revealed that 1% of 
Actinomycetes present in the soil produce streptomycin compared to 0.1% that 
synthesize tetracycline, with other antibiotics isolated at even lower frequencies 
of 1 x 10-7 (Baltz, 2007). Consequently antibiotics that occur at high frequencies 
are easily isolated, thereby potentially masking the presence of novel antibiotics 
that exist in low abundance. The consistent rediscovery of known compounds 
therefore represents a significant technical challenge to screening approaches 
(Williams, 2009).  
Conventional screening strategies have utilised whole cell screens, cell free or 
modular assays to evaluate inhibitors. Whole cell screening involves seeding a 
target organism onto media to which a natural product extract is added (Figure 
1.2). Antibacterial activity is then assessed by observing zones of inhibition 
(Mills and Dougherty, 2012). Refinements to this assay format have lead to the 
development of  mechanism based screening that targets pathways such as the 
cell wall, using hypersusceptible mutant strains to identify β-lactam antibiotics 
(Gadebusch et al., 1992) and the anucleate blue cell assay to detect Type II 
topoisomerase inhibitors of DNA synthesis (Oyamada et al., 2006).  Cell free 
assays differ in that a single target or multiple targets encoding enzymes 
representing a pathway are reconstituted in vitro; inhibition is monitored directly 
using biochemical assay to examine enzyme kinetics. Modular assays are 
similar to cell free systems except that a target is identified in silico. The target 
sequence is cloned into E.coli or other suitable host organisms, expressed with 
a Histag and purified. The isolated target is then screened against natural 
product extracts, and signs of inhibition are evaluated in a binding assay. 
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Table 1.3. Evaluation of antibiotic screening approaches. 
Assay type Advantages Disadvantages 
Wholecell 
antibacterial 
activity 
Identifies  in vivo antibacterial 
activity 
 
Unable to discriminate between 
secondary mechanisms related to 
cytotoxicity and actual antibacterial 
activity 
 Selects compounds capable of 
transversing the cell wall 
Compounds lacking cell penetration, 
but, which would otherwise inhibit the 
target with suitable modification are 
overlooked 
 Enables multi-protein interactions to 
be studied without the need to 
reconstitute complex cell systems 
Secondary biochemical assay 
required to identify the mode of 
action 
  Low sensitivity compared to cell free 
systems 
Target based cell 
free systems 
High sensitivity Requires prior knowledge of the 
target 
 Validates mode of action in addition 
to identifying target 
Complex reaction or substrates make 
enzymatic tests difficult 
  Constrained to targets with enzymatic 
function 
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Figure 1.2. Whole cell screening approach to antibiotic discovery. 
Using whole cell screening provides a number of advantages over cell free 
systems (Table 1.3) and prior to the development of synthetic libraries has been 
the pre-eminent system for evaluating natural products.  Rational Drug Design 
(RDD) represents a further approach that has benefited from advances in 
biophysical characterization techniques, to enable the derivatization of sufficient 
structural data from molecular targets. This information can then be used for the 
construction of putative inhibitors  (Donadio et al., 2002). 
Considerable effort to overcome the inability of  whole cell assays to delineate 
between cellular targets have been pursued using recombinant organisms as 
the basis for target-based screening strategies, in which the expression or 
activity of a specific cellular target is modulated. For example the Keio 
collection, consisting of approximately 4000 individual essential gene knockouts 
strains of E.coli (Baba et al., 2006), which was subsequently screened to 
identify mutants with increased susceptibilities to antibiotics (Tamae et al., 
2008). 
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An alternate approach has been to delete chromosomal copies of essential 
genes in E.coli, replacing them with plasmids containing a complementary copy 
of the gene, under the control of an inducible promoter, to enable gene 
expression modulation. Using this system it is possible to reduce target protein 
expression in order to generate hypersensitivity to target specific inhibitors. 
Screening strains against cognate inhibitors demonstrates increased 
susceptibility, by decreasing the MIC (DeVito et al., 2002). Conversely strains 
have been engineered to overexpress essential proteins from inducible 
plasmids, thereby rendering strains hyposensitive to target protein inhibitors (Xu 
et al., 2006).  
Of the target based assays developed to date many have used known targets 
for which resistance had already been demonstrated. The discovery of novel 
antibiotics therefore requires the identification and validation of either molecular 
targets or components of cellular pathways possessing unique modes of action, 
not currently subject to resistance mechanisms (Black and Hodgson, 2005). 
Potential targets should be evaluated for their capacity to form multiple 
interactions to reduce the likelihood of generating endogenous resistance 
according to the multi-target hypothesis (Silver, 2007). 
1.2 Searching for new antibiotics 
1.2.1 Identification of novel antibiotic targets 
Despite the conserved range of cellular targets exploited by current antibiotics, 
the number of potential targets may be larger then anticipated, due to the 
multiple co-factors and accessory components that cooperate with essential 
targets within biosynthesis pathways (Donadio et al., 2002). A suitable example 
of this multiple- target approach is the peptidoglycan biosynthesis pathway that 
culminates in assembly of the bacterial cell wall. Numerous cytoplasmic 
intermediates have previously been unavailable due to the inability to 
reconstitute them in vitro. Efforts to synthesise key cytoplasmic precursors such 
as UDPMurNAc-pentapeptide, have aided biochemical characterization of the 
peptidoglycan pathway necessary for the development of assays and screens 
for lipid-linked steps. To date screening  for Lipid I and II intermediates revealed 
that MraT a integral membrane translocase, was found to be the target of 
uridine-based nucleoside antibiotics (Bugg et al., 2011). Additional targets have 
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been identified in other metabolic pathways including Aminoacyl t-RNA 
synthetases, Polypeptide deformylase and fatty acid biosynthesis (McDevitt and 
Rosenberg, 2001), enzymes responsible for NAD(P) biosynthesis (Bi et al., 
2011) and component enzymes of cell division (Lock and Harry, 2008).  
Irrespective of novelty, there is a requirement for candidate targets to fulfil the 
following criteria; (i) they must demonstrate an essential function, (ii) the target 
should be conserved across a range of species for broad-spectrum activity, (iii) 
the target should be specific to bacteria with no human homolog to limit toxicity 
and (iv) the target should exist as a single gene copy to minimise potential 
resistance development. Ideally the target should also  display desirable 
physiochemical properties to enable inclusion into a high-throughput screening 
format (Brown and Warren, 1998).  
In recent years a paradigm shift in the identification of potential antibiotic targets 
has  emerged following advances in genomics and bioinformatics (Bull et al., 
2000), specifically following the advent of high-throughput whole genome 
shotgun sequencing, pioneered with Haemophilus influenzae (Fleischmann et 
al., 1995). The number of bacterial genomes sequenced has since increased 
dramatically  following the development of new sequencing technologies such 
as pyrosequencing, DNA ligase-mediated sequencing, and the Illumina platform 
(McLeod et al., 2012). Accompanying the progress in genome sequencing 
technologies have been parallel developments in bioinformatics. Algorithm 
based programs such as TIGR Assembler, Glimmer and Genemark have 
enabled the assembly of contiguous sequences, identification of open reading 
frames and revealed putative function of genes  on the basis of protein 
structural motif homology or operon structure (McDevitt and Rosenberg, 2001; 
McLeod et al., 2012).  Critically, bioinformatics programs such as BLAST and 
FASTA have permitted the development of comparative genomics in silico, 
enabling the identification of conserved orthologues (homologous genes derived 
from a common ancestral gene) across bacteria species. Following the genome 
comparison of H. influenzae and Mycoplasma genatalium, approximately 256 
genes with purported essential functions common to both organisms were 
identified. From this data was established the concept of the minimal genome, a 
core set of genes required for sustaining cellular existence (Mushegian and 
Koonin, 1996). Subsequent genome  studies have assigned essential functions 
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to 620 genes in E.coli (Gerdes et al., 2003), 478 genes in H.influenzae (Glass et 
al., 2006) 658 genes  in S.aureus (Forsyth et al., 2002) and 271 genes in 
B.subtilis (Kobayashi et al., 2003b). 
Within  core gene sets a number of ubiquitous cell functions have been 
identified consistently, representing elementary cell functions of transcription, 
translation, replication, membrane transport and energy conversion (Koonin, 
2003).  From an antibacterial search and discovery perspective, these genes 
may serve as potential targets since they are  evolutionary conserved among 
closely related bacteria species  (Jordan et al., 2002). Critically, the majority of 
genes identified within minimal gene sets are also proportionally biased towards 
enzymes (Gao and Zhang, 2011), representing ideal targets for potential 
inhibitors, since they possess an active site, which is predisposed towards 
ligand interaction and proves highly amenable for biochemical assays to 
validate target function (Bumann, 2008).  
The pursuit of inhibitors with specific activity for an individual essential gene 
target has been questioned due to the high frequency of spontaneous 
resistance mutation (10-6 – 10-9), that occur in single genes (Silver, 2011).  The 
use of hybrid pharmacophores, combinations of single target inhibitors and 
structure based drug design have been suggested as potential methods for 
minimising resistance in individually encoded targets. However, a more viable 
approach would be to identify a range of essential genes amenable to 
polypharmacology, whereby a single inhibitor has the capacity to engage with 
multiple molecular targets (Brötz-Oesterhelt and Brunner, 2008). According to 
the multi-target hypothesis, endogenous resistance development is minimised 
where antibiotics bind with multiple molecular targets, since mutations would be 
required in each gene encoded target to render an antibiotic completely 
ineffective (Silver and Bostian, 1993). 
Indeed the majority of antibiotics discovered using whole cell screening 
approaches, act on multiple encoded targets or on individual structures 
assembled from the products of multiple genes (Silver, 2007).  The targeting of 
Penicillin Binding Proteins (PBP’s) by β-lactams and topoisomerase GyrA/ParC 
subunits by quinolones represents two such examples. More recently it has 
been suggested that the bacterial proteolytic complex may also prove a suitable 
target (Raju et al., 2012). Consequently new targets have been proposed 
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including the MurA ligases (D and E), involved in the catalysis of peptidoglycan, 
and Lpx acyrltransfereases (A and D), which are involved in lipidA biosynthesis 
(East and Silver, 2013). 
Defining core gene sets however  has proved  problematic, with varying 
estimates that obscure consensus as to the number of essential genes a set 
comprises (Juhas et al., 2011). A phylogentically balanced study that analysed 
147 bacterial and archaea genomes, found the core set to consist of 38 
essential genes  (Charlebois and Doolittle, 2004). More recently a 
comprehensive analysis comparing the genome of M.genitalium to 92 gram 
negative and 93 gram positive bacteria revealed a core set of 151 genes 
(Huang et al., 2012).  The discrepancy in the core set suggests that not all 
essential genes are conserved among species (Koonin, 2003). It has been 
determined that the number of core genes decreases as the number of 
phylogenetically diverse groups used in comparative analysis increases. This 
reflects Non-orthologous gene displacement (NOGD), whereby non-orthologous 
genes replace orthologous counterparts encoding the same essential cellular 
function. Consequently alternative biochemical pathways arise, which provide a 
capacity for metabolic redundancy rendering many gene targets dispensable 
and therefore unsuitable as target candidates for screening (Becker et al., 
2006).  A known example of this phenomenon is the fabI homologue fabK in 
Streptococcus pneumonia, which is not the subject to the same degree of 
inhibition by triclosan (Heath and Rock, 2000).  
Further discrepancies arise depending on the environmental conditions under 
which a minimal gene set is defined (Koonin, 2003). The requirements imposed 
by an organism’s lifestyle and environment conditions may actually abolish the 
function of some essential genes.  Notably the type II fatty acid synthesis 
pathway can be negated by gram positive pathogens capable of utilising C18 
unsaturated fatty acids from human serum (Brinster et al., 2009). Further 
variability among core gene sets arises from the experimental strategy used to 
validate gene essentiality. The majority of techniques used are based upon the 
generation of mutants, grown as clonal populations or as part of mixed 
populations. Clones grown as part of a mixed population are selected against 
by competitive outgrowth, thus demonstrating reduced fitness rather then true 
essentiality which can result in false assignment (Gerdes et al., 2006).  
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Common experimental techniques for determining gene essentiality are 
founded upon random mutagenesis and targeted gene disruption (Miesel et al., 
2003; McLeod et al., 2012). Random mutagenesis strategies include 
Transposon Saturation Mutagenesis and variants such as Genomic Analysis 
and Mapping By In vitro Transposition (GAMBIT) (Akerley et al., 1998), 
Genome scanning (Reich et al., 1999) and Transposon-Mediated Differential 
Hybridisation (TMDH) (Chaudhuri et al., 2009). A common theme to these 
techniques is the use of transposons (mobile genetic elements), which are 
engineered into plasmids containing a conditional replicon and antibiotic 
selection marker. Once introduced into a cell the transposon inserts randomly in 
the chromosome with its location mapped by sequencing. Transposition into an 
essential gene coding sequence disrupts the gene function resulting in cell 
death thereby confirming essential function (McLeod et al., 2012). Targeted 
gene disruption techniques involve plasmid insertion mutagenesis, whereby the 
central sequence of a target gene is cloned into a suicide vector. Integration of 
the vector via a single crossover recombination event involving the target gene 
and homologous sequence on plasmid results in allelic replacement of the 
target gene with a resistance marker (McLeod et al., 2012).  
Mutagenesis based techniques pose the risk of generating polar effects, that 
involve gene disruption arising from non-sense mutations in translation regions, 
reducing the synthesis of distal proteins in operons (Zipser, 1969). The gradient 
of polarity is evident due to the distance between the mutant and distal genes, 
often with strongest effects at the proximal end (Epstein and Beckwith, 1968). 
Integration of external DNA sequences within a single operon gene may disrupt 
the transcription of genes downstream to the insertion event that may also be 
essential, subsequently essentiality may be attributed in error (McLeod et al., 
2012). Characteristic of all techniques is the definition of essentiality through 
abolition of function, whereby all genes that cannot tolerate replacement or 
disruption are deemed essential. Such techniques are incapable of assessing 
the contribution to fitness of individual essential genes, which may be 
conserved due to small advantage presented under some growth conditions. 
This difficulty has been addressed using gene down regulation, whereby an 
inducible promoter is inserted upstream of the target gene. One variant 
technique in particular has proved useful and is founded on natural 
phenomenon of Antisense RNA based regulation.  
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1.2.2 Antisense RNA 
Despite the recognized and accepted concepts of gene organization, It was 
suggested that gene regulation  could be coordinated by  genes that encode a 
transitory intermediate composed of RNA (Jacob and Monod, 1961).  
Regulation via RNA was later confirmed in prokaryotes, following investigation 
into the replication of plasmid colE1(Tomizawa et al., 1981), where it was 
determined that a complementary RNA blocks  primer RNA formation required 
by  DNA polymerase I to initiate synthesis (Eguchi, 1991). Although many 
fundamental principles have been ascertained through the study of bacterial 
plasmids (Simons and Kleckner, 1988), RNA based regulation has also been 
observed in eukaryotes (Almeida and Allshire, 2005) and plants (Baulcombe, 
2004).  
RNA based gene regulation has been associated with heterogeneous RNAs 
that coordinate gene expression through diverse mechanisms and can be 
classified into four broad groups (Waters and Storz, 2009). Riboswitches are 
multidomain RNA’s capable of binding metabolites which initiates a global 
conformational change enabling the riboswitch to bind within the 5’ untranslated 
region (UTR), where it occludes the Shine Dalgarno sequence (Montange and 
Batey, 2008). Protein binding small RNA’s possess innate enzyme activity, or 
antagonize binding (Waters and Storz, 2009). Clustered Regularly Interspaced 
Short Palindromic Repeats (CRISPR) represents the most recent addition to the 
RNA regulatory family and comprises a defensive system against phages 
(Sorek et al., 2008). The most significant group consists of small RNAs encoded 
in cis (or Antisense) and trans form (Waters and Storz, 2009). Trans-encoded 
RNA’s are transcribed at distant genomic locations in relation to  the target 
mRNA they regulate, in contrast to cis-encoded RNA which are transcribed 
parallel to their respective target mRNA on the sense DNA strand and therefore 
share full sequence complementarity  (Thomason and Storz, 2011). 
 Antisense RNA are of particular interest since they represent a subset of small 
RNA entities (sRNA’s) in prokaryotes, responsible for the coordination of gene 
expression through mechanisms that influence transcription and translation.  
Following advances in transcriptome analysis, in particular the use of Deep 
RNA sequencing (RNA-Seq) (Wang et al., 2009) the number of antisense RNA 
transcripts identified has increased.  In E.coli alone over 1000 antisense 
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transcripts have been identified (Dornenburg et al., 2010). From this wealth of 
data has emerged an array of regulatory roles including the inhibition of 
transposition, repression of toxic protein synthesis, regulation of transcription 
factors and metabolic enzymes (Thomason and Storz, 2010). Roles in bacterial 
virulence (Gripenland et al., 2010) and  more recently the restriction 
modification system in prokaryotes have also been observed (Mruk et al., 
2011).  
The regulatory functions performed by (cis-encoded) antisense  RNAs is 
founded  upon complementary hybridization with cognate mRNA sequences at 
the 5’> 3’ end, internally or 3’ and  5’ untranslated regions (UTRs) (Georg and 
Hess, 2011). The capacity for target hybridization is attributed to the 
characteristic secondary structural features of antisense RNA, consisting of a 
ubiquitous YUNR motif (Y= pyrimidine, R=purine). The motif forms a U-turn loop 
which serves as a recognition element and provides a scaffold for facilitating 
helix formation with the target mRNA (Franch et al., 1999). The process of 
sequence hybridization is thought to proceed via two independent binding 
pathways, that are initiated by a recognition event between loop structures on 
both the antisense and target mRNA, before progressing towards the formation 
of duplex RNA (Brantl, 2007). 
A multistep pathway elucidated from the CopT/CopA antisense system of 
plasmid R1 (Kolb et al., 2000), is initiated with the binding of stem loops to  form 
an unstable kissing complex that is extended via a single stranded region to 
form a four-helix junction intermediate. The intermediate is transformed into a 
stable inhibitory complex which converts to a stable RNA duplex. An alternative 
single step binding pathway was reported for the RNA-IN/RNA out antisense 
system responsible for regulating the transposition of transposase IS10 (Kittle et 
al., 1989). In this particular system, an initial interaction occurs between stem 
loop and single stranded target that permits extension via the loop and stem 
domain. Following complete RNA duplex formation between antisense RNA and 
it’s cognate mRNA target, gene expression can be modulated, by altering 
transcript stability and either transcription  or translation efficiency of the target 
mRNA via distinct mechanisms (Figure 1.3. Mechanisms of antisense RNA 
inhibition.) (Georg and Hess, 2011). 
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Figure 1.3. Mechanisms of antisense RNA inhibition. 
The stability and half-life of target mRNA is known to decrease following 
antisense duplex formation through a degradation pathway. In the 
cyanobacterium Synechocystis 6803, the expression of iron stress induced 
protein (Isia) is known to decrease following over expression of its antisense 
counterpart IsrR (Iron stress repressed RNA) (Duhring et al., 2006). Conversely 
stability may also be increased as exemplified with the glutamate decarboxylase 
transcriptional activator/repressor (gadX/gadW) of the E.coli acid response 
system. Glutamate decarboxylase contains an intergenic region between gadX 
and gadW that encodes the antisense RNA GadY, complementarily to the 3’ 
UTR of gadX. Overexpression of GadY increases accumulation of gadX mRNA 
which increases expression of downstream decarboxylases (Opdyke et al., 
2004). 
The alteration in mRNA stability is thought to involve a common degradative 
pathway that regulates mRNA decay. The process is dictated by the structural 
organization of prokaryote mRNA transcripts. Bacterial mRNA’s possess a 5’-
terminal tri-phosphate, while the 3’-terminus typically forms a stem loop 
structure, which is subject to processing events that effect stability and initiate 
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the process of mRNA degradation (Belasco, 2010).  The 3’ terminal can be 
destabilized by polyadenylation by  Poly(A)polymerase  (Dreyfus and Régnier, 
2002),  while RNA pyrophosphohydrolase (RppH) is known to convert  5’ 
triphosphate to 5’ monophosphates (Deana et al., 2008). Both events initiate 
mRNA degradation via two distinct pathways, involving the RNA degradosome, 
a multi-protein assembly responsible for mRNA processing and degradation 
(Carpousis, 2007). The principle component of the degradosome is RNaseE, a 
multi-domain endoribonuclease, which cleaves polyribosomal RNA to 
fragments. The C-terminal of RNaseE serves as  a molecular scaffold for 
assembly of accessory proteins including; Polynucleotide phosphorylase (PNP) 
a endoribonuclease with 3’ activity, RhlB a DEAD-box RNA helicase with 
ATPase dependent activity for unwinding RNA, and enolase, a glycolytic 
enzyme which has a purported role as a metabolite sensor (Carpousis, 2007). 
Degradation may occur via the 5’-dependant pathway, whereby the 5’ single 
stranded regions are subject to hydrolysis of 5’-terminal triphosphate to 5’- 
terminal monophosphate by RppH. The 5’ terminal monophosphate facilitates 
the binding of RNaseE via subdomains, thereby enabling the correct orientation 
for initiating internal cleavage (Bouvier and Carpousis, 2011). Alternatively 
endonucleolytic degradation by RNaseE is initiated by a 5’ independent 
mechanism that generates multiple fragments which are then subject to 
polyadenylation by polyA polymerase. This permits 3’ exonucleases such as 
PNPase, to attempt to remove structural features such as stem loops 
(Carpousis et al., 1999).  
In some cases, antisense RNA exerts its modulatory effects at the level of gene 
transcription. The hybridization between antisense RNA and it’s cognate mRNA 
target can initiate the formation of secondary structure which prevents RNA 
polymerase proceeding, thereby inhibiting transcription. A known example of 
this mechanism has been observed in Vibrio anguillarum, where transcription of 
the Iron uptake biosynthesis operon was due to a 427 nucleotide antisense 
transcript that formed a terminator structure consisting of a stem loop (Stork et 
al., 2007).  
An alternate mechanism of antisense RNA based regulation referred to as 
transcriptional interference has been noted, which arises from the proximity and 
transcriptional direction of promoters. Convergent promoters facilitate the  
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collision of independent RNA polymerases, causing displacement of one 
polymerase and generating  inverse correlations of mRNA and antisense RNA, 
similar to those observed following analysis of the ubiGmccBA operon in 
Clostridium acetobutylicum (Andre et al., 2008). Alternatively the collision event 
may stall elongation or promote backtracking of the polymerase (Crampton et 
al., 2006). If the strength of converging promoters differs, then the weaker 
promoter may be occluded or RNA polymerase and associated transcriptional 
apparatus may be displaced (Sitting Duck interference) (Georg and Hess, 
2011). 
Antisense RNA based regulation also prevails at the post-transcriptional level, 
where the hybridization of antisense RNA and cognate mRNA target, directly 
modulates ribosome binding efficiency. In E.coli mutation of SymR, a cis 
encoded antisense regulator complementally to the promoter sequence  of  the 
SOS-induced antitoxin gene symE, causes a differential increase in protein 
compared to RNA (Kawano et al., 2007). Post-transcriptional control by 
antisense RNA may be influenced by Hfq, an RNA binding protein, with a 
multimeric pore structure known to interact with small RNAs by facilitating base-
pairing between cis-encoded and target mRNA. Roles of Hfq have been 
postulated in translation repression via binding of sRNA’s that sequester the 
RBS, thereby preventing ribosome binding and subsequently inhibit protein 
translation. Conversely antisense RNA binding may also expose translation 
initiation regions and enhance translation. (Vogel and Luisi, 2011). 
1.2.3 Antisense RNA quantitative effects  
The widespread conservation of antisense RNA based regulation among 
species, suggests a significant evolutionary role, which complements existing 
control mechanisms responsible for  regulating both transcription and 
translation (Thomason and Storz, 2010). From a cellular perspective RNA 
based regulation presents an efficient regulatory mechanism, since the energy 
costs associated with transcription are considerably less in comparison to the 
process of protein translation and assembly. In addition, due to speed of 
synthesis and degradation, mRNA expression can be rapidly modulated  unlike 
protein regulation (Gripenland et al., 2010). Indeed, it was shown that the rate of 
synthesis is up to two magnitudes faster for  antisense RNAs compared to 
mRNA (Shimoni et al., 2007). Unlike protein based regulation, antisense RNA 
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has the capacity to minimise temporal fluctuations and filters transient signals in 
gene expression arising from stochastic events in transcription and translation, 
thereby minimising surges in protein abundance (Kaern et al., 2005).  The 
regulatory capacity of antisense RNA provides a highly responsive system, 
capable of adapting to diverse and often sudden stimuli. Consequently 
antisense regulation is often associated with genes that require expedient 
expression in response to environmental changes such as regulators of the 
cellular stress response. Such genes include the outer membrane porin protein 
F (ompF) in E.coli, which is regulated by the antisense RNA MicF. Expression 
of MicF causes a reduction in protein expression, thereby limiting extracellular 
uptake, especially in the presence of antibiotics (Delihas and Forst, 2001).  
Antisense based regulation is also prevalent where the accumulation of toxic 
proteins would be detrimental to cell viability. The hok/sok system for regulating 
plasmid stability by post-segregation killing involves the expression of hok (host 
killing), a membrane associated toxin that causes irreversible damage to cell 
membranes and is regulated via a 64 nucleotide antisense RNA sok 
(suppression of killing).  Inhibition occurs indirectly as sok inhibits translation of 
mok (modulation of killing), which in turn mediates the translation of hok 
(Thisted and Gerdes, 1992). Metabolism represents further cellular activity 
requiring a rapid response to variations in nutrient levels, and is represented by 
such systems such as the lac operon of E.coli which is disordinately regulated 
by a 109 nucleotide antisense RNA Spot 42 (Møller et al., 2002). Virulence is 
also reliant on antisense regulation for the expression of key proteins, when 
particular environmental conditions are encountered. In pathogenesis antisense 
regulation provides the appropriate degree of responsiveness to host immune 
threats as observed in  Salmonella enterica, where  a 1.2kb antisense RNA 
AmgR was found to be complementary to MgtC, which encodes an inner 
membrane protein essential for intracellular survival within macrophages (Lee 
and Groisman, 2010).  
Quantitative studies of antisense RNA regulation have suggested that the 
equilibrium between the transcription of antisense and target mRNA dictates 
gene expression via a threshold linear response (Levine et al., 2007; Levine 
and Hwa, 2008). Through the modulation of gene expression, characteristic 
expression profiles are generated for both mRNA and antisense transcripts that 
infer the regulatory mechanism in addition to advocating the physiological 
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effect. (Lapidot and Pilpel, 2006). The fine modulation and temporal effects of 
antisense RNA based regulation, have been exploited for numerous 
experimental purposes (Rasmussen et al., 2007).  Primarily, antisense RNA has 
been developed for gene silencing techniques and applied to the identification  
of essential genes in both gram positive and negative organisms, such as 
Staphylococcus aureus (Forsyth et al., 2002), and more recently E.coli (Meng et 
al., 2012). Adaption of the same antisense RNA silencing strategy has also 
enabled the delineation of bacteriostatic and bactericidal targets in 
mycobacteria (Kaur et al., 2009). Antibiotic discovery strategies have also 
benefited from the implementation of antisense RNA silencing in whole cell 
target-based assays, to elucidate inhibitor mode of action using a differential 
assay format (Singh et al., 2007). Success with this approach has been 
demonstrated, with the identification of  novel  fatty acid synthesis inhibitors 
platencin and platensimycin (Wenzel et al., 2011) and the novel protein 
synthesis inhibitor peptidyltransferase (Bandow et al., 2003). 
More recently antisense RNA silencing has been used to evaluate the individual 
contributions of essential genes in maintaining cell viability. Using a combination 
of insertion mutagenesis and DNA microarrays revealed that the fitness 
contribution of essential genes under specified growth conditions varies 
significantly (Badarinarayana et al., 2001). Further efforts have attempted to 
quantitate essential gene requirement for cell viability termed stringency, by 
examining mRNA transcript abundance. In a novel study the titration of E.coli 
growth rates using antisense RNA silencing of essential gene targets fabI, 
murA, acpP and ftsZ, established a differential transcript requirement for each 
gene to maintain cell growth. By defining the minimum transcript level required 
to maintain 50% cell viability, a hierarchy in stringency was revealed in the order 
of acpP > ftsZ > fabI > murA   (Goh et al., 2009). This concept was supported 
by a recent study that examined cell tolerance to degradation of essential 
protein and it’s subsequent effect on cell growth in  determining cell vulnerability 
(Wei et al., 2011). 
The concept of quantifying essential gene stringency represents a significant 
asset to antibiotic discovery strategies; as it would permit the prioritization of 
essential gene targets for inclusion into screening assays. However, despite the 
apparent relationship between mRNA reduction and decline in cell growth, 
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mRNA abundance provides only a surrogate for expressed protein. Functional 
protein epitomizes the culmination of gene expression, and is viewed as 
accurate reflection of the physiological state of a bacterial cell. Current 
estimates of essential gene stringency based upon mRNA abundance may 
therefore be inaccurate, since the correlation between mRNA and protein 
expression is often non-linear (Lee et al, 2003). Even across different species, 
steady state protein abundance displays a higher correlation then 
corresponding mRNA abundances (Laurent et al., 2010) 
 The lack of concurrence between mRNA and protein expression is attributed to 
regulatory mechanisms that operate during transcription and translation (Vogel 
and Marcotte, 2012). The efficient transcription of mRNA is dependant upon the 
complementarity of its Shine Dalgarno sequence, which dictates ribosome 
binding efficiency and therefore translation. The complex secondary structure of 
RNA represents a further influence since it can either expose or sequester the 
ribosome binding site under different environmental conditions. At the 
translational level small antisense RNA affects post-transcription levels via 
translation inhibition, interference, or degradation of mRNA transcripts, while 
ribosome density affects translation efficiency. Ensuing translation, protein half 
life is influenced by factors such as intrinsic stability, rates of degradation, 
modification by phosphorylation and cell localization (Maier et al., 2009).  
Consequently the evaluation of essential gene stringency may be reflected by 
measuring protein abundance. Protein quantification has previously been 
performed using western blotting, whereby proteins are transferred from SDS-
PAGE gel to an absorbent membrane (e.g.: nitrocellulose) and probed with an 
antibody specific for the protein under investigation. Quantification is achieved 
by chemiluminescence using  a secondary antibody conjugated to an enzyme, 
that catalyses the breakdown of a substrate to a coloured product (Kurien and 
Scofield, 2006). However western blotting lacks quantitative capacity and is 
incapable of distinguishing between post-translational modifications. Critically 
only those proteins targeted are subject to analysis, at the exclusion of the 
global proteome (Mann, 2008). To perform accurate quantification at the protein 
level requires the use of sensitive techniques such as liquid chromatography 
tandem mass spectrometry (LC-MS/MS).  
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1.3 The use of mass spectrometry in antibiotic discovery 
1.3.1 Tandem mass spectrometry 
Technological advances in LC-MS/MS have permitted global proteomic 
analyses, enabling  the systematic identification of primary sequences, 
structural characterization of post-translational modifications, elucidation of 
protein-protein interactions and quantification of expressed proteins in complex 
matrices (Aebersold and Mann, 2003).  
The Proteomics based LC-MS/MS process, initiates with the pre-separation of 
individual proteins from a whole cell lysate using either 1D or 2D gel 
electrophoresis, with the aim of removing low molecular weight contaminants 
capable of interfering with mass analysis. The protein bands of interest are 
exercised from polyacrylamide gels and subject to destaining and in-gel 
digestion. During this process samples are reduced  to covert disulphide bonds 
to free sulfhydryl groups which are then alkylated to a S-carboxymethyl 
derivative, to facilitate disruption of three-dimensional structure and expose 
cleavage sites for heterophase enzymatic digestion (Shevchenko et al., 2006). 
The protease trypsin is frequently utilized, since it predicatively cleaves C-
terminal residues at arginine and lysine, generating an appropriate mass range 
of peptides required for fragmentation during LC-MS/MS (Olsen et al., 2004). 
According to peptide fragmentation models, the N-terminus is protonated, but 
the charge is capable of migrating along the backbone by internal solvation, 
becoming randomly localized on amide bonds.  Cleavage along the peptide 
backbone results in cleavage at either the alkyl carbonyl bond (CHR-CO), 
peptide amide bond (CO-NH) or amino alkyl bond (NH-CHR). Following 
fragmentation, the charge can be retained at either the N terminus producing 
a,b,c ions or at the C terminus producing x y z ions. The peptides generated by 
trypsin are typically doubly charged structurally informative y ions, providing a 
high degree of predictability with respect to their fragmentation patterns (Covey 
et al., 1991). 
Digested peptides are eluted from the polyacrylamide matrix in solvent and 
subject to further separation using High Performance Liquid Chromatography 
(HPLC) to minimise sample complexity. By reducing complexity the dynamic 
range can be increased to permit low abundance peptides to be detected in the 
31 
presence of peptides of higher abundance, thereby increasing the confidence of 
protein identification. Typically a Reversed Phase (RP-HPLC) format is 
employed, involving the differential separation of peptides between a stationary 
(nonpolar matrix) and mobile phase (polar solvent) according to the degree of 
hydrophobic interaction. During this stage hydrophobic peptides interact with 
the stationary phase, while hydrophilic peptides are eluted earlier in the mobile 
phase (Dass, 2007). 
Eluted peptides are then introduced into an ion source and converted to 
charged species by introduction or removal of an electron using electrospray 
ionization, whereby ions are desorbed under a high electric field  (Fenn et al., 
1989). During this process the sample flows through a capillary with high 
potential that generates an electrostatic charge that dispenses solution into 
charged droplets for transportation, via a pressure gradient to a mass analyser 
(Dass, 2007). The mass analyser of choice is often  the orbitrap mass 
spectrometer, which has provided an unprecedented level of sensitivity required 
for high resolution tandem mass spectrometry techniques (Makarov and 
Scigelova, 2010). Using this form of mass analyser provides the high mass 
resolution, accuracy (2-5 ppm), mass charge ratio and dynamic range (103) 
required for protein characterization and quantification. The orbitrap operates on 
the principle of dynamic ion trapping in electrostatic fields (Makarov, 2000) and  
constitutes a central spindle electrode encased by a coaxial outer electrode. 
Following electrospray ionization, ions are transported through a series of 
quadropoles that guide, transport and store ions prior to delivery via an optical 
deflection lens system into the orbitrap. The ions become trapped about the 
central spindle and undergo harmonic ion oscillations, the frequency of which 
provides the basis for mass charge values (Hu et al., 2005). The mass charge 
values of the ions generate a peptide mass fingerprint, which can then be 
compared to an in silico generated mass within a protein sequence database. 
The database is constructed from theoretical spectra, derived from peptide 
fragmentation models. Comparisons between the experimental and theoretical 
spectra is scored to assess the probability of a match and validated using 
algorithm based descriptive, interpretative, stochastic probability or statistical 
and probability models (Sadygov et al., 2004). 
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1.3.2 Proteomic strategies 
The characterization of  functional differences between biological systems 
requires comprehensive proteome coverage, if system-wide variations are to be 
identified and quantified accurately (Cox and Mann, 2007). To date partial 
proteome  coverage has been achieved for 60% of open reading frames in the 
minimal genome bacteria Mycoplasma pneumonia (Kühner et al., 2009), which 
is marginally higher then that of multicellular organisms such as Caenorhabditis 
elegans (54%) (Schrimpf et al., 2009) and Arabidopsis thaliana 50% 
(Baerenfaller et al., 2008). The challenges in obtaining complete proteome 
coverage can be attributed to a number of technical and biological factors (Beck 
et al., 2011). The amenability of proteins to solubilisation and digestion dictates 
whether appropriate tryptic peptides and by extension, characteristic ion spectra 
can be generated. In the event of obtaining quality spectra, identification of 
proteins by matching the MS dataset to known sequences is dependant on the 
quality of annotated open reading frames held within genome databases. 
Inaccuracies may arise due to experimental conditions which may unknowingly 
influence transcription and translation parameters, thereby altering protein 
abundance. Furthermore, sequence coverage is subject to a sufficient fraction 
of peptides being detected, each of which may vary in terms of ionization and 
fragmentation properties. The number of peptides arising from enzymatic 
digestion may also be limited by the size of the protein, with smaller proteins 
generating fewer unique peptides capable of unambiguously identifying the 
protein under investigation (Beck et al., 2011).  In order to provide 
consequential data, experimental workflows must be consistently reproducible 
and accurate for reliable quantification across multiple samples. To this end 
shotgun (discovery), directed and targeted MS-based strategies that differ in 
terms of how prior information is utilised and analysed, have  been introduced 
(Domon and Aebersold, 2010). 
The shotgun approach utilizes ionized peptides arising from electrospray 
ionization (precursor ions) to generate an initial mass spectrum known as a 
survey scan. Data-dependant analysis (DDA) using heuristics is used to 
perform product ion scanning, whereby precursor ion signal intensity is used to 
determine m/z ratio and subsequent peptide mass. A suitable precursor ion is 
then selected for fragmentation by Collision Activated Dissociation (CAD), that 
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generates fragments via collision with inert atoms (Hunt et al., 1986). The 
resulting fragment-ion masses form the product-ion spectra are used for protein 
identification, while the precursor ion signal intensity is used as the basis for 
quantification. Since no prior protein knowledge is required, the shotgun 
approach is suited to open discovery. The method however suffers from bias 
towards the selection of precursor ions, which represent the most abundant 
proteins present in a complex sample.  Furthermore different samples of 
peptide ions in each experiment arise from the heuristics used. A variation to 
this approach is a directed proteomics strategy which entails two independent 
LC-MS analyses. An initial LC-MS/MS run generates survey scans to identify 
precursor ions relating to a peptides of interest, and records their mass 
spectrum characteristics (elution time, m/z ratio, charge), which are formed into 
a master inclusion list as part of the data dependant analysis. The LC-MS/MS is 
repeated in product ion mode using the inclusion list to limit CAD to specific 
fragments identified in the survey scan. Further improvements can be obtained 
by adopting a targeted proteomics strategy, which requires the use of triple 
quadruple instruments operating in Selective Reaction Monitoring (SRM) mode. 
Unlike previous strategies target proteins are preselected and their precursor 
ion m/z, retention time and unique fragment ions formed by CAD are defined to 
form a selected reaction monitoring (SRM) transition, which functions as assay 
parameters for the protein of interest (Picotti and Aebersold, 2012). Ultimately 
the aim of each strategy is achieve consistent detection of individual or subsets 
of protein.  
1.3.3 Mass spectrometry quantification strategies 
The accurate differential (relative) or quantitative analysis of protein is 
paramount and requires the implementation of suitable methods that compare 
individual peptides between experiments. Quantitation is not integral to the 
mass spectrometric process, since instrument response is dependant upon the 
physiochemical properties of proteolytic peptides, which are often influenced by 
matrix effects (Patterson and Aebersold, 2003). A range of techniques have 
been introduced based on the isotope dilution principle, in which isotope 
labelled peptides serve as proxies for their native equivalents. Since isotope 
labelled peptides possess the same physiochemical properties as native 
peptides, they generate the same chromatographic and mass spectrometric 
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profiles. However due to the difference in mass, a differentiation between 
experimental samples can be made. 
Differential (Relative) quantification aims to examine fold changes in protein 
expression between experimental conditions and can be determined using label 
free methods (Spectral counts and MS ion intensity) and stable isotope labelling 
techniques. Spectral counting is founded on an observed linear relationship 
between protein abundance and the number of precursor ions selected for 
MS/MS fragmentation (Liu et al., 2004). The generation of   MS/MS spectra 
associated with a particular peptide can therefore be counted and compared 
relative to the spectral counts of the same peptide under different experimental 
conditions, enabling relative quantification. Variations to this approach have 
lead to the estimation of protein expression using the Protein Abundance Index 
(PAI), derived from the ratio of sequenced peptides and total number of 
predicted tryptic peptides of a protein (Rappsilber et al., 2002) and absolute 
Protein Expression profiling (APEX) (Lu et al., 2007) . 
Alternatively the peak area or ion intensity of all identifiable tryptic peptides 
including their associated parameters of elution time and m/z ratio can be 
integrated over a time chromatographic scale. The subsequent data generates 
an extracted ion chromatogram (XIC) profile that is subsequently normalized to 
the peak area of an internal protein standard (Bondarenko et al., 2002). 
Although both techniques provide cost-effective approaches to compare 
changes in protein expression for multiple experiments, across higher dynamic 
range, accuracy is unreliable. Systematic and non systematic variations relating 
to ionization efficiency, sample preparation and instrumental drift are emulated 
in data, requiring normalization to correct for variation. Furthermore, the linearity 
of response for each protein is problematic due to variations in saturation 
effects for individual proteins (Bantscheff et al., 2007; Xie et al., 2011).  
Stable isotope labelling provides an alternative to label free methods, by 
providing greater accuracy for relative quantification. Conceptually, the 
approach involves the incorporation of low abundance heavy isotopes (13C, 15N 
18O) into proteins and peptides, where they function as a label. Differences in 
ion signal intensities for heavy and light forms of the peptide are therefore taken 
to reflect quantitative changes in protein abundance (Becker, 2008). Heavy 
isotopes may be incorporated into proteins metabolically during growth on 
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labelled media, exemplified using the Stable Isotope Labelling with Amino acids 
in Cell culture (SILAC) approach, where culture media deficient in essential 
amino acids is supplemented with isotope labelled equivalents (Ong et al., 
2002). 
A variation of this approach is to introduce heavy isotopes of 18O directly into 
peptides via the C-terminal of proteins following protease digestion.  
Alternatively isotope containing tags may be introduced via chemical 
modification of specific amino acid residues.  This approach is utilised by 
Isotope-coded Affinity tags (ICAT), which react with sulfhydral groups of 
cysteine residues (Gygi et al., 1999); isobaric Tags for Relative and Absolute 
Quantification (iTRAQ) which link a carbonyl and reporter group (Wiese et al., 
2007) and Tandem Mass tags (TMT), which react with amine groups 
(Thompson et al., 2003).  
Despite providing adequate means to examine changes in protein expression, 
precise determination of actual protein molecules is not possible without 
reference to a standard of pre-determined quantity.  The requirement for 
accurate quantification of protein per se, has been met by the development of 
the Absolute Quantification strategy (AQUA) (Kirkpatrick et al., 2005). In this 
approach, the target protein under investigation is initially analysed by LC-
MS/MS to identify a suitable unique tryptic peptide representative of the target 
protein, for use as an internal standard (Figure 1.4). The standard is 
synthesised with an appropriate heavy label and evaluated using LC-MS/MS to 
determine parameters of retention time and product ion intensities. A quantified 
amount of standard is then introduced to the sample during tryptic digestion and 
analysed by LC-MS/MS. Quantification is performed by integrating peaks for 
light and heavy ions corresponding to the sample and standard respectively and 
analysing the ratio of the peak area, which over a linear range enables 
extrapolation of the sample concentration. Using this strategy has enabled the 
quantification of low abundance yeast proteins including phosphorylated forms 
(Gerber et al., 2003). 
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Figure 1.4. Overview of the LC-MS/MS based quantification. 
The use of isotope labelled peptides as internal standards has been developed 
further to enable multiplex protein quantification, using artificially constructed 
proteins known as quantification concatamers (QconCAT), which can contain 
multiple proteolytic peptides of the target protein (Brun et al., 2007) . A further 
augmentation has been the development of Protein Standard Absolute 
Quantification (PSAQ), which utilises a full length isotope labelled protein 
equivalent to the target protein under investigation. (Brun et al., 2009). 
1.4 Gene silencing using synthetic antisense structures 
Antisense based silencing has not been constrained exclusively to sequences 
derived biologically. Attempts to create synthetic compounds capable of binding 
DNA and RNA in a sequence specific manner have culminated in the 
development of numerous nucleic acid analogues. Initial efforts comprised 
dideoxynucleotide bases interconnected by various chemical linkers such as 
phosphotriester, methylphosphonate, phosphororthiolate, and carbamate 
(Summerton and Weller, 1997). Subsequent improvements in target specificity 
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and biostability were achieved through the structural alterations of 
dideoxynuculeotides to generate non-ionic backbones.  The derivatization of 
morpholine subunits from ribonucloesides, formed the basis for 
phosphorodiamidate morpholino oligonucleotides (PMO’s), with significantly 
improved properties for biological applications (Stirchak et al., 1989). Alternate 
substitutes for nucleobases precipitated in the synthesis of Peptide Nucleic 
Acids (PNA) (Nielsen et al., 1991). Structurally, PNA’s are comprised of 
noncyclic peptides (polyamides of N-2-aminorthyl glycine linked via carbonyl 
linkers to nucleobases), in substitution of the sugar phosphate backbone 
(Lundin et al., 2006). This arrangement creates structural flexibility with a 
neutral charge that negates electrostatic repulsion, thereby increasing 
hybridization efficiency and sequencing specificity with nucleic acid counterparts 
(Good and Nielsen, 1997). The high affinity, discriminatory capacity and 
biostabiliy of  PNAs, has made them pre-eminent for antisense applications 
where short sequences are encountered (Summerton, 2006).  
Recognition between PNA and complementary sequences elicits the formation 
of duplex structures via Watson-Crick hydrogen bonding, when the PNA is 
composed of purine /pyrimidine nucleobases. If the PNA composition 
exclusively incorporates homopyrimidines, then triplex structures are assembled 
via Watson-Crick and Hoogsteen hydrogen bonds (Larsen et al., 1999). To 
date, complexes representing triplex, triplex Invasion, duplex and double duplex 
invasion are been observed (Nielsen, 2010). The formation of these alternate 
complexes, contributes to variant silencing mechanisms. Triplex forming PNA’s 
significantly  distort RNA structure that precipitates steric hindrance, causing 
inhibition of both translation initiation and  ribosome elongation, contrary to 
duplex structures which prevent translation initiation (Knudsen and Nielsen, 
1996) and possibly ribosome read-through (Kulyté et al., 2005). In contrast to 
expressed antisense, translation inhibition of mRNA appears to be the primary 
silencing mechanism, since PNA complexes show a significant degree of 
biostability towards RNaseH (Knudsen and Nielsen, 1996), thereby preventing 
RNase mediated mRNA degradation. 
The biological stability PNA’s have exhibited in bacterial extracts (Demidov et 
al., 1994), and in addition to their hybridization properties, PNA’s makes them a 
novel research tool for synthetic RNA silencing applications in bacteria (Good 
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and Stach, 2011).  Central to this development have been efforts to address 
bacterial entry and accumulation of PNAs to an effective intracellular 
concentration. These factors are critical since growth inhibition is attributed to 
PNA accumulation and slow efflux resulting in potent antibactericidal activity 
(Nikravesh et al., 2007).  
The primary obstacle opposing cellular entry is the bacterial membrane, which 
in gram negative bacteria comprises a cell wall consisting of an outer 
membrane, a thin peptidoglycan layer, a layer of periplasm, and a  plasma 
membrane (Beveridge, 1999). The outer membrane consists of 
lipopolysaccharide (LPS), which provides an effective barrier due to its rigid lipid 
interior and strong interaction between the peptidoglycan layers. The cellular 
accumulation of PNA is opposed by transmembrane porins within the outer 
membrane, which possess the capacity to remove certain peptides (Nikaido, 
2003). However in a recent study, one such membrane transport protein Smba 
was speculated to be involved in actively transporting peptide PNA conjugates 
into cells (Ghosal et al., 2013). 
The significance of cellular entry and accumulation was previously evaluated by 
exposing E.coli strains A19 and D22 deficient in cell walls and specific 
membrane pumps AcrAB and Emr to a PNA targeting the lac repressor to 
enable a correlation between susceptibility and β-galactosidase activity 
following permeabilisation. Although the absence of membrane pumps showed 
little effect on activity, the lack of LPS was found to be a significant factor in 
increasing β-galactosidase activity, suggesting increased membrane 
permeabilisation promotes greater susceptibility (Good et al., 2000a).  
Consequently numerous strategies have been deployed to improve delivery of 
PNA’s across the membrane. Initial attempts utilized microinjection, 
electroporation or co-transfection with cationic lipids (Koppelhus and Nielsen, 
2003). A pioneering approach has been to conjugate  PNA’s to a synthetic cell 
wall permeabilising peptide KFFKFFKFFK possessing cationic, hydrophobic 
and amphiphilic properties (Good et al., 2001b). The presence of a peptide 
promotes uptake across the membrane by receptor independent mechanism, 
through interaction with complementarity groups in the LPS (Vaara and Porro, 
1996). Divalent cation binding sites of the LPS in particular, may have a role in 
compromising membrane integrity through the formation of transient rents that 
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enable PNA entry (Hancock, 1997). The effectiveness of this strategy was 
demonstrated by conjugating permeabilising peptide to a PNA targeting the 
essential gene acpP in E.coli, resulting in growth inhibition (Good et al., 2001b). 
Further evidence was obtained using chromogenic reporter systems to monitor 
permeabilisation of both the outer and inner membrane, which showed an 
increase in flourescence in the presence of PNA peptide conjugates compared 
to free PNA (Eriksson et al., 2002). Although the majority of studies examining 
PNA-conjugates have utilised to gram negative bacteria, their effectiveness has 
also been established in gram positive species such as  S.aureus, where the 
targeting of essential genes also  causes growth inhibition (Nekhotiaeva et al., 
2004). 
Due to the specificity and bactericidal activity displayed in vitro and in vivo, 
there has been intense interest into developing PNA’s into species specific 
antimicrobials, that avoid compromising natural microbiota defences (Good and 
Stach, 2011). Alternative PNA based approaches have focused on re-
introducing antibiotic susceptibility using PNA’s to target resistance 
mechanisms. One study demonstrated that PNA targeting of the multidrug efflux 
transport in CmeABC in Campylobacter jejuni, was found to increase sensitivity 
to ciprofloxacin and erythromycin (Jeon and Zhang, 2009a). Addition roles for 
PNA’s have also been explored including targeted gene repair, whereby PNAs 
are constructed with a corrected sequence of a mutated gene. The formation of 
triplex PNA structure with the target gene sequence perturbs the regular helical 
structure, initiating DNA repair mechanisms that result in homologous 
recombination. Subsequently the repaired sequence is exchanged with the 
mutated gene (Vasquez et al., 2001). A viable demonstration of this potential 
was shown by single base pair modification of β-globin intron using 
pseudocomplementary PNAs (Lonkar et al., 2009). Further roles for PNA’s have 
been demonstrated such as artificial restriction DNA cutters that enable high 
fidelity site selective scission of DNA (Miyajima et al., 2009), probes for 
microarrays (Brandt and Hoheisel, 2004), and investigation of microbial 
communities (Hatamoto et al., 2010). 
  
40 
1.5 Project outline 
The central aim of this project is to investigate the application of antisense 
silencing in two distinct roles. Firstly, as a technique for determining the 
stringency of essential genes in E.coli and how stringency differs between 
individually transcribed and operon based genes.  Secondly as a species 
specific silencer, by evaluating the capacity of synthetic antisense sequences to 
discriminate between essential gene homologues and thereby enable selective 
growth inhibition of a specific organism. 
Expressed antisense RNA silencing using inducible paired termini vectors, has 
been employed to determine essential gene stringency, as defined by a 
Minimum Transcript Level (MTL50) (Goh et al., 2009). Determinations of 
essential gene stringency have been limited to individually transcribed genes 
(Goh et al., 2009), which are not subject to the complex regulation associated 
with operon based genes (Ames and Martin, 1964). This raises the question of 
whether the MTL50 is applicable to operon based genes. Furthermore, 
stringency is based upon the relationship between growth rate decline and 
mRNA abundance, which is assumed as a proxy for expressed protein. 
However post-transcriptional and translation regulation mechanisms, account 
for uncorrelated abundancies between mRNA and protein (Maier et al., 2009). 
Consequently measurements of mRNA abundance may be unsuitable for 
determining essential gene stringency requirements. Determinations of gene 
stringency would therefore have more relevancy if the relationship between 
growth rate decline and protein abundance was examined. From this a 
Minimum Protein Level (MPL50) could be derived to replace MTL50, as a more 
accurate measure of gene stringency. A method capable of accurately 
quantifying expressed protein following gene silencing is therefore essential.  
Historically, protein quantification has been performed using biochemical 
assays (Sapan et al., 1999), immunoassays and more recently protein 
microarrays (MacBeath, 2002). However such techniques lack sensitivity and 
are subject to cross reactivity, which complicates quantification (Patterson and 
Aebersold, 2003). Recent developments in the quantitative capacity of LC-
MS/MS provide a number of advantages over such methods. LC-MS/MS 
provides a greater sensitivity over a large dynamic range, enabling low 
abundance proteins to be detected. This is crucial for antisense silencing 
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experiments, where target protein may be depleted to unpredictable levels. 
Crucially, LC-MS/MS permits the identification of individual proteins from 
complex matrices, such as whole cell lysate. If required parallel identification 
and quantification of more then one protein can also be accomplished, which 
supports the evaluation of operon based genes, where the monitoring of more 
then one protein may be required. Furthermore LC-MS/MS possess the 
capacity to discriminate between proteins subject to subtle post-translation 
modifications that can be used to estimate rates of degradation and synthesis. 
(Bantscheff et al., 2007; Bronsema et al., 2012). The viability of determining 
protein abundance has been demonstrated with LC-MS/MS using label free 
methods a modified protein abundance index method (Ishihama et al., 2005), 
revealing proteins to exist over a dynamic range from 100 to 105  copies per cell 
(Ishihama et al., 2008).  
In this study, an absolute quantification strategy using LC-MS/MS that 
incorporates the use of a stable isotope (15N) labelled protein internal standard 
for absolute quantification, will be used to examine protein expression in E.coli 
subject to antisense silencing. Although LC-MS/MS strategies that use protein 
internal references for absolute quantification are not widely employed, they 
have nonetheless been demonstrated in bacteria such as Leptospira 
interrogans (Malmström et al., 2009).  
The essential E.coli genes fabI and murA have been selected as candidate 
targets for developing protein internal standards, since both genes are 
individually transcribed and have been previously evaluated with regards to 
gene stringency. Furthermore, both genes have well characterised functions 
and are subject to inhibition by antibiotics with known modes of action. In E.coli 
fabI encodes the enzyme enoyl-acyl carrier protein reductase, which functions 
as part of the dissociated (type II) fatty acid synthase system, that regulates 
membrane lipid synthesis (Magnuson et al., 1993). The broad spectrum biocide 
triclosan (trichloro derivitive of 2-hydroxy-phenyl ether) specifically targets FabI 
in E.coli, in addition to gram positive bacteria, fungi and mycobacteria (Saleh et 
al., 2011). Triclosan inhibits lipid synthesis, through direct targeting of fabI as 
demonstrated in mutants, which show an approximate 300-fold increase in 
resistance (McMurry et al., 1998). The established mode of action arises from 
irreversible binding of triclosan to the enoyl substrate site, leading to an 
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increase in affinity for NAD+ (Heath et al., 1999).  Triclosan binds non-
covalently via face to face stacking of the phenol ring and nicotinamide rings 
hydrogen bonding. Consequently a stable ternary complex is formed that is 
incapable of catalysis between phenolic hydroxyl and hydrolysis of 2’ 
nicotinamide robose, causing enzyme inhibition. The binding efficiency of 
triclosan is enhanced by its ability to induce a closed conformation of a flexible 
loop structure located above the enoyl active site (Qiu et al., 1999).  
The essential gene murA encodes enolpyruvyl transferase, which catalyses’ the 
transfer of an enolpyruvate moiety from phosphoenolpyruvate (PEP) to uridine 
diphosphate. This represents the initiating step in the synthesis of alternating N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) glycan units 
that comprise peptidoglycan, of the bacterial cell wall (Lovering et al., 2012). 
The antibiotic fosfomycin ((1R,2S)-1,2-epoxypropylphosphonic acid) Inhibits 
MurA through the formation of covalent interactions between a thiol group of 
cytesine115 residue within the active site of the enzyme, which prevents a 
conformational change in the enzyme required for the   dissociation of the 
product UDP-N-glucosamine (UNAG) (Eschenburg et al., 2005). 
Once validated, LC-MS/MS will be applied to investigating gene stringency in 
operon based genes in E.coli by examining fusA and rplE. The essential genes 
fusA which is encoded  in the str operon (Dean et al., 1981b)  and rplE encoded 
in the spc operon (Cerretti et al., 1983). The essential gene fusA encodes 
elongation factor G (EF-G), a translational GTPase that binds to the ribosome 
complex and induces a conformational change involving hydrolysis of GTP,  
which initiates translocation of tRNA and mRNA (Rodnina et al., 1997). A 
functional role has also been determined in ribosome recycling, where EF-G in 
conjunction with the essential protein Ribosome Recycling Factor (RRF) 
induces dissociation of the 70S ribosome into it’s component subunits in 
preparation for next round of protein synthesis (Hirokawa et al., 2005). In E.coli 
rplE encodes the 5S rRNA ribosome accessory protein L5, which has been 
demonstrated to be essential for cell survival (Korepanov et al., 2007). The L5 
protein is one of 21 accessory proteins that in conjunction with 16S rRNA 
constitute the small ribosome subunit (30S), that interacts with tRNA and mRNA 
(Steitz, 2008) The exact role of rplE was unknown until recently, when it was 
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revealed that the L5 protein forms a prominent part of the central protuberance 
(CP) of the large ribosomal subunit (Korepanov et al., 2012).    
In addition to quantifying expressed protein for the purposes of measuring gene 
stringency, the use of LC-MS/MS can also be applied to support the 
development of an antisense RNA based screening assay for detecting novel 
target specific inhibitors. To date antisense based target assays have 
demonstrated potential, with the discovery of novel antibiotics such as 
platensimycin a FabF inhibitor (Wang et al, 2006), platencin a FabH /F inhibitor 
(Wang et al, 2007) and Phaeosphenone, which targets the encoded product of 
rpsD (Zhang et al, 2008). By sensitizing E.coli to target specific inhibitors and 
then measuring expressed protein abundance at particular MIC’s, would enable 
suitable levels of IPTG induction required for antisense silencing to be defined. 
Consequently assay sensitivity could be optimised for screening target specific 
compounds that are synthesized in low abundance. 
Furthermore the knowledge of the expressed protein abundance following 
antibiotic exposure could be used generate  a characteristic proteomic signature 
(Brotz-Oesterhelt et al., 2005). This data can then be used to identify candidate 
cell targets for antibiotic screening and infer potential modes of action. In 
addition, characterisation of proteomic signatures provides a basis for 
constructing reference compendia for the purposes of identifying novel 
antimicrobial compounds (Freiberg et al., 2004). Using candidate targets fabI 
and murA, this study intends to use a validated LC-MS/MS approach to 
measure protein abundance in E.coli at different inhibitory concentrations of 
triclosan and phosphomycin, which aims to provide sufficient data for a 
mathematical model for estimating assay sensitivity 
An alternate to using  expressed antisense RNA from plasmids, for the purpose 
of evaluating essential gene stringency or fine tuning the sensitivity of 
screening, are peptide PNA’s. The capacity of peptide PNA conjugates to 
induce gene silencing, has been evaluated against expressed antisense 
RNAand found to be highly comparable (Goh et al., 2009). In addition, the 
inherent stability of PNA’s in vivo, has facilitated their development as species-
specific antimicrobials in an effort to address antibiotic resistance (Good and 
Stach, 2011). Indeed bactericidal activity has previously been demonstrated 
against individual gene targets in E.coli (Good et al., 2001b). To date however 
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no effort has been made to ascertain if PNA’s can be designed to differentiate 
between a genes in separate bacterial species. This study intend to evaluate 
species-specificity, by designing a PNA that targets an essential gene 
homologue (ftsZ) in Salmonella typhimurium, when grown in a mixed microbial 
culture with E.coli. 
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1.6 Specific aims and objectives 
1. Identify essential genes for silencing using bioinformatics strategy. 
2. Construct antisense RNA expressing strains for E.coli essential genes 
fusA and rplE. 
3. Validate target specificity of antisense RNA constructs by constructing 
over expression vectors to be used in a transcomplementation strategy. 
4. Delineate whether bactericidal or bacteriostatic inhibition occurs following 
silencing of essential genes fusA and rplE using viable counts. 
5. Design and validate a QPCR assay for the relative quantification of 
mRNA abundance, of fusA, rplE, fabI and murA.  
6. Determine essential gene stringency of fusA and rplE, using expressed 
antisense RNA silencing to achieve a titration of growth rate in E.coli, 
and measure associated mRNA abundance. From this data MTL50 values 
for fusA and rplE will be derived. 
7. Synthesise heavy labelled protein standards for fabI and murA and 
evaluate suitable tryptic peptides for identification and quantification of 
respective proteins 
8. Quantitate heavy labelled standards using a standard curve constructed 
from commercial prequantified peptide using LC-MS/MS. 
9. Determine gene stringency of fabI, using expressed antisense RNA 
silencing to achieve a titration of growth rate E.coli. Protein abundance 
will be measured using LC-MS/MS and FabI molecules per cell will be 
calculated to derive a MPL50 value for measuring gene stringency.  
10. Assess discriminatory capacity of species-specific PNA in mixed 
bacterial culture. 
1.7 Thesis Outline 
Chapter 1. Introduction 
This Introduction describes the significant features of antibiotics and the 
challenges posed by multidrug resistance. New strategies for antibiotic 
discovery are outlined, with particular reference to the use of antisense RNA 
and quantitative LC-MS/MS. An argument is presented for the assessment of 
essential gene stringency based upon expressed protein. 
Chapter 2.  Methods and Materials 
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The materials and methods details the construction of antisense RNA and 
transcomplementation expression vectors, in addition to an LC-MS/MS 
quantitative assay, using a 15N labelled internal protein standard, for the 
evaluation of essential gene stringency.  In addition a method used to assess 
the species specificity of a PNA in a mixed culture of S.typhimurium and E.coli 
is also described. 
Chapter 3. Results 
The experimental findings regarding target specificity of antisense RNA 
expression constructs, their validation by transcomplementation, and 
characterization of inhibitory action of essential gene targets is presented. 
Analysis of essential gene stringency using mRNA abundance of candidate 
genes is given.  This chapter also reports the validation of a quantitative LC-
MS/MS assay for measuring protein molecules per cell following expressed 
antisense silencing, and subsequent deriving of the MPL50 value as a measure 
of essential gene stringency. The analysis of species-specific PNA effects on 
bacteria in a mixed culture is also presented.  
Chapter 4. Discussion 
An evaluation of the experimental findings obtained in this study is made. 
Explanations to account for the observed data including anomalies are 
proposed, with support from appropriate literature.  
Chapter 5. Conclusions and Future Work 
This chapter draws on the discussion to frame the findings of the study in the 
wider context of antibiotic discovery, in addition to extending the scope of the 
research to support applications in other fields of biological enquiry. 
Recommendations to address the limitations highlighted during the course of 
this study are made. 
Appendix 
Additional experimental detail is presented where appropriate. 
References 
Literature used to provide a theoretical background is presented. 
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Chapter 2 Methods & Materials 
2.1 Selection of essential gene targets for silencing  
A hierarchy of gene stringency (Jem .Stach, personal communication) was 
generated by obtaining transcript abundance, presence in an operon and 
number of protein-protein interactions for the essential protein. Transcript 
abundance for E. coli K12 genes was averaged from microarray experiments 
conducted in LB media at 370C (RNA extracted at mid-exponential phase, n = 
50 (Glasner et al., 2003). Presence of the gene in an operon, and location 
within the operon was obtained from the RegulonDB database (Gama-Castro et 
al., 2008), and the number of protein interactions was taken from the 
experimental dataset of the Bacteriome.org database (Su et al., 2008). For each 
category, the essential gene was ranked, in the case of location within an 
operon; weighting was assigned prior to ranking, such that genes that were 
present at the start of large operons, containing other essential genes 
downstream, were scored highly. Weightings of 20:4:2 were applied for the 
number of essential genes downstream, the number of genes in the operon, 
and the number of genes downstream, respectively. The weighted score for 
each gene was calculated as sum product of these categories, multiplied by the 
sum of the weights for each category. The weights were arbitrarily assigned 
considering the mechanism of antisense gene silencing i.e. silencing of the first 
gene in an operon is more likely to affect genes downstream. The estimated 
transcript number and number of protein interactions, were given simple rank 
scores (higher numbers in each giving a higher rank scores).Finally, for each 
essential gene an overall rank score was applied by weighting (6:6:3) for 
transcript copy number, number of interactors and presence in an operon, 
respectively. The final weightings were arbitrarily applied considering that genes 
with high transcriptional abundance, producing products which are highly 
interactive, are more likely to be stringently required. Weighting were also 
applied such that the final rankings for genes acpP, fabI, ftsZ and murA were 
consistent with previous reported MTL50 values (Goh et al., 2009). The genes 
rplE and fusA were chosen for further study, as they were predicted to be 
stringently required (ranked 1 and 8, respectively) and were also present in 
operons. This latter fact was considered important for assessing the utility of the 
MTL50 score for genes present in operons, where downstream affects will likely 
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result from antisense RNA silencing. Nucleotide sequences complementary to 
the ribosome binding region of mRNA transcribed for fusA (-93 +86) and rplE (-
95 +60 ) were identified and cloned into plasmid pHN678, which contains 
flanking inverted repeats that form secondary structure in the form of dsRNA 
termini. The termini increase the stability of antisense transcripts thereby 
improving silencing efficiency (Nakashima et al., 2006). To validate the 
specificity of silencing constructs, transcomplementation plasmids expressing 
the entire ORF of fusA and rplE were also constructed using pBAD (Guzman et 
al., 1995)). For the purposes of comparison, an evaluation was made against 
antisense RNA expression vectors and associated transcomplementation 
vectors for essential gene targets acpP, ftsZ, fabI, and murA  (kindly supplied by 
Shan Goh, Royal Veterinary College, U.K).  
2.1.1 Bacterial growth conditions and strains 
Bacterial growth was performed in liquid and on solid media using Muller Hinton 
Broth (MHB) (Melford) for both E.coli and S.typhimurium. Growth conditions 
were 37C, with aeration at 200-250 rpm for broth cultures. Where maintenance 
of plasmids was required, media was supplemented with antibiotics (Melford) at 
a final concentration of 30g/ml chloramphenicol, 100g/ml ampicillin, 50g/ml 
kanamycin. Detailed recipes or growth media and buffer solutions can be found 
in Appendix: A. All strains used in this study are listed in Table 2.1. 
2.1.2 Bacterial genomic DNA and plasmid extraction 
Both antisense and complete ORF sequences for fusA, rplE, fabI and murA 
were amplified from genomic DNA, which was isolated from E.coli-K12 using 
the GenElute Bacterial Genomic DNA kit (Sigma). Briefly 1.5 ml of overnight 
bacterial culture was harvested by centrifugation at 16,000 x g for 2 minutes. 
The supernatant was removed and pelleted cells were resuspended in 180 µl 
Lysis Solution T with 20 µl of RNase A and incubated for 2 minutes at room 
temperature. After incubation, 20 µl of proteinase K solution was added and 
samples were incubated for 30 minutes at 55°C. A volume of 200 µl of Lysis 
Solution C was added to samples which were then incubated at 55°C for a 
further 10 minutes. GenElute Miniprep Binding columns were prepared by 
addition of 500 µl of Column Preparation solution. Columns were centrifuged at   
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12,000 x g for 1 minute and the flow through was discarded. Prior to loading, 
200 µl of ethanol (95-100%) was added to lysate and vortexed, before loading 
onto columns and centrifuged at   6,500 x g for 1 minute. The spin column was 
placed in a fresh collection tube and 500 µl of Wash Solution I was added, 
samples were then centrifuged at   16,000 x g for 3 minutes. The spin column 
was placed in a fresh collection tube and a further 500 µl of Wash Solution I 
was added, samples were centrifuged at   6,500 x g for 1 minute. The column 
was placed in a fresh collection tube and centrifuged at   16,000 x g for 1 
minute. DNA was eluted by addition of 200 µl of Elute Solution followed by an 
incubation of 5 minutes at room temperature and centrifugation at   16,000 x g 
for 1 minute. Genomic DNA was quantified in triplicate using a NanoDrop 
(Thermo Scientific). 
Plasmid DNA was extracted using the QIAprep® Spin kit (Qiagen).  Briefly 5 ml 
of overnight bacterial culture was pelleted by centrifugation at 2000 x g for 5 
minutes. Pelleted cells were resuspended in 250 µl Buffer P1 containing RNase 
A, to which 250 µl of Buffer P2 was added and the sample mixed by inversion. 
Buffer N3 (350 µl) was added and samples were centrifuged at 17,900 x g for 
10 minutes. The supernatant was added to a QIAprep spin column and 
centrifuged at 17,900 x g for 1 minute. The flow through was discarded and 500 
µl of Buffer PB was then added to the spin column. Samples were centrifuged at 
17,900 x g for 1 minute, and the flow through was discarded. A second wash 
using 750 µl of Buffer PE was added to the spin column, prior to centrifugation 
at 17,900 x g for 1 minute. The wash through was removed and the sample was 
centrifuged at 17,900 x g for 1 minute. Plasmid DNA was eluted addition of 30 
µl of Buffer EB directly to the centre of the spin column, which was incubated at 
room temperature for 1 minute, prior to centrifugation at 17,900 x g for 1 minute. 
Plasmid DNA was quantified in triplicate using a NanoDrop (Thermo 
Scientific). 
2.1.3 Primer preparation and annealing temperature optimization 
To ensure optimal amplification of antisense and ORF sequences, a primer 
validation study was performed. Lyophilized Primers (Sigma/Eurogentec) (Table 
2.4 and Table 2.5), were re-dissolved to a concentration of 100 M, and then 
diluted to a working concentration of 10 M in molecular grade water (Melford). 
Initial gradient Polymerase Chain Reaction (PCR) was performed by preparing 
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a 25l reaction, consisting of 2 x PCR master Mix (0.05 units/l Taq DNA 
polymerase, 4 mM MgCl2, 0.4 mM each of dATP, dCTP, dGTP, dTTP) 
(Fermentas), diluted with molecular grade water to a final concentration of 1 x 
and mixed with forward and reverse primers at a final concentration of 0.2 M. 
A total amount of 100ng of template DNA was added. The thermal Gradient was 
devised by using a range of 3C either side of the average calculated primer 
pair Tm. The PCR thermal profile was as follows: denaturing 95C for 2 minutes, 
30 cycles of denaturing at 95C for 30 seconds, annealing temperature for 30 
seconds, extension at 72C for 2 minutes and a final extension of 72C for 5 
minutes. All gradient PCR were performed on a DYAD™ DNA Engine (MJ 
Research). Optimal primer annealing temperatures were evaluated by visual 
inspection of amplified product using gel electrophoresis (see methods section: 
2.1.4). 
2.1.4 Agarose gel electrophoresis 
Analysis of PCR products was performed by agarose gel electrophoresis to 
ensure correct size of amplified products and ascertain the optimal primer 
annealing temperature. Agarose gels were prepared by dissolving an 
appropriate amount of agarose (Invitrogen) to achieve a final concentration of 
0.5-2% as required for optimal resolution of DNA fragments, in 10 x Tris-borate-
EDTA buffer (1.3 M TRIS, 450 mM boric acid, 25 mM EDTA.Na2 in H2O) 
(Sigma), diluted to 1 x concentrate. Agarose gels were stained with ethidium 
bromide (Sigma) at a final concentration of 0.5µg/ml. Gels were ran at 8v/cm for 
1 hour and photographed using a Uvitec gel doc systems with Essential v12.6 
imaging software  (UVITECH). Samples were prepared by mixing 5-10 µl of 
DNA with 6 x loading dye (Fermentas) to achieve 1 x final concentration. For 
size estimation 5 µl of 100Kb ladder and Hind III digest (Fermentas) were used 
as required. 
2.1.5 Cloning of antisense and ORF sequences into pHN678 and pBAD 
plasmids 
Antisense sequences for essential genes, fusA and rplE and the ORF of target 
genes fabI, murA, fusA and rplE were amplified from E.coli K12 genomic DNA, 
using sequence specific primers (Table 2.4), Antisense sequences were 
designed with restriction sites for XhoI and NcoI, to permit placement of PCR 
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insert in reverse orientation in the multiple cloning site (MCS) of pHN678, in 
order to generate antisense transcript. Transcomplementation vectors were 
designed with restriction sites for XhoI and EcoRI (fabI, murA, rplE) and XhoI 
and SacI (fusA). PCR amplification of target sequences was performed using 
Phusion High fidelity DNA polymerase (New England Biolabs). A 50µl PCR 
reaction was prepared with final concentrations of 1 x reaction buffer, 0.2 µM 
primers with exception of fabI (1 µM), 200 µM dNTP, 0.02 units and 4 µl cDNA 
template.  Thermal cycling was performed on 9700 geneamp thermal cycler 
(Applied Biosystems) using the following conditions: 98C 30 seconds, 98C for 
10 seconds, optimized annealing temperature for 15 seconds, 72C 15 
seconds, and final extension of 72C for 1 minute. Subsequent products were 
purified using QIAquick PCR purification kit (Qiagen) and quantified using a 
NanoDrop Spectrophotometer and associated software ND1000 v3.2.1 
(Thermo Scientific). Confirmation of PCR products was performed by agarose 
gel electrophoresis (see methods section: 2.1.4). 
2.1.6 Restriction digest of PCR inserts and plasmids 
To prepare PCR inserts for cloning into their respective vectors, double 
restriction digests were performed using XhoI and NcoI for antisense 
sequences fusA and rplE. Amplicons of complete ORF sequences were double 
digested with XhoI and EcoRI (fabI, murA, rplE) and XhoI and SacI (fusA) in 
addition to pBAD. Restriction digests were performed according to 
manufacturers’ instructions (Fermentas) and consisted of 10 x Tango buffer 
(330 mM Tris-acetate, 100 mM Mg-Acetate, 660 mM K-acetate, 1 mg/ml bovine 
serum albumin (BSA)) diluted to a final 2 x concentration. For double digests, 
10 units of appropriate restriction enzyme (Fermentas) was added per 1µg of 
DNA, molecular grade water was then added to bring the final reaction volume 
up to 40 l. Samples were incubated at 37C for 2 hours followed by a thermal 
inactivation of restriction enzymes by incubating  at 80C for 20 minutes. 
Digested products were purified using QIAquick PCR purification kit (Qiagen) 
and quantified in triplicate using a NanoDrop (Thermo Scientific). 
2.1.7 Ligation of PCR inserts into plasmids 
Digested antisense and ORF sequences were ligated into pHN678, and pBAD 
respectively. Sticky-end ligation was performed using 100 ng of linear vector 
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DNA according to manufacturers’ instructions. The molar ratio of insert DNA 
was calculated using the Ligations: Molar ratio of insert to vector calculator 
(Promega).   Vector and insert DNA were mixed in a ratio of 1:3 with 10 x T4 
DNA ligase buffer (Fermentas) (400 mM Tris-HCl, 100 mM MgCl2, 100 mM 
DTT, 5 mM ATP), which was diluted to 1 x concentration. For each reaction, 5 
units of T4 DNA ligase (Fermentas), was added. Molecular grade water was 
then added to bring final reaction volume to in a 20 l. Samples were incubated 
for 10 minutes at 22C followed by thermal inactivation of T4 ligase by 
incubating at 65C for 10 minutes. Confirmation of ligation insertion was 
performed by restriction digestion and agarose gel electrophoresis (see 
methods section: 2.1.4). 
2.1.8 Transformation of antisense and transcomplementation plasmids 
into E.coli 
Ligated plasmids containing pHN678 or pBAD with antisense sequences or 
complete ORF sequences respectively were introduced into E.coli by chemical 
transformation. For each plasmid, 5 µl of ligated product was added to one vial 
of One Shot TOP10 Chemically competent E.coli (Invitrogen). The competent 
cells were then incubated on ice for 30 minutes, prior to heat shocking for 30 
seconds at 42C without shaking. Competent cells were then left on ice to 
recover for 2 minutes. A total volume of 250 µl of pre-warmed SOC medium 
(see Appendix: A) was added to each vial, which were subsequently incubated 
at 37C for 1 hour with aeration. A suitable volume of transformants (100 µl) 
was pipetted onto pre-warmed LB agar containing an appropriate antibiotic and 
incubated at 37C overnight. Transformants carrying the correct plasmid with 
insert were screened using colony PCR with plasmid specific primers for 
pHN678 and pBAD respectively (Table 2.4). 
2.2 Evaluation of antisense specificity of fusA and rplE constructs 
To examine the specificity of antisense RNA constructs, antisense growth 
assays were prepared according to the procedure used in a previous evaluation 
of essential gene targets (Goh et al., 2009). A series of IPTG (Melford) 
concentrations were prepared to induce antisense RNA expression from 
pHN678 vectors, to generate a titration in E.coli growth rate. IPTG 
concentrations were prepared in molecular grade water at 10 x concentration, 
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20 l of which was pipetted in triplicate into a 96 well micro plate (Sarstedt). 
Overnight cultures of E.coli were standardized by OD550 readings to 2 x 10
4 
cfu/ml, using a LibraS12 Spectrophotometer (Biochrom). Standardized culture 
volumes of 180 l were added to respective wells, to bring the final assay 
volume to 200 l. The 96 well microplate was incubated in a Powerwave HT 
plate reader (Biotek Instruments Inc) at 37C with agitation every 5 seconds and 
readings at 550nm taken every 5 minutes for a period of 24 hours. Bacterial 
growth curves were plotted using Gen5 software v1.04.5 (BioTek). Raw 
absorbance data corresponding to the exponential phase of E.coli growth was 
exported to Excel (Microsoft). A trendline was applied and the gradient of the 
growth curve recorded. Relative growth rate was derived by normalizing the 
trendline gradient of induced cells to the trendline gradient of uninduced 
controls. 
2.3 Validation of antisense specificity by transcomplementation 
To validate the target specificity of antisense constructs, rescue assays were 
performed by transforming both antisense and corresponding 
transcomplementation vectors into E.coli TOP10. A matrix of IPTG and L-
arabinose induction concentrations were assessed to determine the level of 
induction required to demonstrate the rescue of bacterial growth rate, in 
accordance with a previous study (Goh et al., 2009). A dilution series of IPTG 
and L-arabinose (Melford) were prepared at 20 x concentration, 10 l of each 
substrate was added to respective wells, prior to the addition of 180 l 
standardised culture in MH media supplemented with 30g/ml chloramphenicol 
and 100 g/ml ampicillin.  Bacterial growth curves were plotted using Gen5 
software v1.04.5 (BioTek). Raw absorbance data corresponding to the 
exponential phase of E.coli growth was exported to Excel (Microsoft). A 
trendline was applied and the gradient of the growth curve recorded. Relative 
growth rate was derived by normalizing the trendline gradient of induced cells to 
the trendline gradient of uninduced controls. 
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2.4 Delineation of the inhibitory effects of silencing essential gene 
targets fusA and rplE 
To examine the inhibitory effects of antisense RNA silencing on growth, viable 
cell counts were performed in the presence of 50 M IPTG, which was double 
the concentration used to silence growth in the examination of specificity. As 
per the procedure for antisense and rescue assays, overnight bacterial cultures 
were standardized by OD550 readings to 2 x 10
4 cfu/ml. A 50 ml volume of MH 
broth containing chloramphenicol (30g/ml) was inoculated and then incubated 
at 37C with aeration. Sample volumes of 100 l were removed every hour over 
a period of 8 hours, serially diluted (10-5 and 10-6), plated onto MH agar (in 
triplicate) and incubated 37C overnight. A viable colony count was then 
performed on plates containing between 30 and 300 colonies. 
 
2.5 Evaluation of essential gene stringency by quantitative 
assessment of mRNA transcripts 
To maintain consistency with a previous assessment of essential gene 
stringency (Goh et al., 2009), QPCR was used to provide relative quantification 
of mRNA abundance in E.coli, following silencing of essential gene targets fusA 
and rplE. Normalisation was performed relative to two reference genes; 16S 
rRNA which forms part of the 30S subunit (Shajani et al., 2011) and zipA which 
encodes an inner membrane protein involved in the formation of septal ring 
structure during cell division (Hale and De Boer, 1997). Both genes had 
previously been selected following microarray analysis of the E.coli 
transcriptome (Shan Goh personal communication).  
2.5.1  Isolation and clean-up of total RNA 
E.coli was induced with IPTG and harvested once the OD550 of the control 
(uninduced) culture reached 0.1, as it had previously been determined that 
optimal correlation between mRNA abundance and relative growth rate 
occurred at this point in the growth curve (Goh et al., 2009). Total RNA was 
extracted from E.coli using PureLink™ RNA Mini Kit including on-column 
DNAse treatment (Life Technologies), in accordance with manufacturer’s 
protocol for isolating bacterial cell RNA. Briefly, bacterial cells were harvested at 
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500 x g for 5 minutes and resuspended in 100µl of lysozyme solution (Sigma) 
containing 10 mM Tris-HCl (pH 8.0), 0.1 mM EDTA, 1 mg lysozyme from 
chicken egg white. In addition 0.5 µl of 10% SDS and 350 µl of lysis buffer 
containing 1% 2-mercaptoethanol was also added. Samples were homogenized 
by repeated expulsion through a 21 gauge needle. Cell lysate was centrifuged 
at 12,000 x g for 2 minutes to remove cellular debris, prior to addition of 250 µl 
100% ethanol to precipitate RNA. Samples were vortexed and transferred to a 
spin column with collection tube and centrifuged at 12,000 x g for 15 seconds. 
The spin column containing bound RNA was placed in a fresh collection tube to 
eliminate carryover and DNase treatment was performed. The spin column was 
washed with 350 µl of Wash buffer I and centrifuged at 12,000 x g for 15 
seconds, prior to the  addition of 80 µl of DNAse solution, containing 1 x DNase 
I reaction buffer and resuspended DNase I (~3 U/µl). Samples were incubated 
at room temperature for 15 minutes prior to the addition of 350 µl Wash buffer I 
and centrifugation at 12,000 x g for 15 seconds. The spin column was placed in 
a fresh collection tube and 500 µl of Wash buffer II was added. Samples were 
centrifuged at 12,000 x g for 15 seconds and the spin column was removed and 
placed in a fresh collection tube. Samples were centrifuged at 12,000 x g for 1 
minute and the spin column was transferred to a clean 1.5ml microcentrifuge 
tube. To elute the RNA, 30 µl of RNase/DNase free water was added to the 
center of the column, which was then incubated at room temperature for 1 
minute prior to centrifugation at 12,000 x g for 2 minutes. Additional RNA 
purification was performed using TRI reagent (Molecular Research Centre, 
INC). Briefly 1 ml of TRI reagent was added to the eluted RNA samples and left 
at room temperature for 5 minutes. Following dissociation of nucleoprotein 
complexes, 0.1 ml of 1-bromo-3-chloropropane (BCP) (Sigma) was added, 
samples were mixed and stored at room temperature for 15 minutes. Samples 
were centrifuged at 12,000 x g for 15 minutes at 4C. The aqueous phase 
containing RNA was removed and precipitated with 0.5 ml of isopropanol at 
room temperature for 10 minutes before being centrifuged at 12,000 x g for 8 
minutes at 4 C. RNA was washed with 1 ml of 75% ethanol and centrifuged at 
12,000 x g for 5 minutes at 4C. The RNA pellet was air-dried for 5 minutes 
prior to solubilisation in 50 µl RNase-free water. 
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2.5.2 cDNA synthesis of extracted RNA 
The conversion of RNA template to cDNA was performed using the RevertAid™ 
First Strand cDNA Synthesis Kit (Fermentas). A 20µl  reaction was prepared 
consisting of 5 x reaction buffer (250 mM Tris-HCl (pH 8.3), 250 mM KCl, 20 
mM MgCl2, 50 mM DTT), diluted to 1 x concentration. In addition, 20 units 
Ribolock RNase inhibitor, 1 mM dNTP mix, 5 µM random hexamer and 200 
units of M-MuLV Reverse Transcriptase were added. RNA template was 
standardized to 100 ng for each reaction. Reactions were prepared in two 
steps; initially molecular grade water, random hexamers and RNA template 
were heated to 65C for 5 minutes to remove secondary structure, prior to 
addition of the remaining reaction components. cDNA synthesis was performed 
by incubating samples at 25C for 5 minutes, 42 C for 1 hour, then 70C for 5 
minutes to terminate reverse transcriptase activity. Genomic DNA 
contamination was assessed using reverse transcriptase negative and blank 
reactions. 
2.5.3 Relative quantification of mRNA transcripts by QPCR 
QPCR assay validation was performed according to established guidelines 
(Nolan et al., 2006). Briefly primer matrices consisting of concentrations 0.1 – 
0.3 M for all primers with exception of fabI (1-2 M) were prepared and 
analysed in duplicate. Optimal primer concentrations for forward and reverse 
primers were selected according to the primer pair displaying the lowest CT 
(Cycle threshold) value, which signifies the number of cycles required for the 
fluorescent signal to exceed background level. Reaction efficiency was 
assessed using duplicate reactions of six fold serial dilutions of target amplicon, 
with efficiency calculated from standard curve slopes according to the equation 
E = 10[-1/slope] -1 x 100. Samples were prepared in final volumes of 25 l 
consisting of 2 x Maxima SYBR Green qPCR Master Mix (Fermentas) diluted 
to 1 x concentration and 2 l of cDNA synthesis reaction or 5 l positive control 
DNA. Analysis was performed on a Chromo 4 (DYAD) using Opticon Monitor v 
3.1.32 (Biorad). Relative quantification was performed using the DDCt method 
(Livak and Schmittgen, 2001). 
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Table 2.1 Strains used in this study 
Strain Genotype Function Source 
E.coli TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 
nupG recA1 araD139 Δ(ara-leu)7697 galE15 galK16 
rpsL(StrR) endA1 λ- 
Host Strain for plasmids Invitrogen 
E.coli As-fabI As TOP10, pHN682 Expression of antisense fabI RNA (Nakashima et al., 2006) 
E.coli As-acpP As TOP10, pHN682 Expression of antisense acpP RNA (Goh et al., 2009) 
E.coli As-murA As TOP10, pHN682 Expression of antisense murA RNA (Goh et al., 2009) 
E.coli As-ftsZ As TOP10, pHN682 Expression of antisense ftsZ  RNA (Goh et al., 2009) 
E.coli Ash01 As TOP10, pHN678-rplE Expression of antisense rplE RNA This study 
E.coli Ash02 As TOP10, pHN678-fusA Expression of antisense fusA RNA This study 
E.coli Ash03 As TOP10, pBAD-rplE Overexpression of rplE This study 
E.coli Ash04 As TOP10, pBAD-fusA Overexpression of fusA This study 
E.coli Ash05 As TOP10, pHN678-rplE, pBAD-rplE Transcomplementation rescue of rplE 
antisense 
This study 
E.coli Ash06 As TOP10, pHN678-fusA,  pBAD-fusA Transcomplementation rescue of fusA 
antisense 
This study 
E.coli Ash07 As TOP10, pHN678, pBAD-HisA Transcomplementation  control This study 
E.coli AG1 
ME5305 
recA1 endA1  gyrA96  thi-1  hsdR17(rk- 
mk+)   supE44   relA1 
Overexpression of FabI in minimal media National Bioresource Project 
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Table 2.2 Paired termini antisense expression plasmids used in this study. 
Plasmid Characteristic Features Location and length Source 
pHN678 IPTG-inducible 
promoter (Ptrc) with 
paired termini (PT 
flanking MCS CamR 
E.coli stabilized antisense 
expression vector 
N/a (Nakashima et al., 2006) 
pHN682 fabI antisense insert Inducible expression of fabI 
antisense RNA 
-74 to +68 of fabI (160 nucleotides) (Nakashima et al., 2006) 
pHNA acpP antisense insert Inducible expression of acpP 
antisense RNA 
-42 to +85 of acpP (127 nucleotides) (Goh et al., 2009) 
pHNM murA antisense insert Inducible expression of murA 
antisense RNA 
-54 to +78 of fabI (130 nucleotides) (Goh et al., 2009) 
pHNZ ftsZ antisense insert Inducible expression of ftsZ 
antisense RNA 
-53 to +76 of fabI (129 nucleotides) (Goh et al., 2009) 
pHN678-rplE rplE antisense insert Inducible expression of rplE 
antisense RNA 
-95 +60  of rplE  (155 nucleotides) This study 
pHN678-fusA fusA antisense insert Inducible expression of fusA 
antisense RNA 
-93 +86 of fusA  (179  nucleotides) This study 
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Table 2.3 Over expression vectors used in this study 
Plasmid Characteristic Features Location and length Source 
pBAD-HisA L-arabinose inducible 
promoter (Pbad) 
Inducible expression of 
essential genes 
N/a Invitrogen 
pBAD-HisA-rplE Complete ORF rplE Inducible expression of rplE N/a This study 
pBAD-HisA-fusA Complete ORF fusA Inducible expression of fusA N/a This study 
pGlo Complete ORF Green 
Fluorescent Protein 
(GFP) 
Inducible expression of GFP N/a Biorad 
pDs-Red 
Express 
Complete ORF Red 
Fluorescent Protein 
(RFP) 
Inducible expression of RFP N/a Clontech 
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Table 2.4 PCR primers used in this study 
Primer 
Name 
Target Amplified Sequence Amplicon 
size 
(Bp) 
Purpose 
fusA-XF1 Antisense of fusA CGTCCATGGGTCGATGTGCGCACTGATA 179 Cloning of fusA antisense into 
pHN678, resulting in pHN678-fusA 
fusA-XR2 TGTCTCGAGCCCTTCGGAGTTTTAGTCACC 
rplE-XF5 Antisense of rplE CGTCCATGGGGGACTTGCATGACAGAATTG 155 Cloning of rplE  antisense into 
pHN678, resulting in pHN678-rplE 
rplE-XR5 TGTCTCGAGGGCTGACCGTGTAGGCTTTA 
fabIf fabI ATCCTCGAGATGGGTTTTCTTTCCGGT 827 Cloning of fabI ORF into pBAD, 
resulting in pBAD-fabI 
fabIr ATCGAATTCCGATTATTTCAGTTCGAGTTCGT 
murA-OF-
His 
murA GAGCTCGAGATGGATAAATTTCGTGTTCAGGGGC 1282 Cloning of murA ORF into pBAD, 
resulting in pBAD-murA 
murA-OR-
His 
CCGGAATTCACGATTATTCGCCTTTCACACG 
fusAf fusA ATCCTCGAGATGGCTCGTACAACACCC 2135 Cloning of fusA ORF into pBAD, 
resulting in pBAD-fusA 
fusAr ATCGGTACCGCTTATTTACCACGGGCTT 
rplEf rplE ATCCTCGAGATGGCGAAACTGCATGATTAC 564 Cloning of rplE  ORF into pBAD, 
resulting in pBAD-rplE 
rplEr ATCGAATTCCCTACCTTACTTGCGGAACG 
pHN678 
forward 
pHN678 Multiple 
cloning site 
CTGCAGGTCGTAAATCACTGCA N/a Screening for antisense inserts 
pHN678 
forward 
CTTCTCTCATCCGCCAAAACTAG N/a 
pBAD 
forward 
pBAD multiple cloning 
site 
ATGGCTAGCAAAGGAGAAGAAC N/a Screening for ORF inserts 
pBAD 
Reverse 
TAGAGCTCATCCATGCCATGTG N/a 
61 
Table 2.5 QPCR primers used in this study 
Primer Name Target 
Amplified 
Sequence Amplicon 
size 
(Bp) 
Purpose 
fabI QPCR Forward fabI CTGACCCTTTCCTACCTTG 66 fabI target 
fabI QPCR Reverse TTTTGCCAGACCCATAAC  
murA QPCR Forward murA CACTACCTGCGCGTTGTACGA 64 murA target 
murA QPCR Reverse TGTTCGAGGCCAGAAATGTG  
fusA QPCR Forward fusA ACCTGGGTGGTGAAGAACTG 105 fusA target 
fusA QPCR Reverse TCTTGAACGCAGAACCACAG  
rplE QPCR Forward rplE AAAACCGCTGATCACCAAAG 111 rplE target 
rplE QPCR Reverse AAGAACTCCCACATGCGTTC  
16S QPCR Ref Forward 16S AGGCCTTCGGGTTGTAAAGT 97 Reference gene 
16S QPCR Ref Reverse GTTAGCCGGTGCTTCTTCTG  
ZipA QPCR Ref Forward ZipA ATAAACCGAAGCGCAAAGAA 102 Reference gene 
ZipA QPCR Ref Reverse CCGCTTGTTGAATGCTGTTA  
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2.6 Evaluation of essential gene stringency by protein quantification 
To address the limitation of using mRNA abundance as a proxy for protein 
expression in determining essential gene stringency, a method for absolute 
quantification of expressed protein was developed. Central to this approach is 
the use of an LC-MS/MS assay incorporating a pre-quantified heavy labelled 
(15N) protein as an internal standard for the quantification of expressed protein 
following expressed antisense RNA silencing of essential gene targets.  
2.6.1 Development of a 15N labelled protein internal standard  
To validate the LC-MS/MS approach, the E.coli essential genes fabI and murA 
were selected as targets, since both have previously been evaluated for 
essential gene stringency. To enable complete labelling of the target protein, a 
metabolic labelling strategy was implemented. E.coli expressing pBAD-fabI and 
pBAD-murA were grown in liquid M9 minimal media supplemented with 15N 
ammonium chloride (Cambridge Isotope Laboratories Inc) as the sole nitrogen 
source (see Appendix: A). Due to difficulties in cultivating these particular 
strains of E.coli with ampicillin as a selection agent, an alternative strain was 
sought. E.coli clones overexpressing His-tagged FabI and MurA from the ASKA 
collection (A Complete Set of E.coli K-12 ORF Archive), were obtained from the 
National Bioresource Project-E.coli, (National Institute of Genetics, Japan).  
Suitable growth was achieved in M9 minimal media supplemented with 
chloramphenicol using both these strains. Bacterial cultures were grown to an 
OD550 of 0.5, prior to the induction of protein expression by the addition of IPTG 
to a final concentration of 1 mM. Bacterial cultures were then grown for 
approximately 12 hours prior to harvesting. 
2.6.2 Extraction of 15N labelled protein internal standard from E.coli Lysate 
using IMAC  
Following protein expression in minimal media, His-tagged FabI and MurA were 
extracted from E.coli using Immobilised Metal Affinity Chromatography (IMAC), 
in conjunction with a nickel column (Invitrogen). All reagents used in the 
preparation of IMAC buffers were sourced from Sigma. Approximately 250 ml of 
bacterial culture was centrifuged in a sorvall RC5C Refrigerated Superspeed 
Centrifuge (Dupont) at 10,000 x g for 10 minutes. To each pellet 10 ml of Lysis 
buffer (20 mM Tris-Cl pH 7.6, 1 M NaCl, 0.1 mM PMSF, 20 mM Imidazole, 2% 
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Triton-X-100, 150 mg lysozyme) was added. The sample was then sonicated for 
5 minutes at amplitude of 10 microns using a Soniprep 150 (MSE (UK) Ltd). 
Lysed samples were centrifuged at 20,000 x g for 10 minutes to remove cellular 
debris prior to the  lysate being loaded onto a Nickel column (GE Healthcare 
Life sciences) coupled with AKta Prime (GE Healthcare Life sciences). Bound 
protein was washed and removed from the column using an elution buffer (20 
mM Tris-Cl pH 7.6, 1 M NaCl, 0.1 mM PMSF, 300 mM Imidazole, 2% Triton-X-
100). Binding and elution of his-tagged FabI and MurA was monitored by U.V 
spectrometry on a trace in PrimeView 5.0 (Amersham Biosciences).  
2.6.3 SDS-PAGE of extracted 15N labelled protein internal standards 
Extracted protein was evaluated for approximate size using denaturing SDS-
PAGE. All reagents used in the preparation of polyacrylamide gels were 
obtained from Melford, with the exception of 30% Acrylamide/0.8% 
Bisacrylamide which was sourced from Sigma. Poly-acrylamide gels (12-20% 
concentration) were prepared using Tris-Cl pH 8.8, containing final 
concentrations of 0.1% SDS, 0.375 M Tris-Cl pH8.8 (separating gel), (0.375 M 
Tris-Cl pH 6.8, for the stacking gel) 0.05% ammonium persulfate and 0.03% 
TEMED. A 5 x Tris-glycine running buffer was prepared (0.025M Tris, 0.192 M 
glycine and 0.1 M SDS) and used at 1 x concentration. Gels were photographed 
using Image-Scanner (Amersham Biosciences and Labscan v5.0 (GE 
Healthcare Life Sciences). Protein samples were prepared in 30 l volumes 
using 5 x SDS Page loading dye (Fermentas) and 20 x Reducing agent 
(Fermentas) at final 1 x concentration. Samples were heated at 97C for 4 
minutes to denature protein samples, prior to loading. For size estimation of 
proteins, 5 l of Page Ruler Pre-stained Protein Ladder (Fermentas) was used. 
2.6.4 Purification and concentration of 15N labeled protein internal 
standards  
To remove contaminants associated with the IMAC elution buffer and thereby 
prevent interference with downstream LC-MS/MS analysis, extracted 15N 
labelled protein (FabI and MurA) was purified using an acetone precipitation 
protocol (New England Biolabs). Briefly, 100 µl of 15N labelled protein was 
mixed with 400 µl of ice-cold acetone (Sigma), vortexed and incubated for 1 
hour at -20C. The protein extract was centrifuged at 13,000 x g for 10 minutes 
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and the supernatant was decanted. The protein pellet was then redissolved in 
100 µl of molecular grade water. A small volume of redissolved protein (80 µl) 
was mixed with 120 µl of 5 x SDS loading buffer, 370 µl of molecular grade 
water and 30 µl of 20 x reducing agent. The protein sample was heated to 97C 
for 3 minutes and placed in a sonibath (VWR) for 5 minutes, followed by a 
further heating step of 97C for 3 minutes. The sample was centrifuged at 
16,000 x g for 10 minutes and the supernatant was removed to a fresh tube. 
Protein purity was confirmed by SDS-PAGE, using a 12% polyacrylamide gel. 
2.6.5 Antisense induction for protein and RNA quantification 
An overnight culture of As-fabI was standardized by OD550 readings to 
approximately 2 x 104 cfu/ml in a final volume of 200 ml in MH broth containing 
chloramphenicol (30g/m). An IPTG dilution series was prepared using final 
concentrations of 50, 55 and 70 µM corresponding to growth inhibition of 
approximately 75%, 50% and 25% respectively. Cultures were incubated at 
37C with aeration until the OD550 of a control culture reached 0.1. Bacterial 
cells were harvested at 12,000 x g for 5 minutes, resuspended in 21 ml fresh 
MH broth which was subsequently split into two 10 ml aliquots for protein and 
RNA isolation (see methods section: 2.5.1) for analysis by QPCR respectively. 
The Protein aliquot was centrifuged and resuspended in 1.5 ml MH broth and 
sonicated at 10 microns for 45 seconds five times. 
2.6.6 Protein digestion and SDS-gel extraction from E.coli lysate 
For LC-MS/MS, there is a requirement for protein to be digested into its 
respective peptides, to render it amenable to electrospray ionization. 
Consequently E.coli lysates were separated by SDS-PAGE to reduce sample 
complexity prior to LC-MS/MS analysis. All reagents with the exception of 
trypsin were purchased from Sigma. Proteins were exercised from SDS-PAGE 
gels using a scalpel and placed into a 1.5 ml microcentrifuge tube containing 
140 µl of 200 mM ammonium bicarbonate (NH4HCO3)  pH 7.8. Gel pieces were 
destained in a 37C incubator for 15 minutes. Samples were centrifuged at 
10,000 rpm for 10 seconds, followed by removal of the supernatant, 140 µl of 
200 mM NH4HCO3 pH 7.8/acetonitrile (MeCN) 4:6 was then added, followed by 
the addition of 140 µl of 50mM NH4HCO3 pH 7.8. Samples were incubated at 
37C for 30 minutes. Following incubation, the supernatant was removed after a 
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brief centrifugation at 10,000 x g for 10 seconds after which 140µl of MeCN was 
added, followed by incubation at room temperature for 5 minutes. The MeCN 
was removed following brief centrifugation and the entire destaining procedure 
was repeated until no coomassie dye was visible. The gel pieces were reduced 
by addition of 50 µl 10 mM DTT in 100 mM NH4HCO3 and incubated at 56C for 
1 hour. Samples were briefly centrifuged and the supernatant was removed and 
50 µl of 50 mM iodacetamide was added. Samples were incubated in the dark 
for 30 minutes. The supernatant was removed and gel pieces were washed with 
200 µl 100 mM NH4HCO3 pH 7.8 and incubated at 37C for 15 minutes with 
shaking. The supernatant was removed and 200 µl 50 mM NH4HCO3/MeCN 
(50:50 v/v) was added, followed by incubation at 37C for 15 minutes with 
shaking. Following removal of the supernatant, 140 µl of MeCN was added 
followed by incubation at 37C for 5 minutes with shaking. The MeCN was 
removed following centrifugation and 140 µl of fresh MeCN was added until gel 
pieces turned white. Gel pieces were then digested with trypsin solution 
consisting of 10 µl of 0.5 µg/µl trypsin (Promega), 250 µl 50 mM NH4HCO3 and 
1 mM CaCl2. A 30 µl volume of digest solution was added to the gel pieces 
followed by incubation at room temperature for 5 minutes. A 30 µl addition of 50 
mM NH4HCO was then added to the gel pieces which were then incubated at 
37C overnight. Peptides were extracted by a 10 µl addition of 5% tri-
flouroacetic acid (CF3CO2H), vortexed and then centrifuged at 10,000 x g for 10 
seconds. The supernatant was removed to a fresh (non-autoclaved) 1.5.ml 
microcentrifuge tube. Gel pieces were covered with 2% CF3CO2H acid/60% 
MeCN solution, vortexed and centrifuged again followed by collection of the 
supernatant. A 20 µl volume of 100% MeCN was then added to the gel pieces, 
which were subsequently incubated at room temperature for 5 minutes until 
changing from colourless to white, at which point supernatant was removed. 
Extracted peptide solution was concentrated by in a speed vac (Eppendorf) and 
resuspended in 10 µl 1% CF3CO2H, 5% MeCN and stored at -80C. 
2.6.7 Evaluation of representative tryptic peptides to use for the 
identification and quantification of 15N labelled protein internal 
standard and for the assessment of matrix effects 
To evaluate the potential of matrix effects, a post-extraction spike method was 
employed (Matuszewski et al., 2003). A known volume (2 µl) of purified FabI 
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internal standard was spiked, prior to in-gel digestion with trypsin, into replicate 
samples of different volumes (10µl, 20µl, 30µl) of E.coli TOP10 cell lysate. The 
cell lysate originated from E.coli silenced for fabI expression to achieve a 
titration of the relative growth rate. Induction concentrations of IPTG (50 µM 55 
µM and 65µM) were examined and chosen to achieve an approximate 25%, 
50% and 75% reduction in the relative growth rate respectively. Subsequent 
LC-MS/MS analysis identified 30 tryptic peptides which were evaluated 
according to established criteria (Han and Higgs, 2008). The absolute area 
under each extracted ion chromatogram corresponding to the 15N labelled 
protein internal standard spike and unlabelled species from the E.coli lysate 
were compared, to ascertain if the signal of the 15N labelled standard suffered 
significant variation. 
2.6.8 Quantification of FabI Internal Standard 
The FabI internal standard was quantified using a standard curve, constructed 
from commercially synthesized and pre-quantified peptide analogues of 
EGAELAFTYQNDK and ILVTGVASK peptides (JPT). Both peptides were 
redissolved in RNase/DNase free water (Melford) and serially diluted to 
generate individual standard curves spanning 6 orders of magnitude (0.5-
50,000 fmol). Serial dilutions of each peptide were spiked into trypsin digests (in 
triplicate) containing a 2 µl volume of FabI internal standard and analysed by 
LC-MS/MS (see methods section: 2.6.9). The absolute area under each 
extracted ion chromatogram corresponding to the 15N labelled protein internal 
standard and the unlabelled peptide analogue were averaged. Standard curves 
for each peptide were generated in Sigma plot and a straight line equation 
fitted. The concentration of the 15N labelled internal standard was then 
determined from the straight line equation. 
2.6.9 LC-MS/MS Analysis of FabI protein in silenced samples 
LC-MS/MS was performed by the North East Proteome Facility (NEPAF) using 
an in-house protocol. Peptides were concentrated on a Pepmap C-18 trap 
column (300 μm ID x 5 mm) and separated on a Pepmap C18 reversed phase 
column (Dionex, UK) (3 μm particles, 75 μm ID x 250 mm), using a linear 
gradient over 42 min from 96% A (0.05% formic acid), 4% B (0.05% formic acid, 
80% acetonitrile) to 35% A, 65% B and a flow rate of 300 nl/min. Using the 
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software package; Xcalibur 2.0. Intact peptides were detected between m/z 400 
and m/z 1,600 in the Orbitrap XL (Thermofisher) at a resolution of 30,000. 
Internal calibration was performed using the ion signal of (Si(CH
3
)
3
O)
6
H
+ 
at m/z 
445.120025 as a lock mass Parts per million mass accuracy on an Orbitrap 
mass spectrometer (via lock mass injection into a C-trap). Maximum ion 
accumulation time allowed on the LTQ Orbitrap was 1s for all scan modes. 
Automatic gain control was used to prevent over-filling of the ion trap. Collision 
induced dissociation (CID) spectra of the top 5 peptide ions (rejection of singly 
charged precursors) were acquired between m/z 400 and m/z 1,600 at 
normalized collision energy of 35. Dynamic exclusion was set with a repeat 
count of 1, a repeat time of 30s and an exclusion time of 3 min. The 
chromatography feature was enabled with a correlation area ratio of 1.0. 
Activation Q was set to 0.25 with 30 ms activation time. 
2.6.10 Whole cell screening assays using  triclosan and phosphomycin 
To examine the potential of defining appropriate levels of sensitivity in antisense 
based whole cell screening assays using MPL50 Values, an MIC liquid assay 
was performed. The target specific antibiotics for fabI (triclosan) and murA 
(phosphomycin) were selected as proxies for natural compounds, to examine 
the level of antisense silencing required to reduce the MIC. MIC assays were 
performed as per antisense assays (see methods section 2.22.2). A dilution 
series of triclosan (Sigma) and phosphomycin (Sigma)  were prepared in 100% 
Dimethyl sulfoxide (DMSO) (Sigma) and water respectively, based upon 
published MIC values for triclosan (Bailey et al., 2009) and phosphomycin 
(Takahata et al., 2010). To each well of a 96 well assay plate, 10 l of 
respective antibiotic and 10 l of  and IPTG were added, prior to the addition of 
180 l standardised culture of strains As-fabI or As-murA. 
2.7 Assessment of target specificity using PNA 
To investigate whether peptide conjugate PNA with antisense sequences could  
discriminate between gene homologues, and silence an essential gene target in 
different bacterial species, a mixed microbial assay was performed. 
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2.7.1 Design of Species-specific PNA 
The design of species specific PNA was performed using Artemis (Rutherford et 
al., 2000), according to established rules (Good and Nielsen, 1997). Gene 
homologues from Salmonella enterica serovar Typhimurium LT2 (Knuth et al., 
2004) and Escherichia coli DH10B (Durfee et al., 2008b) were identified by 
BLAST (Altschul et al., 1990) from the Database of essential genes (Zhang and 
Lin, 2009b). Using Artemis, a 20 base pair sequence (-10 to +10) relative to the 
start codon of essential gene homologues were identified and aligned in Clustal 
X version 2 (Larkin et al., 2007) to determine base pair mismatches. A 2 base 
pair cut-off was assigned to identify potential PNA binding sites. A custom perl 
script was used to identify -5 to +5 bases relative  to the start codon for all 
against comparison  (McGinnis and Madden, 2004b), using BLAST to identify  
essential genes with TIR’s amenable to the design of PNA’s. From the 
generated list, a 10 base pair sequence (aacataatct) targeting the TIR of ftsZ 
was identified (PNA Se002). To enable PNA’s to transverse the bacterial cell 
wall, a short peptide (KFFKFFKFFK)   was conjugated to the PNA. The peptide 
sequence is has previously been shown to increase uptake and target 
specificity (Good et al., 2001b). 
2.7.2 Transformation of S. typhimurium and E.coli with reporter gene 
plasmids 
To highlight phenotypic variation arising from the effects of PNA silencing of 
ftsZ, Salmonella typhimurium and E.coli were transformed with pGLo 
expressing Green Fluorescent Protein (Bio-Rad) and pDs-Red expressing red 
fluorescent protein (Clontech) respectively. Salmonella typhimurium LT2 strains 
JR501 was obtained from the Salmonella Genetic Stock Centre, (University of 
Calgary, U.S.A). E.coli TOP10 was obtained from Invitrogen. Transformation of 
S. typhimurium with pGlo was based on an adapted protocol for the 
transformation of enteric bacteria (Tsai et al., 1989). An overnight culture of S. 
typhimurium LT2 JR501, was diluted 1/20 in SOB medium (see Appendix: A) 
and then incubated at 37C with aeration until the OD550 reached mid log phase 
(0.5-0.6). A 50 ml aliquot of the culture was chilled and cells were harvested by 
centrifugation at 10,000 x g for 10 minutes. Harvested cells were washed with 
50 ml of cold (4C) 0.1 M MgCl2 and then resuspended in 25 ml 0.1 M CaCl2 
and incubated on ice for 20 minutes. Cells were centrifuged at 10,000 x g for 10 
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minutes and resuspended in 5 ml of cold 0.1 M CaCl2, which was dispersed as 
0.2 ml aliquots into thin wall 15 ml tubes (Falcon). Upon addition of plasmid 
DNA, cells were incubated on ice for 20 minutes prior to heat shocking for 2 
minutes at 42C without shaking. A total volume of 250 µl of pre-warmed SOC 
medium was added to Transformants, which were then incubated at 37C for 1 
hour with aeration. A suitable volume of transformants (100 µl) was pipetted 
onto pre-warmed LB agar containing ampicillin and incubated at 37C overnight. 
E.coli TOP10 was transformed with pDs-Red as per previous E.coli 
transformations (see methods section: 2.1.8) 
2.7.3 Mixed microbial assay 
Overnight cultures of E.coli Top 10 harbouring pDs-Red and Salmonella 
typhimurium LT2 JR501, containing pGlo, were incubated overnight in low salt 
LB media containing ampicillin. Overnight cultures were diluted in fresh low salt 
LB containing 0.2% L-arabinose (Sigma) and standardized by OD550 readings to 
approximately 2×104 cfu/ml. Equal volumes were then combined to produce a 
mixed culture. Prior to use, PNAs (Panagene, Korea) were heated at 55C for 
10 minutes as per manufacturer’s instructions and added to a final 
concentration of 2.5 and 1.25 M, in a 96 well tissue culture plate (Sarstedt). 
The well volume was made up to 100 l with low salt LB containing 0.2% L-
arabinose, prior to the addition of 100 l of mixed bacterial culture.The 96 well 
plate was sealed with breathable self-adhesive film (Starlab) and incubated in a 
Powerwave HT plate reader (BioTek) at 37C with medium intensity shaking. 
After 6 hours the plate was removed and 10l samples were removed and 
harvested by centrifugation, prior to re-suspension in 1 x PBS (Sigma). 
Microscope slides were prepared by addition of 2 l of sample to a 1% agarose 
pad (Levin, 2002a) and heat fixing for Fluorescent Microscopy. Images were 
captured using a Lecia DMRB microscope with Aqua EXI bioimaging camera 
(Qimiaging).and processed using Image pro plus software (MediaCybernetics). 
2.8 Statistics 
All statistical analyses used in this study were performed using Minitab (Minitab 
Inc).  Before the selection of statistical analysis methods, data was assessed for 
normality using a Kolomogorov-Smirnov test prior to the use of parametric tests 
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(T-test). Where data did not confirm to a normal distribution non-parametric 
statistical analyses (Mann-Whitney U test) were undertaken. 
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Chapter 3 Results 
3.1 Evaluation of gene silencing of fusA and rplE 
3.1.1 Specificity of expressed antisense RNA constructs 
The assessment of essential gene stringency requires exclusive silencing of a 
target gene, to generate a reduction in growth rate. Determining the specificity 
of expressed antisense RNA sequences is therefore necessary to ensure no 
additional genes are inadvertently targeted. Antisense sequences of 
approximately 101-152 nucleotides complementary to the ribosome binding 
region of mRNA for essential genes fusA and rplE, were cloned into a paired 
termini antisense expression vector (pHN678) (Nakashima et al., 2006) and 
transfected into E.coli (TOP10) to create strains Ash01, and Ash02 (see 
methods section 2.1.5-2.18). The growth rate of each strain was titrated down 
using a range of IPTG concentrations to induce increased expression of 
antisense RNA. The growth rates of silenced clones were measured relative to 
uninduced controls to obtain relative growth rate (see methods section: 2.2).  
Both antisense RNA expression constructs demonstrated significant growth 
inhibition of E.coli (2 sample T-test n =3 P <0.005), compared to controls 
containing empty constructs (Figure 3.1). Greater silencing efficiency was 
displayed for rplE, as evident from the early decrease in the relative growth rate 
compared to fusA. The specificity of both fusA and rplE constructs were 
compared to expressed antisense RNA constructs targeting essential genes 
acpP, ftsZ, fabI and murA (Goh et al., 2009). The relative growth rates of acpP, 
ftsZ, fabI and murA (Figure 3.2) were comparable to those obtained previously. 
However a greater level of silencing efficiency was demonstrated for  fusA and 
rplE  over a low IPTG induction range, with growth inhibition occurring at  20-25 
µM compared to acpP (80 µM), ftsZ (60 µM), fabI (70 µM), and murA (50 µM). 
Antisense RNA expression constructs for fusA and rplE demonstrate the 
capacity to reduce bacterial growth, which suggests specificity for their 
respective essential gene targets in E.coli.  
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Figure 3.1 Relative growth rate of E.coli following expressed antisense RNA silencing of 
essential gene targets fusA and rplE.  
Growth rate titration was achieved by induction with increasing concentrations of IPTG to 
increase the expression of antisense RNA and measuring OD550. Raw OD550 data 
corresponding to the exponential phase of growth was plotted and a trendline applied to obtain 
the rate of growth from the straight line equation y = mx + c. Relative growth rate was 
determined by normalising the growth rate of induced samples to uninduced controls. Graph 
shows average relative growth rate with standard error bars (n=3). 
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Figure 3.2 Relative growth rates of E.coli following expressed antisense RNA silencing of 
essential gene targets acpP, ftsZ, fabI, and murA.  
Growth rate titration was achieved by induction with increasing concentrations of IPTG to 
increase the expression of antisense RNA and measuring OD550. Raw OD550 data 
corresponding to the exponential phase of growth was plotted and a trendline applied to obtain 
the rate of growth from the straight line equation y = mx + c. Relative growth rate was 
determined by normalising the growth rate of induced samples to uninduced controls. Graph 
shows average relative growth rate with standard error bars (n=3). 
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3.1.2 Validation of antisense construct specificity by 
transcomplementation 
The validation of target specificity of expressed antisense RNA constructs was 
attempted using a transcomplementation strategy. This approach aims to 
rescue cells from growth inhibition induced by antisense RNA silencing, through 
over-expression of the complete open reading frame (ORF) for each target 
gene from a separate plasmid. Target specificity can then be confirmed 
following the rescue of clones from growth inhibition and restoration of normal 
growth. The entire ORF’s for fusA and rplE were cloned into pBAD-HisA 
containing an L-arabinose inducible promoter to generate strains E.coli Ash03 
and Ash04 (see methods section 2.1.1-2.1.9). The rescue constructs were 
extracted and transfected with their corresponding expressed antisense RNA 
constructs to create E.coli strains, Ash05 and Ash06 respectively.  Strains was 
grown in the presence of IPTG and L-arabinose  to induce expression of both 
antisense  RNA and corresponding episomal copy of the target genes, to 
determine appropriate levels of induction required to demonstrate rescue of 
growth rate (see methods section 2.3).  
Growth inhibition of E.coli, following expressed antisense RNA silencing of rplE 
at 25 µM IPTG, was prevented following gene complementation using 2% L-
arabinose (Figure 3.3). However this was deemed statistically insignificant 
(Mann Whitney, P=0.104, n=7). Difficulties were encountered with the 
transcomplementation of fusA, for which suitable levels of induction for 
expressed antisense RNA and gene overexpression could not be determined. 
Subsequently no significant rescue of growth rate following silencing of fusA 
(Mann Whitney, P=0.734, n=7) was observed with L-arabinose induction (Figure 
3.5). To investigate the potential influence of metabolic load associated with 
expression of two plasmids, strain Ash07 containing empty expression vectors, 
was examined using identical rescue conditions for both rplE (Figure 3.4) and 
fusA (Figure 3.6). Induction with IPTG and L-Arabinose concentrations did not 
significantly affect the growth rate of E.coli using the same rescue conditions for 
rplE (Mann Whitney, P=0.610, n=7) or fusA (Mann Whitney, P=0.710, n=7). 
Higher OD550 readings were observed in the control strains. In summary using 
transcomplementation validated target specificity of rplE but not for fusA. 
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Figure 3.3 Transcomplementation of expressed antisense RNA silencing effects of the 
essential gene rplE in E.coli.  
Growth rate of E.coli strain Ash05 following rplE over-expression, induced with 2% L-arabinose. 
Antisense RNA expression was induced with 25 µM IPTG. Graph shows bacterial growth curves 
derived from average OD550 readings with standard error bars (n=3). 
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Figure 3.4 Transcomplementation control mimicking the expression conditions used for 
the rescue of rplE.  
Expression of E.coli strain Ash07 was induced with 25 µM IPTG and 2% L-arabinose as used in 
the rescue of E.coli strain Ash05. Graph shows bacterial growth curves derived from average 
OD550 readings with standard error bars (n=3). 
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Figure 3.5 Transcomplementation of expressed antisense RNA silencing effects of the 
essential gene fusA in E.coli.  
Growth rate of E.coli strain Ash06 following fusA over-expression, induced with 0.001% L-
arabinose. Antisense RNA expression was induced with 25 µM IPTG.  Graph shows bacterial 
growth curves derived from average OD550 readings with standard error bars (n=3). 
 
   
78 
 
Figure 3.6  Transcomplementation control mimicking the expression conditions used for 
the rescue of fusA.  
Expression of E.coli strain Ash07 was induced with 25 µM IPTG and0.001% L-arabinose as 
used in the rescue of E.coli strain Ash06. Graph shows bacterial growth curves derived from 
average OD550 readings with standard error bars (n=3). 
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3.1.3 Delineating inhibitory effects caused by gene silencing of fusA and 
rplE 
To ascertain whether the effects of expressed antisense RNA silencing of fusA 
and rplE promoted a bactericidal or bacteriostatic effect on cell growth, a 
survival assay was performed (see methods section 2.4). Silencing of fusA and 
rplE was induced using 50 µM IPTG with viable cell counts performed over 8 
hours. Prior to the assay, It was postulated that silencing of fusA would cause a 
bacteriostatic effect on cell growth, in accordance with inhibitory effects 
observed in S.aureus by the target specific antibiotic fusidic acid (Howden and 
Grayson, 2006). Similarly silencing of rplE was also expected to cause a 
bacteriostatic effect, based upon the inhibitory action exerted by the majority of 
antibiotic classes that target the ribosome, with the exception of 
aminoglycosides (Kohanski et al., 2010).  
Both fusA and rplE silenced strains exhibited significant growth inhibition rather 
then cell death following gene silencing. A significant reduction in viable cell 
numbers was observed upon silencing for both fusA (Mann Whitney U Test, 
P=0.0118, n= 9) and rplE (Mann Whitney U Test, P = 0.0009 n=9). In the case 
of rplE (Figure 3.7) the viable number of cells initially decreased prior to 
increasing after 8 hours. For fusA (Figure 3.8) the number of viable cells 
remained relatively static throughout the 8 hour growth period. The growth 
effects of gene silencing of both rplE and fusA were determined to be 
bacteriostatic, since cell number decline was below the >3 log reduction of the 
final inoculum required for the demonstration of bactericidal activity. One 
particular observation was that growth curves generated for uninduced 
antisense RNA expression of fusA and rplE displayed an exponential increase 
with a plateau at approximately 4 hours. This anomaly was not observed with 
both the uninduced and induced control plasmid, where no difference in viable 
cell count was observed (Figure 3.9), following induction (Mann Whitney U Test, 
P=0.8946, n= 9)  
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Figure 3.7 Delineation of growth effects following expressed RNA silencing of the 
essential gene rplE in E.coli.  
Antisense RNA expression was induced using 50 µM IPTG E.coli strain Ash01 and viable cell 
counts were performed over 8 hours. Graph shows average viable cell count with standard error 
bars (n=3).  
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Figure 3.8 Delineation of growth effects following silencing of the essential gene fusA in 
E.coli.  
Antisense RNA expression was induced in E.coli strain Ash02 using 50 µM IPTG and viable cell 
counts were performed over 8 hours. Graph shows average viable cell count with standard error 
bars (n=3).  
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Figure 3.9 Viable cell counts of E.coli expressing empty pHN678 construct.  
As per previous experimental conditions 50 µM IPTG was used to induce expression of empty 
antisense expression plasmid in E.coli strain Ash03 and viable cell counts were performed over 
8 hours. Graph shows average viable cell count with standard error bars (n=3). 
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3.1.4 Evaluation of gene stringency of fusA and rplE using Mean 
Transcript Level 50 (MTL50) 
To enable comparisons of stringency among essential genes, a Mean 
Transcript Level (MTL50) value, representing the amount of mRNA required to 
maintain 50% of relative growth has been proposed, which reflects the 
relationship between transcript abundance and growth rate decline. (Goh et al., 
2009). The MTL50 of rplE and fusA was initially evaluated by performing a 
titration of growth rates of E.coli strains Ash01 and Ash02, using increasing 
concentrations of IPTG, to promote expressed antisense RNA expression and 
measuring the corresponding mRNA abundance by performing relative 
quantification with QPCR, (see methods section 2.5). Examination of the 
relative growth rate and corresponding mRNA abundance for rplE and fusA 
(Figure 3.10 and Figure 3.11 respectively), reveals an increase in mRNA 
abundance with relative growth rate decline. This is contrary to the expectation 
that mRNA abundance would decline with relative growth rate, due to antisense 
mediated degradation of mRNA transcripts. 
A reduction in growth rate was observed following silencing of rplE yet mRNA 
abundance initially decreased then remained stable, prior to an increase in 
abundance at the lowest relative growth rate. Silencing of fusA, caused the 
relative growth rate and mRNA abundance to initially decline, followed by a 
large increase in mRNA abundance at the lowest relative growth rate. No 
significant correlation between relative growth rate decline and mRNA 
abundance, following silencing for either rplE (rs= -0.02) or fusA (rs = -0.6) was 
observed.  
To compare the stringency of rplE and fusA against previously validated targets, 
the MTL50 value was determined by plotting relative growth rate against relative 
mRNA abundance (Figure 3.12 and Figure 3.13 respectively). The MTL50 
reveals an inverse trend to previously investigated gene targets, whereby 
mRNA abundance increases as relative growth rate declines. The number of 
rplE transcripts required to maintain 50% cell viability increases to 
approximately 2.4 relative value (or 240% of a normal cell growth). For fusA the 
50% decrease in growth rate was not achieved, but indicates that a large 
number of transcripts are present, approximately 1.5 relative value (or 150% of 
a normal cell growth). 
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Figure 3.10 Relative growth rate and mRNA abundance profiles following expressed 
antisense RNA silencing of the essential gene rplE in E.coli.  
Transcript and relative growth rate profile for E.coli strain Ash01. Total RNA was isolated from 
cultures, which were harvested once the OD550 of the uninduced control had reached 0.1. 
mRNA abundance was determined by QPCR using E.coli genes 16S and ZipA as endogenous 
references for relative quantification by DDCt method. Graph shows average relative growth rate 
and average relative mRNA abundance with standard error bars (n=3). 
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Figure 3.11 Relative growth rate and mRNA abundance profiles following expressed 
antisense RNA silencing of the essential gene fusA in E.coli.  
Transcript and relative growth rate profile for E.coli strain Ash02. Total RNA was isolated from 
cultures, which were harvested once the OD550 of the uninduced control had reached 0.1. 
mRNA abundance was determined by QPCR using E.coli genes 16S and ZipA as endogenous 
references for relative quantification by DDCt method Graph shows average relative growth rate 
and average relative mRNA abundance with standard error bars (n=3). 
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Figure 3.12 MTL50 for essential gene rplE.  
The MTL50 was calculated by plotting the mean relative mRNA abundance against its 
corresponding mean relative growth rate. This enables stringency of essential genes to be 
determined by examining the number of transcripts required to maintain 50% relative growth 
rate. 
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Figure 3.13 MTL50 for essential gene fusA.  
The MTL50 was calculated by plotting the mean relative mRNA abundance against its 
corresponding mean relative growth rate. This enables stringency of essential genes to be 
determined by examining the number of transcripts required to maintain 50% relative growth 
rate. 
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3.2 Development of LC-MS/MS protein quantification method 
3.2.1 15N labelled protein internal standard preparation for LC-MS/MS 
The evaluation of stringency in essential gene targets fusA and rplE in this 
study, suggests that mRNA may be limited as a surrogate for expressed 
protein, and therefore inappropriate as a measure of gene essentiality.  Indeed 
correlations between mRNA and protein abundance are known to vary widely, 
due to numerous post-transcriptional and post-translational mechanisms that 
operate within prokaryotes (Maier et al., 2009). 
To circumvent the use of mRNA for determining essential gene stringency, an 
LC-MS/MS assay was developed to provide absolute quantification of target 
protein, following expressed antisense RNA silencing. Development of the 
assay required the synthesis of a heavy labelled (15N) target protein for use as 
an internal standard. The use of a fully labelled protein enables an initial LC-
MS/MS analysis to identify the most suitable tryptic peptides, possessing the 
same physiochemical properties as their native equivalent, but distinguishable 
by mass difference for the purpose of quantifying protein in experimental 
samples. The essential genes fabI and murA were selected as candidate 
targets for use as internal standards, due to their extensive characterization and 
previous evaluation as stringently required genes (Goh et al., 2009).  
As an alternative to commercially synthesized heavy labelled peptides, fully 15N 
labelled proteins were generated from E.coli MG1 AE5305 obtained from the 
ASKA collection (Kitagawa et al., 2005a).  Using a complete stable isotope 
labelled form enabled correction for variability in the analytical workflow, and 
has been show to be preferable choice compared to other forms of internal 
standard (Bronsema, 2013). Candidate proteins were overexpressed in minimal 
media containing 15N labelled NH4 as the sole nitrogen source (see methods 
section 2.6.1), extracted from whole cell E.coli lysate by Immobilised metal 
affinity chromatography (see methods section 2.6.2) and subject to acetone 
precipitation to remove contaminants (see methods section 2.6.4). Purified 15N 
labelled FabI and MurA (Figure 3.14) revealed both target proteins (27.9 and 
44.8 kDa respectively), in addition to high molecular weight contaminants. 
Contamination was more prevalent for MurA, which revealed numerous bands 
in the range of 100 – 130 kDa, including two low molecular weight bands in the 
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predicted range of MurA. Unlike FabI which resides in the cytosol, MurA is a 
membrane associated protein; therefore contaminating bands were likely to 
have been accessory proteins that co-eluted. The identity of each protein was 
confirmed by LC-MS/MS (see results section 3.2.2). 
 
Figure 3.14 Purification of 
15
N labelled FabI and MurA protein from E.coli whole cell 
lysate.  
E.coli MG1 ME5305 overexpressing His-tagged FabI and MurA was grown in minimal media 
until mid log phase and then induced with 1 mM IPTG and grown over 24 hours prior to 
harvesting. Extracted protein was eluted from a nickel column over an imidazole gradient 
generating 10 eluted fractions. A protein ladder (first lane) was used to confirm approximate 
protein size. 
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Both FabI and MurA protein elutes were subsequently concentrated and purified 
further using Amicon filters with appropriate molecular weight ranges. However 
SDS-PAGE of filtered protein revealed the presence of warped bands indicative 
of high salt concentration (Figure 3.15 A), that could detrimentally effect 
electrospray ionization efficiency. Both proteins were therefore subjected to an 
additional purification step using acetone precipitation (Figure 3.15 B), which 
subsequently removed contaminants. Following purification, the yield of FabI 
and MurA appeared to be reduced. This however was not deemed to affect the 
quantification strategy as both protein batches would be quantified 
independently using a standard curve, prior to use as internal standards (see 
methods section: 2.6.8). This would ensure known quantities of internal 
standard would be spiked into experimental samples. 
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Figure 3.15 Purification and concentration of 
15
N labelled FabI and MurA.  
(A) Contamination in 
15
N FabI and MurA, following initial clean-up after elution from IMAC. High 
molecular weight bands corresponding to co-eluted contaminants were observed for MurA (B) 
Acetone precipitation of 
15
N FabI and MurA, revealing the removal of contaminants. Purified 
protein was pooled and 10 µl aliquots were ran on a 15% polyacrylamide gel. A protein ladder 
(first lane) was used to confirm protein size. 
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3.2.2 Confirmation of complete 15N labelling of protein internal standards 
For reliable quantification, the heavy labelling of an internal protein standard 
requires complete and stable 15N incorporation to a level approaching  95 %, as 
a minimum for quantitative analysis (Huttlin et al., 2008). The use of 15N is 
particularly suited as a heavy label, since peptides contain fewer types of 
nitrogen compared to carbons. This has the effect of reducing the complexity of 
isotopic envelopes in 15N labelled peptides, which subsequently reduces the 
distribution of the m/z signal thereby increasing the signal to noise ratio. This 
subsequently increases confidence in identification and quantification   (Huttlin 
et al., 2008). Purified FabI and MurA samples were digested with trypsin and 
analysed by LC-MS/MS to determine the relative degree of 15N incorporation. 
The degree of 15N incorporation in FabI was assessed by submitting the raw 
LC-MS/MS  data to the  gpm (Global Protein Machine), a publically available 
system, comprising a data analysis server, user interface and a relational 
database, containing experimentally generated peptide mass data (Craig et al., 
2004). Within this system, raw tandem mass spectra is compared to spectra 
derived from the same peptide sequences using X! Tandem, a class B open 
source search engine.  An algorithm performs a two step calculation, initially a 
‘survey’ is performed whereby experimentally derived spectra are compared to 
the protein sequences, under the assumption that complete peptide cleavage 
occurs.  Peptides identified with statistically significant matches are then re-
matched taking into consideration potential chemical modifications (e.g.: 
oxidation).To ascertain the level of incorporation the gpm search was initially 
performed with the assumption of  no 15N incorporation (i.e. the search engine 
would only identify peptide sequences with spectra relating to native unlabelled 
protein sequences specific for FabI or MurA). The gpm search (Figure 3.16) did 
not match any spectra corresponding to native FabI or MurA, with spectra 
generated from 15N labelled internal standards, or any other E.coli proteins. The 
only positive identifications made were keratin and bovine trypsin, which 
represent typical contaminants arising from sample preparation. Due to financial 
constraints, a decision was made to proceed with developing an LC-MS/MS 
assay for fabI only. 
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Figure 3.16 GPM Results for unlabelled FabI and MurA.  
No hits for native (unlabelled) FabI and MurA were obtained when gpm search parameters were modified to assume the absence of 
15
N incorporation. This supports 
complete incorporation of 
15
N in both FabI and MurA. 
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The gpm search was repeated by altering the search parameters to 
accommodate for 15N incorporation (Figure 3.17) in peptides specific to FabI 
and MurA proteins. The probability of peptide identification was ranked 
according to a logE score, which represent the base -10 logarithm of the 
probability that a peptide identification is a random match. Log E scores of -
251.6 and -220.4 were obtained for MurA and FabI respectively, indicating that 
the chance of false positive identification is low (for reference a logE score of -3 
corresponds to 1 in 1000 chance). The logE scores for 15N labelled FabI and 
MurA correspond to approximately 1 in 1 x 102000 chances that identification has 
been made at random, which represents a statistically significant probability of 
identification. 
To provide direct evidence of complete 15N labelling, characteristic peptide 
sequences for FabI (ILVTGVASK and SMLNPGSALLTLSYLGAER) and MurA 
(MGAHAEIESNTVICHGVEK and LQGEVTISGAK), were selected to confirm 
the degree of 15N incorporation.  Incomplete labelling of each protein would be 
confirmed by the presence of mass spectra corresponding to unlabelled 
peptides.The mass spectrum for peptide ILVTGVASK (Figure 3.18) revealed an 
isotopic envelope corresponding to 15N labelled pseudo-molecular ion for the 
doubly charged peptide, with a m/z of 449.27 and no trace of the unlabelled 
native protein with a m/z of 444.27. The mass spectrum for 
SMLNPGSALLTLSYLGAER (Figure 3.19) also revealed a characteristic 
isotopic envelope corresponding to a 15N labelled pseudo-molecular 3+ ion for 
the doubly charged peptide, with a m/z of 677.9 and the absence of 
corresponding unlabelled peptide. For MurA the mass spectrum of 
MGAHAEIESNTVICHGVEK revealed the presence of a 15N labelled 
pseudomolecular  3+ ion with a m/z of 702.9  (Figure 3.20). The mass spectrum 
of LQGEVTISGAK (Figure 3.21) revealed the presence of a 15N labelled 
pseudomolecular 2+ ion with m/z of 558.2.  No unlabelled species were 
observed for either peptide. The absence of unlabelled species (14N) indicates 
that complete labelling (i.e. every 14N atom is replaced by 15N) was achieved, as 
expected in unicellular systems grown over eight generations (Snijders et al., 
2005).  The complete 15N incorporation of FabI and MurA validates their use as 
internal standards for absolute quantification of cellular protein, since the high 
level incorporation permits an optimal signal to noise ratio, which aids 
identification and permits accurate quantification. 
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Figure 3.17 GPM Results examining 
15
N Incorporation in FabI and MurA.  
The gpm search parameters were adjusted to assume complete 
15
N labelling of FabI and MurA, which revealed significant log (e) scores, indicating a significant 
probability that labelled protein internal standards were fully labelled.  
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Figure 3.18 Mass spectrum of tryptic peptide ILVTGVASK used for establishing the level of 
15
N incorporation in FabI.  
The red arrow indicates where a completely unlabelled (
14
N labelled) peptide would be observed for peptide ILVTGVASK. 
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Figure 3.19 Mass spectrum of tryptic peptide SMLNPGSALLTSYLGAER used for establishing the level of 
15
N incorporation in FabI.  
The red arrow indicates where a completely unlabelled (
14
N labelled) peptide would be observed for peptide SSMLNPGSALLTLSYLGAER.  
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Figure 3.20 Mass spectrum of tryptic peptide MGAHAEIESNTVICHGVEK used for establishing the level of 
15
N incorporation in MurA.  
The red arrow indicates where a completely unlabelled (
14
N labelled) peptide would be observed for peptide MGAHAEIESNTVICHGVEK. 
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Figure 3.21 Mass spectrum of tryptic peptide LQGEVTISGAK used for establishing the level of 
15
N incorporation in MurA.  
The red arrow indicates where a completely unlabelled (
14
N labelled) peptide would be observed for peptide LQGEVTISGAK. 
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3.2.3 Selection of peptides for quantification of protein internal standard 
by LC-MS/MS 
The strategy for evaluating essential gene stringency in this study incorporates 
the use of absolute quantification of cellular protein using LC-MS/MS. 
Quantification is achieved by comparing the ratio of peak areas of extracted ion 
chromatograms for native peptide to an internal standard of known amount. It is 
critical that tryptic peptides representative of both labelled and unlabelled 
protein generate an equivalent response during electrospray ionization. Ideally 
heavy labelled and native peptides should be equivalent in elution times, 
generate characteristic spectra and be consistently detected in both 15N labelled 
and unlabelled forms over orders of magnitude. Furthermore, the detection of 
peptides should be resilient to potential effects arising from the sample matrix. A 
key requirement of LC-MS/MS method validation is therefore to assess for 
matrix effects that can alter the instrument response through the suppression or 
enhancement of electrospray ionization. Such effects are associated with 
endogenous components of sample (biological) matrices that co-elute and 
compete with peptides or interfere with ionization, specifically the efficiency of 
droplet formation (Van Eeckhaut et al., 2009).  
To evaluate any potential matrix effects associated with whole cell E.coli lysate, 
a post-extraction spike method was employed (see methods section 2.6.7). A 
known volume of internal standard was spiked prior to in-gel digestion with 
trypsin into replicate samples of cell lysate. The cell lysate originated from E.coli 
silenced for fabI expression to achieve a titration of relative growth rate. 
Induction concentrations of IPTG were examined and chosen to achieve an 
approximate 25%, 50% and 75% reduction in the relative growth rate.  LC-
MS/MS analysis identified 30 tryptic peptide sequences indicative of FabI, which 
were evaluated according to established criteria (Han and Higgs, 2008). 
Suitable peptides were selected based on optimal length, (7-30 residues), lack 
of extreme hydrophillic or hydrophobic regions and absence of residues 
susceptible to chemical modification, that could alter m/z values thereby 
complicating identification and quantification. Peptide sequences containing 
specific residues were avoided particularly those containing methionine (subject 
to oxidation), asparagine (can be glycooslytaed or deaminated), glycine or 
glutamic acid (undergo cyclization to pyroglutamic acid), or peptides with 
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internal trypsin cleavage sites. The absolute areas of extracted ion 
chromatogram peaks for selected peptides, identified in both 15N labelled and 
unlabelled FabI, were determined and converted to a Light/Heavy ratio. An 
arbitrary cut-off value of 0.15 was used to identify peptides displaying the lowest 
L/H ratio (approximately 1:1). Four candidate peptides were subsequently 
determined as suitable for quantification standards that could be used to 
quantitate the FabI Internal standard (Figure 3.22). 
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Figure 3.22 Tryptic peptides identified for the quantification of FabI internal standard.  
The Light/Heavy ratio for four tryptic peptides specific to FabI were generated from extracted ion 
chromatograms and plotted against the relative growth rate of E.coli, which was titrated using 
different concentrations of IPTG to achieve increased antisense RNA silencing of fabI. Graphs 
show average peptide L/H ratio with standard error bars (n=3). Peptide VNAISAGPIR was 
discounted from analysis due to substantial variability in the L/H peptide ratio obtained for 50 % 
relative growth rate  
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For quantitation of the 15N labelled internal standard, two tryptic peptides 
EGAELAFTYQNDK and ILVTGVASK were selected due to their similarity in L/H 
ratio’s across all relative growth conditions. Significant variation was displayed 
for VNAISAGPIR at 50% relative growth, hence it was discarded from selection 
with ASLEANVR.   
In order to provide accurate quantitation of the FabI internal standard, the mass 
spectra and elution characteristics for respective peptide ions was determined. 
Since these characteristics are specific to each peptide ion, they can be used to 
confirm that extracted ion chromatogram peaks are assigned to the correct 
peptide ion, which serves a proxy for both the internal standard and the protein 
under investigation. 
Evaluation of EGAELAFTYQNDK revealed spectra corresponding to both 
unlabelled and 15N labelled tryptic peptides (Figure 3.23 and Figure 3.24 
respectively). A pseudomolecular 2+ ion was identified with a m/z of 743.35 for 
the unlabelled peptide and 751.32 for the 15N labelled counterpart (Figure 3.25). 
Extracted chromatograms revealed an elution time of 16.85 minutes (Figure 
3.26 A and B). Similarly ILVTGVASK also revealed characteristic spectra for 
unlabelled and 15N labelled forms of the peptide (Figure 3.27 and Figure 3.28). 
The pseudomolecular 2+ ion was identified with a m/z of 444.28 and 449.27 for 
the unlabelled and 15N labelled counterpart respectively (Figure 3.29). Extracted 
ion chromatograms revealed a peptide elution time of approximately 15 minutes 
(Figure 3.30 A and B).  Due to the consistent detection of tryptic peptides 
EGAELAFTYQNDK  and ILVTGVASK in all relative growth conditions, both 
peptides were selected for incorporation as template profiles into LC-MS/MS 
data analysis software, for subsequent identification and quantitation of the 15N 
labelled FabI internal standard. 
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Figure 3.23 LC-MS/MS spectra for unlabelled EGAELAFTYQNDK.  
The spectra for peptide EGAELAFTYQNDK revealed eight individual m/z peaks that could be used to confirm identity of the native (
14
N) peptide. 
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Figure 3.24 LC-MS/MS spectra for 
15
N labelled peptide EGAELAFTYQNDK.  
The spectra for 
15
N labelled EGAELAFTYQNDK revealed eight individual m/z peaks that could be used to confirm identity. A noticeable shift in m/z values was 
observed compared  to the spectra for the native peptides. 
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Figure 3.25 LC-MS/MS characteristics of peptide EGAELAFTYQNDK.  
Zoomed MS spectra showing characteristic isotopic envelope of native and 
15
N labelled EGAELAFTYQNDK with m/z of 743.35 and 751.32 respectively. 
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Figure 3.26 LC-MS/MS characteristics of peptide EGAELAFTYQNDK.  
Extracted ion chromatogram of native (A) and 
15
N labelled (B) EGAELAFTYQNDK peptide with 
a co-elution time of 16.85 minutes. Relative abundance represents the ion intensity 
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Figure 3.27 LC-MS/MS spectra for unlabelled and 
15
N labelled peptide ILVTGVASK.  
The spectra for peptide ILVTGVASK revealed six individual m/z peaks that could be used to confirm identity of the heavy labelled peptide.  
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Figure 3.28 LC-MS/MS spectra for 
15
N labelled peptide ILVTGVASK.  
The spectra for peptide ILVTGVASK revealed seven individual m/z peaks that could be used to confirm identity of the heavy labelled peptide. A noticeable shift in 
m/z values is observed compared to spectra for corresponding unlabelled peptides. 
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Figure 3.29 LC-MS/MS characteristics of peptide ILVTGVASK.  
Zoomed MS spectra showing characteristic isotopic envelope of native and 
15
N labelled EGAELAFTYQNDK with  m/z of 444.28 and 449.27 respectively.  
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Figure 3.30 LC-MS/MS characteristics of peptide ILVTGVASK.  
Extracted ion chromatogram of native (A) and 
15
N labelled (B) peptide ILVTGVASK with a co-
elution time of approximately 15 minutes. 
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3.3 Quantification and assessment of gene stringency using protein 
abundance 
3.3.1 Quantification of 15N labelled FabI protein internal standard 
Prior to utilizing the 15N labelled fabI as an internal standard, quantification of 
the purified protein was performed using commercially synthesized (pre-
quantified) peptide analogues of EGAELAFTYQNDK and ILVTGVASK (see 
methods section 2.6.8). Both peptides were serially diluted to generate 
individual standard curves spanning 6 orders of magnitude, to enable 
extrapolation of the amount of internal standard. Serial dilutions of each peptide 
were spiked into trypsin digests containing a known volume of FabI internal 
standard and analysed by LC-MS/MS. 
Insufficient data was obtained for both peptides corresponding to spiked 
amounts in the lower range of the standard curve (0.5 and 5 fmol).  
Consequently standard curves were generated over 4 orders of magnitude (50 
– 50,000 fmol). Standard curves for EGAELAFTYQNDK and ILVTGVASK 
(Figure 3.31 A and B respectively), generated by linear regression displayed 
good correlation (r2 = 0.99). Using the linear regression equations y = 7x10-6x – 
765.71 and y = 4x10-6x + 113.66, the amount of internal standard was 
calculated as 675 pmol for EGAELAFTYQNDK and 4547 pmol for ILVTGVASK. 
The average amount of 15N FabI internal standard was subsequently calculated 
as 2.61 nmol 
.  
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Figure 3.31 Tryptic peptide standard curves for quantification of 
15
N FabI internal 
standard.  
(A) Standard curve for tryptic peptide EGAELAFTYQNDK. (B) Standard curve for tryptic peptide 
ILVTGVASK. Standard curves were constructed from 10-fold serial dilution of peptides ranging 
from 50-50,000 fmol. The average amount of 
15
N FabI was calculated using linear regression. 
Standard curves show average amount of peptide with standard error bars (n=3). 
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3.3.2 Quantification of FabI protein per cell following gene silencing of fabI 
in E.coli 
To evaluate the differential growth requirement of the essential gene fabI, the 
growth rate of E.coli strain As-fabI was titrated down using expressed antisense 
RNA silencing. Concentrations of IPTG (50, 55 and 65 µM) were used to 
achieve approximate growth reductions of 25%, 50% and 75% (see methods 
section: 2.6.5). For comparative purposes the amount of FabI synthesised 
following overexpression in E.coli MG1 ME5305 was investigated using IPTG 
induction at 0.5 and 1 mM.  
Transcript abundance was measured by QPCR and protein was quantified by 
LC-MS/MS. The peak area derived from extracted ion chromatograms for 
peptides EGAELAFTYQNDK and ILVTGVASK was used to generate ratios of 
unlabelled: 15N labelled peptide. The amount of protein was obtained by 
multiplying the calculated ratios for each peptide by the amount of internal 
standard spiked into tryptic digests. The calculated amount was converted to 
protein molecules by multiplying by Avogadro’s number and corrected for viable 
cell counts to provide an estimation of FabI molecules per cell (Figure 3.32).   
The number of FabI molecules per cell decreased with declining growth rate, 
following silencing of fabI. A 3-fold decrease in FabI molecules per cell was 
observed as the relative growth rate decreased to approximately 75% of normal 
growth. A smaller decrease in FabI molecules per cell (1.2 fold) was observed 
as the growth rate declined to approximately 50% of normal growth. A 2-fold 
decrease in FabI molecules per cell occurred as the relative growth rates 
dropped to approximately 25% of the normal growth rate.  
When overexpressed the amount of FabI per cell increased by approximately 
100-fold in comparison to both wild-type E.coli and uninduced controls (Figure 
3.33). The number of FabI molecules per cell increased slightly (1.2-fold) when 
the concentration of IPTG was doubled from 0.5 to 1 mM. Interestingly the 
number of FabI molecules per cell in the antisense control (uninduced) was 3.5-
fold higherthen wild-type E.coli and 5-fold higher when compared to the ASKA 
control (uninduced). Both wild-type E.coli and the ASKA control revealed a 
similar basal expression of FabI. 
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Figure 3.32 FabI protein molecules per cell following expressed antisense silencing of 
the cognate essential gene.  
IPTG induction was used to titrate down the relative growth rate of E.coli As-fabI to 
approximately 75% 50% and 25% of normal growth. Protein was measured by comparing the 
extracted Ion chromatogram peak areas of light and 
15
N labelled forms of tryptic peptides 
EGAELAFTYQNDK and ILVTGVASK. Protein amounts were corrected by viable cell counts. 
Graph shows average protein molecules per cell with standard error bars (n=3). 
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Figure 3.33 FabI protein molecules per cell in E.coli MG1 ME5305 and Wild-type E.coli. 
FabI overexpression was induced with 0.5 and 1 mM IPTG. Protein abundance was measured 
by comparing the extracted Ion chromatogram peak areas of light and 
15
N labelled forms of 
tryptic peptides EGAELAFTYQNDK and ILVTGVASK. Protein amounts were corrected by viable 
cell counts. Graph shows average protein molecules per cell with standard error bars (n=3). 
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Both mRNA and protein abundance following gene silencing of fabI was 
evaluated to identify any correlation between the decrease in either mRNA or 
protein, with the observed decline in relative growth rate (Figure 3.34). No 
significant correlation (Pearson product correlation, n = 4, P >0.05) was 
observed.  The abundance of fabI transcripts appeared to initially increase prior 
to a large spike at approximately 50% of normal relative growth rate, after which 
mRNA abundance declined. When evaluated over the induction range of IPTG, 
the decline in protein abundance followed the decrease in growth rate (Figure 
3.35), although again, no significant correlation was observed (Pearson product 
correlation, n = 4, P>0.05). The decline in relative growth rate and mRNA 
abundance also revealed no significant correlation (Pearson product correlation, 
n = 4, P>0.05) (Figure 3.36). 
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Figure 3.34 mRNA transcript and protein abundance in E.coli following expressed 
antisense RNA silencing of the essential gene fabI.  
Relative mRNA abundance and protein molecules per cell were plotted against corresponding 
relative growth rate. Pearson product correlation revealed no significant correlation (n = 4, 
P>0.05) between mRNA and protein abundance. Graph shows average protein molecules per 
cell and mRNA abundance with standard error bars (n=3). 
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Figure 3.35 Relative growth rate correlation with FabI molecules per cell following 
expressed antisense RNA silencing of the essential gene fabI in E.coli.  
Growth rate titration of E.coli strain As-fabI was achieved with increasing concentrations of IPTG 
(50, 55 and 65 µM). Pearson product correlation revealed no significant correlation (n = 4, 
P>0.05) revealed between FabI molecules per cell or relative growth rate decline.  Graph shows 
average protein molecules per cell plotted with average relative growth rate against IPTG 
induction with standard error bars (n=3). 
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Figure 3.36 Relative mRNA abundance correlation with FabI per cell following expressed 
antisense RNA silencing of the essential gene fabI in E.coli.  
Growth rate titration of E.coli strain As-fabI was achieved by induction with increasing 
concentrations of IPTG (50, 55 and 65 µM). No significant correlation was revealed between 
protein molecules per cell or growth rate decline. Pearson product correlation revealed no 
significant correlation (n = 4, P>0.05).  Graph shows average protein per cell plotted with 
average relative growth rate against IPTG induction with standard error bars (n=3). 
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3.3.3 MTL50 and MPL50 for evaluating stringency of the essential E.coli 
gene fabI 
In this study the stringency of the essential E.coli gene fabI has been assessed 
using the concept of an MTL50 value (Figure 3.37). An MTL50 of 5 relative value 
or 500% of normal growth was determined for fabI, suggesting a large number 
of mRNA transcripts are required to maintain cell viability, and thus provides a 
measure of how stringency required the gene is. 
An alternative measure to MTL50 values for determining gene stringency can be 
obtained by substituting relative mRNA abundance for protein molecules per 
cell.  Relative growth rate can then be expressed as a function of protein 
molecules per cell to create a Minimum Protein Level (MPL50), whereby the 
number of protein molecules required for maintaining cell viability at 50% growth 
can be estimated. Application of this measure to fabI reveals a MPL50 value of 
approximately 7.5 x 102 molecules per cell (Figure 3.38).   
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Figure 3.37 Determining MTL50 value for the essential gene fabI.  
Average relative mRNA was plotted against corresponding average relative growth rate to 
generate the MTL50. This enables an estimation of the amount of mRNA required at the point 
where growth is reduced by 50% (y=0.5). This value represents the MTL50 which serves as a 
measure of gene stringency. Due to the increase in relative mRNA abundance at approximately 
50% and 75% of normal growth rate, no linear relationship could be established; hence MTL50 
could not be estimated in this case. 
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Figure 3.38 Determining MPL50 value for the essential gene fabI.  
Average protein molecules per cell were plotted against corresponding average relative growth 
rate to generate the MPL50. The resulting curve enables an estimation of the protein required at 
the point where growth is reduced by 50% (y=0.5). This value represents the MPL50 which 
provides an alternative measure of essential gene stringency. 
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3.3.4 Antisense RNA based whole-cell screening assays using triclosan 
and phosphomycin 
In addition to identifying essential gene targets, MPL50 values could be utilised 
for the optimisation of antisense RNA based whole cell screening assays. 
Appropriate levels of IPTG induction for antisense RNA expression required to 
achieve a specific level of sensitivity could therefore be defined. This is 
considered critical requirement for assays when screening for low abundance 
natural products (Baltz, 2008).  
As the initial phase of this experiment, the level of antisense RNA expression 
required to achieve a decrease in the MIC of target specific antibiotics was 
investigated. Having found a level of IPTG induction required to decrease the 
MIC for example 2-fold, cellular protein would then be quantified using the 
quantitative LC-MS/MS protocol incorporating the FabI protein internal 
standrad. 
 The MIC of strains sensitized for FabI (Figure 3.39) and MurA (Figure 3.40) 
were determined by liquid growth assay (see methods section: 2.6.10). The 
FabI inhibitor triclosan and MurA inhibitor phosphomycin were used since both 
compounds directly inhibit their respective encoded targets. Sub-inhibitory 
concentrations of each antibiotic were used based on previously determined 
MIC’s for the susceptibility of wild-type E.coli to triclosan (Bailey et al., 2009) 
and phosphomycin (Takahata et al., 2010). 
Expressed RNA silencing of fabI, resulted in a significant difference between 
relative growth rates at each triclosan concentration (Kruskal-Wallis, H= 13.705, 
3 df, P<0.05). At the highest level of IPTG induction (110 µM) an approximate 7 
fold increase in triclosan sensitivity was observed. In the case of murA 
silencing, no significant difference was observed between relative growth rates 
at selected phosphomycin concentrations  (Kruskal-Wallis, H= 0.628, 3 df, 
P>0.05).  
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Figure 3.39 Triclosan sensitivity in E.coli following expressed antisense RNA silencing of 
fabI.  
IPTG was used to induce antisense RNA expression in order to sensitize E.coli As-fabI to sub-
inhibitory concentrations of triclosan at 0.0339, 0.0078 and 0.0156 µg/ml. This was intended 
demonstrate how MIC changes with increased gene silencing. Graph shows average relative 
growth rates with standard error bars (n=3). 
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Figure 3.40. Phosphomycin sensitivity in E.coli following expressed antisense RNA 
silencing of murA.  
IPTG was used to induce antisense RNA expression in order to sensitize E.coli As-murA to sub-
inhibitory concentrations of phosphomycin at 0.0156, 0.0313 and 0.0625 µg/ml. As with the 
assay for triclosan, this was intended demonstrate how MIC changes with increased gene 
silencing. Graph shows average relative growth rates with standard error bars (n=3). 
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3.4 Species-specificity of peptide-PNA conjugates 
3.4.1 Evaluation of PNA to discriminate between bacterial species in a 
mixed culture 
The capacity of peptide PNA conjugates to induce gene silencing has been 
assessed directly with expressed antisense RNA from plasmids and found to be 
highly comparable (Goh et al., 2009). In addition to defining gene stringency, 
the inherent stability of PNA’s in vivo has facilitated research into their 
development as species-specific antimicrobials, in an effort to address antibiotic 
resistance (Good and Stach, 2011). The use of MPL50 values could therefore be 
applied to in the context of PNA’s to ascertain sufficient dose concentrations 
required to achieve bactericidal activity. Indeed bactericidal activity has 
previously been demonstrated against individual gene targets in E.coli (Good et 
al., 2001b). To date however, the capacity for PNA’s to promote bactericidal 
activity in an individual species within a mixed culture has not been evaluated. 
To examine the discriminatory potential of PNA’s further, a bioinformatics 
approach (see methods section: 2.7.1), was employed to identify the +5 to -5 
translation initiation region (TIR) of essential genes conserved between 
S.typhimurium and E.coli.  A total of 93 orthologous genes were identified, 47 of 
which possessed TIR’s with >2 base-pair mismatches necessary for effective 
silencing (Dryselius et al., 2006a). The essential gene ftsZ was selected for 
further investigation. In the majority of prokaryotes ftsZ encodes an FTPase that 
functions as a cytoskeletal element, analogous to the mammalian homologue 
tubulin in the regulation of cytokinesis (Bi and Lutkenhaus, 1991; De Boer et al., 
1992). Following chromosome replication, FtsZ self-assembles into 
protofilaments that form a Z-ring structure via isodesmic mechanisms. Once 
assembled the Z-ring localizes to the interior of the cytoplasmic membrane at 
the midcell, where it is stabilised by FtsA and ZipA and recruits other cell 
division proteins in the formation of a division septum (Margolin, 2005).  
Mutations that reduce the expression of ftsZ cause a characteristic change in 
cell morphology, whereby highly elongated cells are formed (Bi and 
Lutkenhaus, 1992).  Therefore PNA inhibition of ftsZ would enable phenotypic 
differentiation between S.typhimurium, which would be expected to form 
elongated cells compared to E.coli, where normal cell size would be maintained 
thereby allowing microscopic observation of PNA specificity within a mixed 
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culture. To provide contrast, E.coli AC01 and S.typhimurium AC02 were 
transfected with L-arabinose inducible plasmids, expressing DS-red and Green 
Fluorescent Protein (GFP) respectively. Mixed cultures were prepared, induced 
with L-arabinose and treated with 1.25 µM of Peptide-PNA Se0002. Samples 
were taken after 6 hours incubation and viewed using fluorescent microscopy 
(Figure 3.41). The phenotype of E.coli AC01 treated with Se0002 was 
consistent with untreated controls, indicating the absence of gene silencing. In 
contrast S.typhimurium AC02 displayed cell elongation, indicating a failure in 
cellular division associated with the inhibition of ftsZ. These results demonstrate 
the capacity for PNA’s to discriminate between species in a mixed culture.   
 
Figure 3.41 Effects of species-specific PNA essential gene ftsZ on E.coli and 
S.typhimurium.  
Mixed cultures of E.coli AC01 expressing DS-Red and S.typhimurium AC02 expressing GFP 
were treated with 1.25 µM Peptide PNA Se0002 targeting ftsZ and observed with fluorescent 
microscopy after 6 hours incubation. A filamentous phenotype associated with ftsZ silencing 
was observed for S.typhimurium AC02, but not E.coli AC01. 
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Chapter 4 Discussion 
4.1 Introduction 
The threat of increasing antibiotic resistance has created an urgent requirement 
for the development of targeted screening strategies for identifying novel 
antibiotics. Critical for such assays is the identification of suitable molecular 
targets that sustain cellular growth.  Essential genes have previously been 
identified as potential candidates using various genetic strategies. However, 
only recently has a concerted effort been made to ascertain the minimally 
required amount of gene expression necessary to sustain bacterial growth. A 
differential growth requirement (stringency) has been observed among essential 
genes. To date stringency has been assessed using mRNA abundance to 
represent expressed protein, yet issues have been raised concerning the large 
variation in mRNA-protein correlations for many genes. The lack of correlation 
between mRNA and protein is attributed to distinct post-transcriptional and post 
translational processing mechanisms, but also gene stochasticity. This study 
aimed to evaluate the stringency of essential gene targets in E.coli; firstly by 
examining operon based targets fusA and rplE and secondly; developing an LC-
MS/MS strategy for measuring stringency at the protein level, using the 
essential gene fabI to validate the approach. 
4.2 Specificity of antisense constructs 
The concept of antisense RNA based regulation in prokaryotes has been 
adapted to provide practical tools for studying gene expression (Rasmussen et 
al., 2007). Typical strategies involve the plasmid based expression of natural 
RNA transcripts within cells. Gene silencing occurs through a trans-mechanism, 
whereby expressed antisense RNA hybridizes to cognate mRNA, inducing 
transcript degradation and steric hindrance, and subsequently reducing the 
amount of translated protein. Using this strategy  two essential gene targets in 
E.coli; fusA encoding elongation factor G (EF-G), a translational GTPase 
involved in protein synthesis (Rodnina et al., 1997) and rplE encoding the 5S 
rRNA  ribosome accessory protein L5 (Korepanov et al., 2007), in addition to 
previous gene targets fabI, murA, ftsZ and acpP, have been evaluated. Growth 
assays revealed that expressed antisense RNA silencing of both essential gene 
targets fusA and rplE, causes a significant decline in cell growth rate. Notably a 
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reduction in growth rate was achieved at lower levels of IPTG induction, in 
comparison to previously assessed essential genes (Goh et al., 2009).  
Experimental conditions may have exerted significant influence in this study  
since the specificity of fusA and rplE was examined using MH media compared 
to LB media used in the assessment of fabI, murA, ftsZ and acpP (Goh et al., 
2009). In LB media carbon sources are limited and promote a change in the 
physiological state of E.coli, which switches metabolism to utilize amino acids 
causing a diauxic growth profile (Sezonov et al., 2007). In comparison, the use 
of MH media may support a higher rate of growth and subsequent antisense 
expression, resulting in higher silencing efficiency. A comparison between fabI, 
murA, ftsZ and acpP grown in MH and LB media however, revealed similar 
growth profiles over the same induction range of IPTG. An additional source of 
variability may arise from exogenous small RNA’s present in complex growth 
media, that arise from either the environment or as a by-product of RNA 
biogenesis from cells grown in the media. It has been determined that the 
presence of such exogenous sRNA’s exerts a significant effect on protein 
profiles (Pavankumar et al., 2012). Whether the presence of such entities would 
significantly enhance or suppress the effects of expressed antisense silencing is 
unknown. To validate any potential effects of exogenous sRNA’s would require 
growth profile comparisons of each strain using media pre-treated with RNase 
to prevent extraneous interference, ideally supported by transcript analyses. 
With regards to the difference in growth rate to previously examined essential 
gene targets, It is more plausible that the low level of IPTG induction required 
for growth inhibition of fusA and rplE compared to acpP, ftsZ, fabI or murA, can 
be ascribed to antisense sequence design. Silencing efficiency is dependent 
upon mRNA turnover, efficiency of translation initiation and accessibility of the 
paired termini-antisense sequence to mRNA (Nakashima and Tamura, 2009). 
Such factors could be assessed using an array of bioinformatics frameworks 
that incorporate structural fluctuation and the transition state mRNA undergoes 
according to environmental conditions to predict silencing efficiency (Johnson 
and Srivastava, 2013). Critically a BLAST alignment of the fusA antisense 
sequence reveals an alignment with the 3’ translated region of rpsG, which 
encodes the 30S ribosomal subunit protein S7. Similarly the rplE antisense 
sequence is complementary to the 3’ translated region of the 50S ribosomal 
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subunit protein L24. Conseqently off target effects may have occurred, resulting 
in reduced transcription of rpsG and rplX.  
Despite the significant growth inhibition which indicated a high degree of 
specificity for fusA and rplE paired constructs, speculation regarding gene 
stringency should be avoided in the absence of transcript or protein data. 
 
4.3 Validation of fusA and rplE expressed antisense RNA specificity 
Transcomplementation strategies are an established method to validate target 
specificity and mechanisms of action in gene silencing studies, since the 
expression of a complete ORF accounts for all transcript variations (Goh et al., 
2009). Although the specificity of rplE could be validated by 
transcomplementation, cell growth in fusA silenced E.coli could not be rescued. 
Currently no published data exists regarding the transcomplementation of either 
rplE of fusA in E.coli, following expressed antisense silencing. However 
transcomplementation has been used successfully to validate the specificity of 
expressed antisense RNA constructs for acpP, ftsZ, fabI and murA (Goh et al., 
2009).  
The overexpression of fusA appeared to contribute towards further growth 
reduction with increasing concentrations of L-arabinose. Furthermore, growth 
curves exhibited an extended lag phase in addition to a final cell density that 
was considerably lower compared to rplE. The absence of rescue may reflect a 
number of phenomena associated with gratuitous protein expression. The 
overexpression of certain genes is known to be toxic and detrimentally affects 
the growth rate of E.coli, due to a decrease in protein synthesis and 
accumulation of heat shock proteins (Dong et al., 1995). In addition the 
perturbation of normal cellular protein concentrations can disrupt the 
homeostasis of protein-protein interactions, thereby altering the rate of protein 
degradation and post–translational modification. Consequently protein half-life 
can be extended culminating in an accumulation of extraneous protein, which 
localizes at critical intracellular sites and disturbs normal cell functions (Koller et 
al., 2000). Excessive protein expression can induce an internal starvation 
response, resulting in a depletion of nutrients which through an unknown 
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mechanism,  initiates the destruction of rRNA and ribosomes, thereby reducing 
cellular capacity for protein synthesis (Kurland and Dong, 1996). The 
breakdown of rRNA also increases competition between the mRNA species of 
clones and native proteins for functional ribosomes, contributing towards further 
growth reduction (Dong et al., 1995). Although not examined further, 
microscopic examination of E.coli under these conditions would confirm if 
protein aggregation was occurring during transcomplementation of fusA. This 
would suggest if production was excessive and prompt the redesign of 
transcomplementation plasmid, possibly to incorporate a weaker promoter to 
reduce expression. 
Alternatively the reduced growth rate could be due to the metabolic burden 
associated with the simultaneous expression of plasmids with different selection 
markers. This state arises as a consequence of excess requirements for cell 
resources (energy and biosynthetic precursors), associated with the 
transcription and translation of encoded genes (Glick, 1995). Previous studies 
have reported growth defects arising from the expression of two strong 
promoter gene cassettes from multicopy plasmids that increase the metabolic 
burden on cells promoting plasmid loss (Anthony et al., 2009). Furthermore 
plasmid maintenance can alter the intracellular concentrations of cAMP-crP, 
disrupting the transcription of many host regulons (Diaz Ricci and Hernández, 
2000). However rplE did not reveal a similar trend using the same plasmids and 
selection marker genes, which suggests that fusA itself, may have been 
contributory factor in the failure to rescue cell growth.  
Although the fusA encoded protein functions as a translational GTPase in 
protein synthesis, a secondary role has been suggested as a molecular 
chaperone in facilitating the stabilization and folding of denatured proteins 
(Caldas et al., 2000). This purported role has been supported by increases 
amounts of FusA in response to exogenous stressors in E.coli (Han et al., 
2008). Consequently, the excess of FusA synthesized following induction may 
exceed a critical level required for protein synthesis.  Excess FusA may 
therefore have been available to function inappropriately as a chaperone and 
bind non-specifically with cytosol proteins to detrimental effect. This could be 
evaluated by examining cell lysate via SDS-PAGE or by using western blotting 
to detect increased levels of FusA. 
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The inability to validate antisense function by transcomplementation in the case 
of fusA may reflect a disruption in protein homeostasis, by altering protein-
protein interactions and stoichiometry. Such changes may promote the 
misfolding and aggregation of numerous cellular proteins and alteration in 
protein turnover. Where excessive synthesis occurs, chaperone proteins and 
proteases that constitute the intracellular quality control system can no longer 
compensate (Mogk et al., 2011) . Alternatively fusA expression for cell viability 
may be dependant upon a fine equilibrium between mRNA transcripts and 
translated protein. This could be attributed to the IPTG and L-arabinose based 
expression systems, which may lack the capacity to provide sufficiently refined 
induction ranges to maintain optimal expression. Indeed cross talk has been 
observed between PBad and PLac promoters through an undefined mechanism, 
which was found to be alleviated through directed evolution of the arabinose 
transcriptional activator AraC (Sung et al., 2007). Incidentally the detrimental 
effects on cellular growth observed from transcomplementation would suggest 
that fusA may be a stringently required target. Due to the discrepancies 
observed with transcomplementation however, in particular with fusA, this 
technique may be limited to the validation of expressed antisense specificity of 
individually transcribed genes. 
4.4 Growth inhibitory effects of silencing rplE and fusA in E.coli 
Essential gene targets that display bactericidal activity upon inhibition are 
desirable due to the reduced prospects of resistance developing and increased 
therapeutic efficacy (Stratton, 2003). Therefore characterizing the activity of 
molecular targets is a pre-requisite for the selection of suitable targets as part of 
antibiotic screening assay development. 
The inhibitory effects of silencing both fusA and rplE in this study were 
determined to be bacteriostatic, since viable cell counts did not show a 3 log 
reduction in cfu/ml, representing the benchmark for bactericidal activity. The 
bacteriostatic nature of fusA is supported by the documented activity of known 
inhibitors such as fusidic acid in sensitive E.coli strains (Harvey et al., 1966). To 
date there is no known antibiotic that specifically targets rplE, however, 
inhibition following the silencing of ribosomal genes rplJ and rpsL, (encoding 
50S ribosomal protein L10 and 30S ribosomal subunit protein S12 respectively) 
in M. smegmatis, have been characterized as bacteriostatic (Kaur et al., 2009). 
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Further support is evident in the mechanism of macrolide antibiotics, which are 
characteristically bacteriostatic and have a speculated capacity to interact with 
the L5 subunit (Schlünzen et al., 2003). Bacteriostatic inhibition arising from 
targeting of the ribosome has been linked to the inhibition of the in vitro folding 
capacity of the 23S rRNA, preventing the peptidyl transferase reaction rather 
then ribosome destruction (Chattopadhyay et al., 1996). This is especially 
prevalent with antibiotics that target the 50S subunit exclusively (Chattopadhyay 
et al., 1999), where the L5 ribosome protein encoded by rplE is assembled.  
Despite the specificity and rapid decline in growth rate observed following 
silencing of fusA and rplE, the experimental findings characterize both genes as 
bacteriostatic targets. Whether the use of expressed antisense provides an 
accurate characterization of target inhibition is unclear, since inhibition of the 
same gene targets by different entities can cause variable effects. In the case of 
antibiotics, chloramphenicol is bacteriostatic in E.coli, but bactericidal in 
H.influenza. Furthermore, the inhibitory effects of PNA’s on gene targets are 
bactericidal, despite bacteriostatic inhibition observed with target specific 
antibiotics. 
The bactericidal activity observed with ribosome targeting has been attributed to 
the mistranslation and misfolding of membrane proteins which initiates a stress 
response. Antibiotic induced conformational changes in the ribosome, causes 
tRNA mismatching resulting in mistranslated proteins, which are bound to 
chaperone proteins and directed towards the membrane. At this stage defective 
proteins undergo translocation across the inner membrane which activates the 
envelope two-component stress response sensor CpxA. CpxA phosphorylates 
CpxR which in turn activates the stress response proteins including the redox 
responsive two-component  transcription factor ArcA which upregulates both 
metabolic and respiratory systems leading to oxidative stress (Kohanski et al., 
2008). In contrast antisense mediated inhibition reduces target mRNA 
abundance through decay or steric hindrance, neither of which initiates a 
secondary pathway capable of initiating oxidative stress. Consequently the use 
of antisense silencing may not be predictive of the mode of action utilised by 
target specific inhibitors. Although the silencing of one essential gene may be 
insufficient to generate bactericidal activity, the silencing of two essential  genes 
simultaneously may prove synergistic. Dual silencing of the ackA-pta operon in 
   
135 
E.coli, demonstrated increased silencing compared to individual expression 
(Nakashima and Tamura, 2009). Therefore essential genes within the same 
operon may be assessed in tandem to determine if bactericidal activity is 
evident. 
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4.5 Evaluation of stringency in essential genes rplE and fusA 
Evaluating the stringency of essential genes supports gene characterization, 
network analyses and the identification of suitable molecular targets for 
antibiotic screening assays. This study has evaluated the stringency of essential 
genes rplE and fusA in E.coli, using expressed antisense RNA silencing to 
titrate down the growth rate and measure the associated transcript abundance. 
Gene silencing of both rplE and fusA although causing a significant decline in 
growth rate, failed to cause a significant decrease in mRNA abundance. In 
E.coli expressing antisense rplE, the transcript abundance initially increased 
upon induction and remained stable as relative growth rate decreased. 
Silencing of fusA revealed an initial decrease in mRNA abundance, prior to a 
large increase in mRNA at the lowest growth rate. The standard error for 
relative growth rate showed significant variation, especially for two data points 
in fusA. This may reflect variation in cDNA synthesis despite batch reactions 
being performed. These results contradict previous determinations of essential 
gene stringency for fabI, murA, acpP and ftsZ, where mRNA abundance 
decreased in parallel with growth rate (Goh et al., 2009).  
For direct comparisons of stringency with previously validated essential targets, 
MTL50 values were calculated. An inverse trend for both fusA and rplE was 
observed, whereby expressed antisense silencing causes an increase in 
transcription, resulting in higher target mRNA abundance. The transcript 
abundance required to maintain a 50% growth rate was higher then the level for 
normal growth rate. This finding initially suggests that rplE and fusA are not 
stringently required for cell viability.  However, the apparent increase and 
stability of mRNA abundance could be ascribed to partial degradation of mRNA, 
resulting in non-functional transcripts that were still viable templates for 
amplification during QPCR. If true, then a reduction in growth rate would be 
expected, while mRNA abundance remains high. The location of amplified 
regions used by primers in QPCR would likely play a significant role. If amplified 
regions were located at the 5’ end of the mRNA transcript, then the possibility of 
viable template persisting is likely, since enzyme mediated destruction of 
antisense bound transcripts occurs primarily from the 3’end (Condon, 2007). 
Unlike fusA and rplE, previously assessed essential genes were individually 
transcribed (Goh et al., 2009). In contrast both rplE and fusA are located within 
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ribosomal operons, which are subject to an autogenous feedback mechanism 
from genes encoding ribosomal subunit proteins (Yates et al., 1980). The spc 
operon encodes rplE in addition to nine other genes encoding sequential 
subunits; rplN (L14), rplX (L24),  rplE (L5),  rpsN (S14),  rpsH (S8),  rplF (L6),  
rplR (L18),  rpsE (S5),  rpmD (L30),  and rplO (L15),  (Cerretti et al., 1983). 
Within this operon the ribosomal protein S8, functions as a translational 
repressor (Dean et al., 1981a), through binding in proximity to the translation 
initiation region of rplE, inhibiting its translation and that of distal proteins. 
Additionally S8 also governs the expression of proximal proteins (L14 and L24) 
via a retro-regulation mechanism, involving exonuclease degradation following 
translation repression of L5 (Mattheakis et al., 1989). These regulatory 
mechanism may account for the discoordinate expression of mRNA, which has 
been observed following mutations in the start codon region of rplE, which 
reduce the synthesis of distal proteins 20-fold, yet exhibit little effect on mRNA 
synthesis. In addition overproduction of the S8 repressor causes a 3-fold 
reduction in protein synthesis, but not mRNA synthesis (Mattheakis and 
Nomura, 1988). A separate ribosomal operon str encodes both ribosomal 
protein subunits; rpsL (S12), rpsG (S7), elongation factors fusA (EF-G) and tufA 
(EF-Tu). Within this operon, S7 acts as a translational repressor and regulates 
the synthesis of EF-G and EF-Tu by translational coupling (Dean et al., 1981b), 
and S12 by retro regulation (Saito and Nomura, 1994).  
Unlike individual genes, the transcription of polycistronic mRNA and subsequent 
translation is discoordinated (Dryselius et al., 2006a).  Evidence For this 
phenomena is derived from a study of the lac operon in E.coli using targeted 
PNA’s to the structural genes lacZ, lacY and lac, which revealed a directed 
inhibitory effect. PNA mediated inhibition of lacZ reduces expression of 
downstream lacY and lacA, yet inhibition of lacY does not affect the expression 
of lacZ, only lacA (Dryselius et al., 2006a). A further discrepancy was observed 
with the number of lacZ transcripts that were 3-4 fold higher,  due to cleavage 
by RNaseE within an intergenic region between lacZ and lacY, resulting in 
increased stability of lacZ transcripts and decay of lacA (Li and Altman, 2004). 
The lack of decline in mRNA abundance observed following gene silencing of 
fusA and rplE, may reflect a disturbance in normal feedback regulation within 
each operon due to translational coupling of distal genes. For rplE in particular,  
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the regulation of r-protein expression is founded on the interaction between 
rRNA and mRNA, due to structural features that recognize homologous 
sequences. A single subunit can therefore coordinately regulate the synthesis of 
other subunits via translational feedback (Nomura et al., 1980). In the context of 
these results a reduction in rplE encoded L5 protein may alter the stoichiometry 
of ribosomal subunits, consequently reducing repressor mediated effects of the 
S8 regulatory protein. Parallel examination of both mRNA and protein 
abundance would aid in elucidating these effects. Indeed disproportionate 
reductions of mRNA and protein have been observed for genes within operons 
(Dryselius et al., 2006a).  
The lack of consistent mRNA decline with increased antisense RNA silencing 
may also reflect the inherent heterogeneous nature of isogenic (genetically 
identical) cell populations. Within these populations, sub-populations exist that 
exhibit variations in physiologically state, manifesting as in growth rate, cell age, 
metabolic state or stage in the cell cycle. These variations arise due to 
intracellular differences in resources and cell machinery, which are amplified by 
cellular cascade mechanisms (Lidstrom and Konopka, 2010). These differences 
underlie the phenomena of gene stochasticity (noise), whereby the expression 
of genes occurs at irregular intervals and in short burst of transcription and 
translation to generate variable numbers of proteins (McAdams and Arkin, 
1997). Early studies of gene stochasticity identifying key causes, which were 
attributed to Intrinsic noise; associated with the expression of a gene sequence, 
and  extrinsic noise arising from the interactions of other cellular components 
(Elowitz et al., 2002).From an evolutionary perspective, these stochastic events  
have been speculated to function as a survival strategy, that confers a selective 
advantage, by priming regulatory pathways for the onset of sudden 
environmental changes (Fraser and Kærn, 2009). Subsequent studies into gene 
stochasticity have lead to the development of fluorescent based techniques that 
permit the measurement of mRNA in individual bacterial cells (Golding et al., 
2005). Such techniques represent an alternative to QPCR and provide a more 
direct and visible means of quantifying transcript abundance. 
From an experimental perspective, the abnormally high MTL50 values could also 
reflect the narrow range of IPTG used to induce silencing. For fusA and rplE, 
this ranged from 5 – 25 µM in comparison to wider range of inducer 
   
139 
concentrations for fabI, murA, ftsZ, acpP (Goh et al., 2009). In retrospect, both 
rplE and fusA represent poor targets and highlight the limitations of assessing 
gene stringency based upon mRNA abundance, especially for gene targets 
encoded within operons with regulatory feedback mechanisms. 
Recently a method for evaluating operon genes in isolation was developed to 
address such discoordinate expression. A dynamic transcriptional control on/off 
switch was constructed using the Lambda repressor, which was inserted into 
the chromosomal position of the lac repressor. A plasmid expressing fusA under 
control of the lambda promoter was then used for constitutive expression. The 
addition of IPTG, subsequently enabled gene expression to be switched on and 
off (Min et al., 2012). In summary the determined MTL50 values for fusA and 
rplE suggest neither gene is stringently required for cell viability, based on the 
present definition.  
These results emphasize the complexities of evaluating operon based essential 
genes due to translation coupling and regulatory feedback mechanisms. 
Consequently the MTL50 value may be limited as a measure of gene stringency 
and supports the case for evaluating essential genes at the level of protein 
expression. 
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4.6 Evaluation of gene stringency in essential gene fabI by proteomics 
Previous measures of essential gene stringency have assumed that relative 
mRNA transcripts are directly related to the amount of translated protein. 
However a lack of correlation between mRNA and protein due to gene 
organization and regulatory mechanisms is well documented.  Consequently the 
direct measurement of expressed protein provides the most appropriate 
determination of cell physiology and therefore gene stringency. This study 
aimed to address the limitations of the MTL50 value used for measuring 
essential gene stringency. An LC-MS/MS assay was devised to quantify the 
abundance of fabI protein in E.coli in parallel with mRNA abundance, following 
expressed antisense RNA silencing.  
The LC-MS/MS assay revealed a significant decrease in the abundance of FabI 
following gene silencing; however no correlation with mRNA abundance was 
observed.  Indeed relative mRNA abundance increased when the relative 
growth rate reached 50% of normal growth. Although transcriptome and 
proteome analyses often reveal divergent profiles (Jayapal et al., 2008), the 
silencing of fabI in a previous study did show an overall decline in mRNA 
abundance with IPTG induction ranging from 20 to 80 µM. At induction 
concentrations above 80 µM however, mRNA abundance was seen to increase 
marginally (Goh et al., 2009). The lack of definitive decrease in mRNA 
abundance observed in this study may reflect the narrow range of IPTG 
concentrations used to induce antisense expression (50 – 65 µM). Over this 
range, decreases in mRNA abundance may be obscured by inherent noise 
associated with stochastic gene expression (Raj and van Oudenaarden, 2008). 
However the observed growth reduction suggests expressed antisense is 
functioning. As in the case of rplE and fusA, those transcripts detected in QPCR 
analyses may be non functional, yet provide viable templates for amplification, 
generating mRNA profiles. 
The disproportionate correlation between mRNA and protein abundance may 
also reflect the dynamic relationship between  their respective rates of synthesis 
and degradation (Vogel and Marcotte, 2012). The synthesis of  mRNA is 
dictated by factors that effect recruitment of RNA polymerase and associated 
transcription factors to the transcription start site, such as chromosome 
structure and promoter strength (Balleza et al., 2009). The stability of mRNA 
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transcripts is governed by RNaseE and the length of mRNA. Although mRNA 
turnover contributes to mRNA-protein correlation, the greatest influence is 
attributed to post-transcriptional and post-translational mechanisms that 
regulate protein turnover (Maier et al., 2009). The secondary structure of 
transcribed mRNA, strength of the Shine Dalgarno sequence, codon bias and 
ribosome density all contribute to translational efficiency (Maier et al., 2009). 
Following translation mRNA-protein ratios are influenced further by protein half-
life, which is dictated by protein stability and post-translational processes (Maier 
et al., 2009). Consequently examining mRNA and protein turnover may provide 
a more comprehensive assessment of gene stringency. Attempts at quantifying 
mRNA and protein turnover have been attempted in the minimal genome 
bacterium Mycoplasma pneumonia, where protein abundance ranged over 
three orders of magnitude (Maier et al., 2011). Furthermore the ratio of mRNA: 
protein varied during the growth phase and was highly uncorrelated for genes 
existing within operons. Notably, a higher correlation was observed if operons 
were short and genes were not situated at the 3’ end (Maier et al., 2011). 
However a global analysis of mRNA decay and abundance of 4288 predicted 
mRNA’s in E.coli, suggested that generalizations concerning the decay of 
transcripts was limited in applicability. This conclusion arose from the finding of 
an inverse relationship between transcript abundance and stability. A similar 
inverse trend was found following analysis in M.tuberculosis, where a global 
stabilization of transcripts was observed in response to cellular stress (Rustad 
et al., 2013). 
An alternative to the use of QPCR would be to employ RNA sequencing to 
quantitate expression of silenced genes. The approach utilizes deep 
sequencing technologies based on the conversion of mRNA to cDNA which is 
ligated to adapters and sequenced. RNA sequencing displays a high level of 
sensitivity and is not susceptible to background interference resulting in strong 
signal:noise ratios.  Furthermore, unlike QPCR RNA sequencing does not 
require normalization of data sets (Wang et al., 2009). The quantitative capacity 
of RNA sequencing has been demonstrated, and shows strong correlation with 
both QPCR (Nagalakshmi et al., 2008)  and label--free LC-MS/MS methods (Fu 
et al., 2009).  
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A comparison of FabI molecules per cell between E.coli As-fabI, AG1 ME5305 
and a wild-type control revealed a significant difference in protein abundance. 
The number of FabI molecules per cell was higher in the antisense control, 
which may be evidence of high basal promoter (Ptrc) activity associated with 
the paired termini vector in the absence of IPTG (Nakashima and Tamura, 
2009). To date limited published data exists regarding the protein abundance of 
fabI quantified using LC-MS/MS following antisense expressed silencing. In 
E.coli a value 12,500 FabI copies per cell has been determined (Ishihama et al., 
2008).  A basal expression level of 12,000 copies per cell has also been 
determined in S.aureus (Slater-Radosti et al., 2001).  These estimations are 
approximately 5-fold higher then this study’s observations in the E.coli As-fabI 
control (2561 FabI molecules per cell) and approximately 17 fold higher then the 
basal level observed in wild-type E.coli (718 FabI copies per cell). An accurate 
comparison is limited however, since abundance measurements in E.coli was 
determined using a linear ion trap rather then an orbitrap mass spectrometer, 
resulting in faster scan cycles and increased m/z range. The use of additional 
protein fractionation steps to increase identification coverage, in addition to the 
use of an emPAI approach for quantitative analysis (Ishihama et al., 2008), 
would also account for the variation observed with this study. With regards to 
S.aureus, genetic differences such as the presence of homologues and the 
semi-quantification of protein abundance using western blotting, also limit a 
direct comparison (Slater-Radosti et al., 2001). 
The quantfication of the 15N FabI internal standard revealed a significant 
difference in the fmol amount after extrapolation from independent standard 
curves generated for EGAELAFTYQNDK and ILVTGVASK. Experimental error 
is a feasible explanation due to the low volumes of standard spiked into pre-
trypsin digests. However, steps were introduced to limit potential inaccuracies, 
such as the preparation of serial dilutions at fixed ratio rather then fixed interval 
(Han and Higgs, 2008).  Further variation in the quantitative analysis may be 
accounted for by the effects of 15N incorporation. Absolute quantification using a 
15N labelled internal standard is reliant upon the isotope dilution principle. This 
concept is based on the assumption that physiochemical properties between 
light and heavy labelled peptides are equivalent. The concept  also assumes 
that the effects of isotope incorporation on protein structure and function are 
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negligible. This notion has been disputed following a recent study of 15N 
labelling on protein expression in E.coli. where incorporation of 15N was found to 
effect the expression of over 40 cytoplasmic proteins. Critically the proteins 
affected included key metabolic enzymes, which accounted for significantly 
reduced growth rates (Filiou et al., 2012). The direct incorporation of a heavy 
isotope may result in decreased enzyme function due to conformational 
changes in key residues such as the active site. It is known that 15N can alter 
structural integrity of proteins, through changes in peptide backbone torsion, 
side-chain orientation of residues and hydrogen bonding between neighbouring 
peptides (Xu and Case, 2002). This phenomenon has been validated by studies 
of copper metallothioneins in S.cerevisiae, which show aberrant spectroscopic 
profiles, indicating the distortion of normal protein architecture with 15N labelling 
(Hartmann et al., 2003). 
The incorporation effects of 15N may therefore influence the quantification 
process in particular the tryptic digestion step, as trypsin has been found to 
cleave light proteins at a faster rate compared to heavy labelled proteins 
(Konopka et al., 2012). False L\H ratios could therefore be generated 
compromising accurate quantification of protein abundance. Despite this risk, 
the effects of 15N incorporation have been limited to physiochemical properties 
of peptides, such as chromatographic retention time and found to exert no 
influence on quantification accuracy (Webhofer, 2013). Nonetheless, 
incorporatation effects on trypsin digestion should be evaluated as part of the 
LC-MS/MS validation. Ideally this would be incorporated as part of the internal 
standard validation process and would be evaluated by analysing  tryptic 
digests of equal quantities of 15N labelled and unlabelled FabI protein over 
varying incubation times. LC-MS/MS could then be used to examine the degree 
of variance in the L:H ratio, which would be expected to be equal if the effects of 
15N incorporation were negligible. 
The absence of correlation between transcripts and expressed FabI in E.coli as 
demonstrated in this study, highlight the limitations of using mRNA as a direct 
proxy for expressed protein. The obtained results demonstrate the capability of   
an LC-MS/MS strategy incorporating a fully 15N labelled internal standard, for 
measuring protein concentration per cell.  From the quantitative data, essential 
gene stringency has been established using the MPL50 value to define the 
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absolute growth requirement of the essential gene fabI. These findings 
therefore support the argument for quantifying expressed protein, which 
provides a more accurate reflection of essential gene stringency.  
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4.7 Species specificity of peptide-PNA conjugates in mixed bacterial 
cultures 
Alternative strategies for the treatment of bacterial infections have been 
pursued to address the limitations posed by the development of multiple 
antibiotic resistance mechanisms. Gene silencing using peptide-PNA 
conjugates demonstrates the potential to discriminate between gene 
sequences, since they can be designed to exploit the degeneracy of the genetic 
code, thereby allowing gene silencing to be used in a discriminatory capacity.. 
This study has examined this potential of peptide-PNA conjugates as a species-
specific antimicrobial, by designing a PNA sequence incorporating a 2 base-pair 
mismatch, to delineate the effects of silencing of the essential gene ftsZ in 
S.typhimurium and E.coli.  Treatment of mixed cultures with PNA revealed no 
effect on E.coli, however elongated cells of S.typhimurium were observed. This 
phenotype is consistent with mutations that reduce expression of ftsZ causing a 
characteristic change in cell morphology to form highly elongated cells (Bi and 
Lutkenhaus, 1992). Further validation is provided by similar results in previous 
silencing studies of ftsZ using peptide-PNA conjugates (Goh et al., 2009). The 
results confirm that a peptide-PNA conjugate with sequences incorporating a 2 
base-pair mismatch were sufficient to selectively bind to and inhibit translation 
of ftsZ thereby interrupting cell division causing cell elongation in S.typhimurium 
but not E.coli.  
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Chapter 5 Conclusion and Future Work 
The sustained threat of multiple antibiotic resistance has invoked interest in 
empirical target based screening assays, for the discovery of novel antibiotic 
compounds.  An integral component of target based strategies is the selection 
of an encoded molecular target, such as essential genes which provide suitable 
candidates. Defining essential genes has been previously founded on 
systematic gene deletion studies, where cessation of cell growth in the absence 
of a gene defines essentiality. The aim of this study was to expand on previous 
findings that a differential growth requirement or stringency exists among 
essential genes and is reflected in both the transcriptome and proteome profiles 
of E.coli, following gene silencing 
The unpredictable effects of silencing operon based genes presents a 
significant limitation with the antisense silencing strategy for evaluating gene 
stringency, as observed   in this study with divergent transcript and protein 
profiles. Consequently, alternative approaches have been sought to provide 
temporal gene regulation. The development of inducible protein degradation 
systems represents one such example. This strategy is founded upon adaptor 
mediated proteolysis, which regulates protein turnover in prokaryotes. The 
central  component is the  protease complex  ClpXP consisting of an ATPase 
(ClpP) and a peptidase (ClpX), which recognises and binds to unstructured 
peptide sequences at the N or C terminus of proteins that function as 
degradation tags (degrons) (Baker and Sauer, 2012). A known degron tag is the 
short peptide SsrA which is translated and added to incomplete proteins, 
following ribosome stalling, due to the absence of stop codons or premature 
transcription termination (Keiler et al., 1996). Adapting this process enabled an 
assessment of antibiotic inhibition required to inactivate encoded gene products 
(termed vulnerability) (Wei et al., 2011). In this study, phage homologous 
recombination was used to insert a sequence encoding a modified SsrA tag 
fused to a protecting peptide, into chromosome regions encoding individual 
antibiotic targets in M.smegmatis. A virus-specific protease targeting the 
protecting peptide was put under the control of a tetracycline promoter and also 
integrated. Expression of the viral protease removed the protecting peptide and 
exposed the SsrA tag to ClpXP mediated degradation of individual target 
proteins causing an increase in antibiotic sensitivity. This strategy also enabled 
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the differentiation between bactericidal and bacteriostatic antibiotic targets (Wei 
et al., 2011).  
More recently an alternative inducible protein degradation system has also been 
described in E.coli. Strains were constructed using homologous recombination 
to insert a proteolytic system consisting of a promoter (lac) driven ClpA gene for 
inducible degradation and constitutive promoter driven ubiquitin protease. A 
modified tryptophan promoter was combined with the trpR gene encoding 
tryphtophan repressor and replaced the tryphanonanse tnaA gene. The ORF for 
ubi4 (target for ubiquitin protease) was then inserted upstream of the target 
gene. This system enabled biphasic control of target protein and also 
delineation between bactericidal and bacteriostatic activity (Yoshida et al., 
2012).  
Unlike expressed antisense RNA silencing, inducible protein degradation 
systems are capable of maintaining basal expression levels, while avoiding 
directional effects associated with operon silencing, including the disruption of 
feedback regulation. Protein half-life can also be strictly regulated to prevent 
extraneous accumulation and potential toxicity.  The experimental approach in 
this study could therefore be improved by combining inducible protein 
degradation with a quantitative LC-MS/MS strategy, to provide a comprehensive 
determination of gene stringency.  
Whether using antisense RNA or protein degradation systems for studying gene 
stringency, consideration should be given towards the unknown consequences 
of silencing a single gene on the expression of other genes, either directly or 
through feedback regulation. Due to the lack of knowledge concerning how 
cellular pathways interact, a pre-requisite to determining gene stringency, would 
therefore be to validate the effects of silencing strategies on the global 
transcriptome and proteome of model organisms such as E.coli. 
An intended aim of evaluating essential gene stringency was to facilitate the 
pre-screening of genes to enable the prioritization of targets for natural product 
screening assays and for designing species specific PNA’s (Goh et al., 2009).  
Further applications have since become apparent in the emerging research field 
of synthetic biology, which aims to combine investigative biology techniques 
with engineering concepts such as standardization, decoupling and abstraction 
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(Endy, 2005). This multidisciplinary approach is envisaged to facilitate the 
rationale design and systematic construction of a library of compatible modular 
devices, which can be assembled to form functional metabolic pathways and 
networks.  This would support the elucidation of a minimal genome chassis, and 
ultimately the development of synthetic organisms (Purnick and Weiss, 2009).   
In order to facilitate the assembly of complex cell systems, there is a 
requirement for a library of characterized and standardized elements to enable 
interchangeability between modules (Güttinger, 2013). With regards to the 
construction of a minimal genome, a pre-requisite would be the characterization 
of minimal gene sets for cell viability. Previous efforts to define minimal genes 
have generated inconsistent results, due to inherent limitations in the 
experimental techniques used.  Transposon mutagenesis overestimates the 
number of essential genes by considering those that slow growth, but do not 
stop it as essential. Antisense RNA silencing is also limited to genes that can be 
inhibited by sufficiently expressed levels of antisense inhibitor and does account 
for redundant genes (Moya et al., 2009). Consequently misinterpretations arise 
as evident from genome reductions of up to 30% which do not decrease cell 
viability (Fehér et al., 2007), despite many deleted genes having previously 
been characterized as essential (Gerdes et al., 2003).  
Given these discrepancies, the evaluation of essential gene stringency would 
support characterization efforts and enable the creation of an essentiality 
threshold. Knowledge of stringently required genes would therefore minimise 
biological complexity through the removal of non-stringent genes from minimal 
gene sets, facilitating the construction of a minimal genome chassis and 
supporting the classification of modular functionality (Esvelt and Wang, 2013). 
Furthermore, essential gene stringency would aid the development of in silico 
modelling especially for metabolic reconstitutions (Chavali et al., 2012) and 
genome scale engineering (Esvelt and Wang, 2013). 
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Appendix A: Growth Media & Buffer compositions 
Luria-Bertani (LB) Agar 
Tryptone    - 10.0 g/L 
Yeast Extract   - 5.0 g/L 
Sodium Chloride   - 5.0 g/L 
Agar     - 15.0 g/L 
Muller Hinton Broth 
Beef Infusion Solids   - 2.0 g/L 
Casein hydrolysate   - 17.5 g/L 
Starch     - 1.5 g/L 
SOB medium 
Tryptone    - 20g/L 
Yeast extract    - 5g/L 
Sodium chloride   - 0.5g/L 
Potassium chloride   - 10 ml of 250 mM 
Magnesium Chloride  - 5ml sterile 2 M prior to use  
SOC Medium 
As SOB medium with the addition of 20 m l of 1 M glucose to provide a final 20 
mM concentration. 
M9 Minimal media 
Disodium phosphate  -  33.78 g/L   
Monopotassium phosphate - 15 g/L  
Sodium chloride   - 2.5 g/L  
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Ammonium chloride   - 5 g/L  
Magnesium sulphate  -  2 mM  
Glycerol    - 20%   
Calcium chloride   - 0.1 mM  
Iron Sulphate   - 0.01 mM  
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Appendix B: Publications associated with this study 
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Broad-spectrum antimicrobials kill indiscriminately, a property that can lead to 
negative clinical consequences and an increase in the incidence of resistance. 
Species-specific antimicrobials that could selectively kill pathogenic bacteria 
without targeting other species in the microbiome could limit these problems. 
The pathogen genome presents an excellent target for the development of such 
antimicrobials. In this study we report the design and evaluation of species-
selective peptide nucleic acid (PNA) antibacterials. Selective growth inhibition of 
B. subtilis, E. coli, K. pnuemoniae and S. enterica serovar Typhimurium in 
axenic or mixed culture could be achieved with PNAs that exploit species 
differences in the translation initiation region of essential genes. An S. 
Typhimurium-specific PNA targeting ftsZ resulted in a cell elongation phenotype 
that was not observed in E. coli, providing phenotypic evidence of the selectivity 
of PNA-based antimicrobials. Analysis of the genomes of E. coli and S. 
Typhimurium gave a conservative estimate of >150 PNA targets that could 
potentially discriminate between these two closely related species. This work 
provides a basis for the development of a single class of antimicrobial with a 
tuneable spectrum of activity. 
 
Introduction. 
Treatment of bacterial infections with antimicrobial drugs has been clinically 
effective for over six decades. However, the rise of antimicrobial resistance 
threatens to limit options for the treatment of life-threatening microbial diseases 
(Jayaraman, 2009). Arturo Casadevall noted that antimicrobial therapy ‘is the 
only branch of medicine where therapeutic options were better in the mid-20th 
century than at the beginning of the 21st century (Casadevall, 2006)’. A critical 
factor behind the rise in resistance is the spectrum of activity of the antibacterial 
agent; the development of broad-spectrum agents (effective against a number 
of microbial species) enabled empirical usage (i.e. without the use of diagnostic 
identification of the pathogen) and rapid treatment of fulminate microbial 
infections. However, it is this broad-spectrum of activity that is partly responsible 
for the prevalence of multi-drug resistant bacterial pathogens. Also, the human 
body plays host to hundreds of microbial species, collectively termed the 
microbiome (Eckburg et al., 2005), the majority of which are beneficial to health. 
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Thus, the use of non-specific broad-spectrum antimicrobial agents will have 
unintended detrimental affects on the microbiome, which can result in 
colonization of pathogenic microbes. Examples of such opportunistic infections 
include Clostridium difficile-associated diarrhea, antibiotic-associated colitis and 
candidiasis (Fowler et al., 2007; Casadevall, 2009). Perhaps of greater concern 
is the link between the microbiome and the normal development of the immune 
system; there are indications that the use of broad-spectrum agents may 
increase the risk of diseases such as asthma, eczema, rhinoconjunctivitis and 
breast cancer (Velicer et al., 2004; Foliaki et al., 2009). Furthermore, broad-
spectrum antimicrobial treatment selects for resistance mechanisms in non-
target species that are readily transferred to pathogenic species (Hoban, 2003; 
Yates et al., 2006). The impact of broad-spectrum antimicrobial agents on the 
gut microflora was highlighted in a recent study by Jakobsson et al (Jakobsson 
et al., 2010): the authors reported that treatment of Helicobacter pylori infection 
with the macrolide antibiotic clarithromycin, resulted in perturbation of the gut 
microflora associated with an increase in level of the macrolide antibiotic 
resistance gene erm(B). These effects were observable four years after 
antibiotic exposure.  
Recent findings demonstrating the importance of the microbiome in host health, 
have led to a growing interest in the use of microbiota-targeted therapies that 
can eliminate individual strains of single species (Lemon et al., 2012), for 
example, through targeting of drugs to microbial genes (Holmes et al., 2012). 
The increasing incidence of multi-drug resistant bacteria, coupled to declining 
discovery of novel broad-spectrum antimicrobial compounds, will likely make 
the development of species-specific antimicrobials a necessity; simultaneously 
providing the market conditions required for such a change in emphasis within 
drug development companies. Improved on-site diagnostics should soon enable 
pathogen/drug pairing in clinics. The development and implementation of any 
species-specific antimicrobial possess significant clinical challenges: 
nevertheless, the approach, alongside immunotherapy aimed at improving host 
responses, is predicted to deliver the “Third Age of antimicrobial therapy 
(Casadevall, 2006; Casadevall, 2009; Then and Sahl, 2010)”.  
     Technologies for species-specific pathogen inhibition include 
immunotherapy, radioimmunotherapy, anti-virulence agents, and phage therapy 
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(Then and Sahl, 2010, and references therein). Growing interest in narrow-
spectrum antimicrobial compounds is evident in recent studies that have 
developed species-specific antimicrobial screens (Granieri et al., 2009) and 
through the identification of species-selective antimicrobial compounds (Qiu et 
al., 2003; Qiu et al., 2005; Eckert et al., 2006a; Eckert et al., 2006b; Yamaichi et 
al., 2009; Srinivas et al., 2010). Theoretically, the DNA sequence of the genome 
itself provides the ultimate species-specific target; antimicrobial compounds that 
bind to nucleic acids in a sequence-specific manner, can be used to define the 
spectrum of activity. Natural products such as netropsin and distamycin bind to 
adenine and thymine rich DNA sequences in the minor groove of DNA (Turner 
and Denny, 2000), with synthetic compounds that recognise all four bases 
having been described (Dervan, 2001). An alternative approach to targeting 
specific sequences in the chromosome is silencing of essential genes using 
antisense mechanisms. Exogenously delivered antisense DNA 
oligonucleotides, designed to bind to specific mRNA sequences, have been 
demonstrated to be effective against bacterial targets (White et al., 1997; Harth 
et al., 2000). Furthermore, DNA mimics such as peptide nucleic acid (PNA) and 
phosphorodiamidate morpholino (PMO) have uncharged backbone structures 
that enable delivery across negatively-charged bacterial cell barriers, and offer 
superior hybridization and stability properties when compared to modified DNA 
oligonucleotides (Good et al., 2000b). Attachment of carrier peptides to 
PNAs/PMOs can enhance cell permeation and uptake and improve antisense 
effects (Good et al., 2001a). PNAs and PMOs targeted to the translation 
initiation region (TIR) of essential mRNAs are bactericidal and have been 
successfully applied to a number of different species (Good and Nielsen, 1998; 
Nekhotiaeva et al., 2004; Kurupati et al., 2007; Shen et al., 2009). Bactericidal 
PNAs/PMOs are typically 10 bp in length and are more sensitive to target 
mismatches than equivalent DNA oligonucleotides, properties that make them 
highly suited to species discrimination.  
 In this study we tested the hypothesis that the selective binding 
properties of peptide PNA antimicrobials can be exploited to selectively target 
certain species in mixed culture based on sequence differences in the 
translation initiation region of essential genes. We report, for the first time, that 
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peptide-PNAs can form the basis of a single class of antimicrobial with a 
tuneable spectrum of activity. 
  
MATERIALS AND METHODS 
 
Bacterial strains and growth conditions. A list of the strains used in this study is 
given in Table 1. All strains were grown in Miller’s modified Luria broth (MMLB; 
Sigma-Aldrich, UK) with constant shaking (200 rpm) at 37oC. For mixed-culture 
growth, MMLB was inoculated with 1 x 104 CFU/ml; the proportion of each 
species needed to give reproducible species counts after 16 h of growth at 
35oC was experimentally determined (Table S1 in the supplementary material). 
 
Design of species-specific peptide PNAs: General guidelines for the design of 
antibacterial peptide-PNAs are described elsewhere (Good and Nielsen, 1998; 
Good et al., 2000b; Good et al., 2001a; Good, 2002). Criteria used for the 
design of species-specific peptide-PNAs are described in the results section. 
The Database of Essential Genes (Zhang and Lin, 2009a) and BLAST (Altschul 
et al., 1990) were used to identify any essential gene homologues present in all 
four species used in this study. The Artemis program (Rutherford et al., 2000) 
was used to extract twenty base-pairs (-10 - + 10 bases relative to the start 
codon) of the TIRs from the genome sequences of Bacillus subtilis (Kobayashi 
et al., 2003a), Escherichia coli DH10B (Durfee et al., 2008a), Klebsiella 
pneumoniae and Salmonella enterica serovar Typhimurium LT2 (Knuth et al., 
2004) (GenBank accession numbers: AL009126; CP000948; CP000647; and 
AL513382 respectively). The 20 bp TIRs from gene homologues were aligned in 
Clustal X version 2.0 (Larkin et al., 2007) and the number of base-pair 
mismatches between species was determined. The predicted thermal stability 
(Tm) of PNA/DNA duplexes was determined according to formula of Giesen et 
al. 1998 (Giesen et al., 1998). A genomic analysis of the possible binding sites 
of the PNAs within their target species was conducted in Artemis, using a cut-off 
of greater than 2 bp mismatches. Secondly, to comprehensively examine the 
number of potential antibacterial PNAs that could be used to discriminate 
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between two closely related species, a semi-automated method was employed: 
genome sequences were use to identify the start codon positions of essential 
genes from E. coli DH10B and S. Typhimurium LT2. A custom PERL script was 
used to extract the -5 - + 5 bases relative to the start codon of each gene. The 
10 bp sequences were used for an all-against-all comparison using standalone 
BLAST (Altschul et al., 1990; McGinnis and Madden, 2004a) to identify the TIRs 
of essential genes that were amenable to the design of species specific PNAs. 
The peptide-PNAs used in this study and their properties are listed in Table 2. 
 
Antimicrobial susceptibility and peptide-PNA minimal inhibitory concentration 
(MIC) testing. Strains were tested with twenty different antibiotic disks (Oxoid, 
UK) representing the major classes of antimicrobial compounds. Tests were 
done according to the standardized disc susceptibility testing method of the 
British Society for Antimicrobial Chemotherapy (Andrews, 2001; Andrews, 
2009). The minimum inhibitory concentration (MIC) of the peptide-PNA 
conjugants were determined using a method modified from Hacek et al (Hacek 
et al., 1999) and Friedman et al (Friedman et al., 2006): Peptide-PNA 
conjugants, obtained as lyophilized powder (Panagene, Korea), were dissolved 
in ddH20. MIC assays were performed in an ultra low-bind (Costar, UK) 
polystyrene 96-well plate format in a final volume of 150 µl MMLB. An extended 
gradient of peptide-PNA concentrations was created by combining five sets of 
twofold serial dilutions from four starting concentrations (10, 4.8, 3.2 and 3 and 
2 µM); giving 55 final peptide-PNA concentrations which extended over five 
rows of the 96-well plate. All cultures were incubated at 35oC for 16 h without 
shaking or agitation. Each peptide-PNA MIC calculation was performed in 
triplicate, each replicate representing a different starting colony. Mixed-culture 
experiments were conducted as above with a 1 x 104 CFU/ml starting inoculum. 
For growth curve analysis, 200 l cultures were grown in a BioTek PowerWave 
HT spectrophotometer, under constant agitation at 37oC in a 96-well plate 
covered with a breathable film. Growth (OD550) was monitored every 5 mins, 
each experiment was performed in triplicate. 
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Microscopy. Cells prepared for fluorescence imaging were grown in a BioTek 
PowerWave HT spectrophotometer as above. After six hours 10 l of culture 
was removed, washed and resuspended in 1 X PBS by centrifugation (13, 000 x 
g). Cells were applied to an agarose pad (Levin, 2002b) and viewed using an 
epifluorescence Leica DMRB microscope. An EXi Aqua CCD camera 
(QImaging) and Image Pro Plus (MediaCybernetics) were used for image 
acquisition and processing. 
 
Species identification. In mixed-culture experiments, colonies on MMLB plates 
were identified using a combination of phenotypic and genotypic properties. In 
order to rapidly identify species post peptide-PNA treatment, we designed a 
species-specific PCR-based identification method. Primer sets for peptide 
deformylase (def) were designed that yielded different sized amplicons for each 
species: B. subtilis (352 bp), E. coli (394 bp), K. pneumoniae (231 bp) and S. 
Typhimurium (280 bp) (see Table S2). All colonies were picked from the plates 
with the most countable dilution (30-50 cfu per plate) and used directly for 
colony multiplex PCR in 10 l reaction volumes according to the simplified 
method of (Menossi et al., 2000). Colonies were identified using standards 
prepared from pure cultures. Furthermore, in the three-species mixed-culture 
experiments, colonies were identified using the colony PCR protocol with 16S 
rRNA gene primers. The sequences of both strands of the resulting amplicons 
were determined with the BigDye (version 3.1) cycle sequencing kit and a 3730 
DNA analyzer (Applied Biosystems, UK). Species identity was confirmed using 
the SEQMATCH function of the Ribosomal Database Project (Cole et al., 2009) 
 
RESULTS 
 
Peptide-PNA mediated growth inhibition and species-selectivity. The four 
bacterial species used in this study were chosen as they have all been reported 
to be susceptible to antisense antibiotics (Good et al., 2001a; Tilley et al., 2006; 
Kurupati et al., 2007; Shen et al., 2009). The parameters used in the design of 
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species-selective peptide-PNAs resulted in a number of potential gene targets 
that could be used for species-selective growth inhibition. The following criteria 
were used for the design of species-selective peptide PNAs were: 1) target 
gene is essential and homologues are present in all four species used in this 
study; 2) the translation initiation region (TIR) of the mRNA had at least two 
base-pair differences between species (see below); 3) the TIR sequence was 
amenable to the design of peptide-PNAs with low melting temperatures; 4) 
where possible, off-target sites within and between species were not in the TIRs 
of essential genes; and 5) evidence that gene silencing of the target and/or 
inhibition of its cognate protein is growth inhibitory. We have previously shown 
that murA and ftsZ are good targets for peptide-PNA mediated growth inhibition 
(Goh et al., 2009), both genes were identified in this study as potential targets 
for species-selective peptide-PNAs, and thus, were selected for further study. 
Two base-pair mismatches were selected, as PNAs with one base-pair 
mismatch will bind to the target, but with reduced affinity (Good et al., 2001a); 
peptide-PNAs with one base-pair mismatch to their target sites have 
approximately 33% increase in MIC (Liam Good, unpublished). This is in 
agreement with the design parameters suggest by Dryselius et al. (Dryselius et 
al., 2003) in which they suggest 1-bp mismatches within the TIR of off-target 
genes should be avoided.  
The peptide-PNAs designed in this study were assayed for their antibacterial 
activity against both target and non-target species. The previously reported 
En108 peptide-PNA (called Ec108 in (Goh et al., 2009)) was used as a control 
to test the feasibility of species-selectivity at a broad taxonomic level; E. coli, K. 
pneumoniae and S. Typhimurium (Gram-negative, Enterobacteriaceae) have 
identical acpP TIRs and thus all three species should be susceptible to En108, 
while the acpP TIR of Bacillus subtilis (Gram-positive, Bacillaceae) has six 
base-pair mismatches and should be resistant to En108. Antibacterial assays 
with En108 proved this to be the case; En108 had an MIC of 1.2, 0.4 and 0.3 
M for E. coli, K. pneumoniae and S. Typhimurium respectively (Table 2), and 
had no detectable antibacterial activity against B. subtilis at concentrations of up 
to 20 M (data not shown). Similarly, the species-selective PNAs for B. subtilis, 
K. pneumoniae and S. Typhimurium were only antibacterial to the intended 
species (Fig. 1A). The E. coli-selective Ec1000 was unexpectedly cross-reactive 
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with S. Typhimurium (discussed below). Table 3 shows the analysis of potential 
binding sites within the genomes of the target species. Of note is the difference 
in MIC between E. coli, K. pneumoniae and S. Typhimurium when treated with 
the acpP-targeting En108; the MIC of this PNA was 3 and 4 fold less in K. 
pneumoniae and S. Typhimurium, respectively (Table 2). Analysis of the binding 
sites of En108, Kp0001 and Se0001 in the genomes of these species revealed 
that En108 likely binds in the TIR region of other essential genes in K. 
pneumoniae (mukF and ribH) and S. Typhimurium (yhhM) each with a 1 bp 
mismatch. This could account for the decreased MIC in these species, however 
the relationship is not straightforward as Se0001 is predicted to bind in the TIR 
of at least three other genes determined to be essential in E. coli and S. 
Typhimurium (hemK, lnt and rluA) and has an MIC equivalent to that of En108 
in E. coli (Table 2). Furthermore, there is no obvious relationship between the 
MIC of a peptide-PNA and the number of off-targets in the genome of the target 
species, including those that bind in the TIRs of both essential and non-
essential genes (Table 3). Reasons for the possible differences between the 
MICs of the different peptide-PNAs are discussed below.  
Use of species-selective PNAs in mixed culture. To test the selectivity of 
peptide-PNAs in mixed culture, we first used reciprocal treatment in two-species 
culture (Fig. 1B). When mixed cultures of E. coli and K. pneumoniae were 
treated with 3.2 M of E. coli-selective Ec1000, after 16 hrs of incubation only K. 
pneumoniae was detectable. Untreated control cultures maintained both 
species throughout the incubation period. Reciprocal treatment of the same 
mixed culture with 3.2 M of K. pneumoniae-specific Kp0001 showed equivalent 
selectivity. Species-selective growth inhibition was also observed in mixed 
culture of K. pneumoniae and S. Typhimurium treated with 3.2 M Kp0001 or 
2.0 M Se0001 (Fig. 1B). S. Typhimurium was successfully removed from 
mixed culture with E. coli when treated with 2.0 M Se0001, but reciprocal 
removal of E. coli could not be achieved with Ec1000 (see above). Three-
species mixed culture of B. subtilis, K. pneumoniae and S. Typhimurium was 
used to test the possibility of specifically targeting either one or two species, 
with a single peptide-PNA or a combination of two. Kp0001 and Se0001 both at 
4.5 M were successfully applied to the three-species mixed culture; only B. 
subtilis and S. Typhimurium could be detected after 16 hrs incubation with 
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Kp0001, and only B. subtilis and K. pneumoniae after Se0001 treatment (Fig. 
2). Treatment of the three-species culture with 3.5 M En108 resulted in the 
expected selective growth inhibition of both enteric species, with only B. subtilis 
detectable after after 16 hrs. Combined use of Kp0001 and Se0001, at 4.5 M 
each was also able to specifically remove K. pneumoniae and S. Typhimurium 
from the mixed culture, however there was a significant difference in the final B. 
subtilis CFU count between the En108 and dual Kp0001/Se0001 treated 
cultures. This indicates that, while both Kp0001 and Se0001 had no affect on B. 
subtilis at concentrations of > 4.5 M, combined use of the PNAs may have a 
weak synergistic antibacterial effect (Stach and Good, 2011). Mixed culture 
experiments with four species were not attempted in this study, however the 
potential of peptide-PNAs as species-selective antibacterial compounds is 
highlighted by a comparison of all possible species combinations for the four 
species tested in this study, alongside the antibiotic spectrum of the peptide-
PNAs and twenty known antibiotics (Fig. S1). Only peptide-PNAs are capable of 
species-selective growth inhibition for the three Gram-negative species. For 
these species, there are six possible outcomes for species-selective 
antibacterial treatment of two-species mixed cultures. Treatment with the twenty 
antibiotics assessed in this study (Table S3), could theoretically achieve four of 
these outcomes (all combinations except those requiring inhibition of E. coli or 
K. pneumoniae in combination with S. Typhimurium). Use of peptide-PNAs 
Ec1000, Se0001 and Kp0001 enabled five of the possible outcomes; 
unexpected cross-reactivity of Ec1000 prevented selective inhibition of E. coli in 
combination with S. Typhimurium. However, it is very likely that evaluation of 
other E. coli-selective peptide PNAs would be able to rectify this result (see 
below). Furthermore, of the known antibiotics, only streptomycin could select 
between E. coli and S. Typhimurium. This would not be the case for most 
strains of E. coli as strain DH10B has an rpsL mutation that confers resistance 
to streptomycin. Unlike the peptide-PNAs, in mixed culture experiments with 
three species (Fig. 2), no combination of the known antibiotics would be able to 
selectively kill any of the Gram-negative species tested without killing B. subtilis. 
Peptide-PNA mediated discrimination of E. coli and S. Typhimurium. The 
observation that Ec1000 was antibacterial to the non-target S. Typhimurium led 
us to use a comprehensive genomic analysis to determine the number of 
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potential targets that could be used to design peptide-PNAs that would 
discriminate between these two closely related species. For the purposes of 
defining potential discriminatory target sites, we allowed for 1 bp mismatch 
difference between the target site of S. Typhimurium and E. coli; while 1 bp 
mismatch is not likely to be sufficient to prevent binding, differences in gene 
silencing activity may be sufficient, in some cases, to enable the development of 
peptide-PNAs that would be selectively antibacterial to S. Typhimurium. Three 
separate BLAST analyses were done: 1) TIR sequences of genes described as 
essential in S. Typhimurium against the TIRs of E. coli essential genes; 2) TIRs 
of S. Typhimurium genes described as essential in E. coli, against TIRs of E. 
coli essential genes and 3) the TIRs of E. coli essential genes against TIR 
sequences of genes described as essential in S. Typhimurium (Tables S4-6). 
Using the essential genes of S. Typhimurium from the DEG database, and the -
5 to +5 TIR region we identified 113 genes that could serve as targets for 
peptide-PNAs that would be selectively antibacterial to S. Typhimurium over E. 
coli (Table S4). Of these, 68 genes had orthologues not identified as essential 
in E. coli, 34 did not have orthologues in E. coli and of the 11 genes that had 
essential orthologues in E. coli, 5 of these had TIR sequences with > 2 bp 
mismatches. The fact that peptide-PNA Se0001, was selectively antibacterial 
for S. Typhimurium, and designed to target a gene not reported to be essential 
in S. Typhimurium indicates that orthologues of genes that are identified as 
essential in E. coli are likely to be essential in S. Typhimurium. Furthermore, E. 
coli genes have been identified as essential by failure to construct a specific 
knockout, whereas those of S. Typhimurium were identified by trapping lethal 
insertions (Knuth et al., 2004). We applied the bioinformatic screening 
technique described above to identify peptide-PNAs that would discriminate 
between S. Typhimurium and E. coli using the essential genes of E. coli as the 
query sequences. This analysis identified a further 93 orthologous genes that 
could potentially act as targets for discriminatory peptide-PNAs (Table S5). Of 
these, 47 genes had TIRs with > 2 bp mismatches between the two species, 
from which ftsZ was chosen for further study.  This target was chosen for the 
reasons given above, and because gene silencing of ftsZ should result in a cell 
filamentation phenotype that would enable microscopic evaluation of the 
specificity of the peptide-PNA in mixed culture. DsRed-labelled E. coli AC01, 
and GFP-labelled S. Typhimurium AC02 were exposed to peptide-PNA Se0002 
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at concentrations ≤ 5 M. E. coli AC01 was unaffected by Se0002 at all 
concentrations tested, whereas S. Typhimurium growth was inhibited at 1.25 
M (0.5 × MIC), with a lag phase ca. 7.5 hrs longer than that of the untreated 
sample (Fig. 3a). Growth of S. Typhimurium observed in Se0002-treated 
cultures after 10. 5 hrs was not due to the generation of spontaneous resistance 
mutants, as samples of cells taken after 14 hrs of incubation, passaged into 
fresh media containing the same concentration of Se0002, exhibited identical 
growth kinetics to the parent culture. Growth is more likely due to the effective 
concentration of Se0002 falling below the minimum inhibitory concentration, 
caused by the peptide-PNA accumulating in non-growing cells, adsorbing to the 
plastic of the well, or proteolysis of the carrier peptide. Mixed cultures of E. coli 
AC01 and S. Typhimurium AC02 prepared as above, treated with 1.25 M of 
Se0002 were sampled after 6 hrs of growth and were observed by fluorescence 
microscopy (Fig. 3b). As predicted, E. coli AC01 treated with Se0002 had an 
identical phenotype to untreated controls, whereas S. Typhimurium AC02 cells 
displayed a distinct filamentous phenotype only upon treatment with Se0002. 
This phenotype is consistent with previous studies using anti-ftsZ peptide-PNAs 
in E. coli (Goh et al., 2009). These results, and those of the mixed culture 
experiments detailed above, prove that it is possible to employ antisense-based 
molecules as species-selective antimicrobial agents in mixed culture.  
 
  
   
13 
DISCUSSION 
 
The aim of this study was to test the hypothesis that peptide-PNAs can be 
applied as species-selective antimicrobial compounds. We demonstrate, for the 
first time, the design and application of species-selective antisense 
antibacterials. Antibacterial peptide-PNAs evaluated against B. subtilis, E. coli, 
K. pneumoniae and S. Typhimurium, both in single and mixed cultures, with the 
exception of Ec1000, displayed detectable antibacterial activity against the 
intended species only. Peptide-PNA treatment of mixed cultures enabled 
selective growth inhibition that, in theory, could not be achieved using the 
twenty antibiotics evaluated in this study. The current requirement for narrow-
spectrum antimicrobial agents will likely be met by both small molecule 
approaches, where examples already exist (Then and Sahl, 2010), and by novel 
approaches such as the use of antisense agents. Our findings suggest that 
PNAs are good candidates for narrow-spectrum antimicrobials. For species-
selectivity, 16S rRNA would appear to be a logical candidate. However, while 
peptide-PNAs targeted to 16S rRNA have been demonstrated to be bactericidal 
and sequence selective (Good and Nielsen, 1998; Hatamoto et al., 2009), prior 
to this study, species selectivity has not been observed and may be difficult to 
achieve due to sequence conservation within functional regions of 16S rRNA. 
Currently, while the mode of action of peptide-PNA antimicrobials is well 
understood (Good and Nielsen, 1998; Good et al., 2000b; Good et al., 2001a; 
Good, 2002), differences in uptake of the peptide-PNA (see below), species 
sensitivity and the affect of non-target binding remain important areas for future 
experimentation.  
The observation that En108 has different activity in three closely related species 
is intriguing from the perspective of improving the antibacterial activity of 
peptide-PNAs. Analysis of the binding sites of En108 in the genomes of the 
three species provides a possible explanation: En108 will bind (allowing for 1 bp 
mismatch) to the TIRs of off-target essential genes in both, K. pneumoniae and 
S. enterica, and only the intended target in E. coli. Antisense-based 
antimicrobials have been shown to have greater growth inhibitory activity when 
the expression of multiple essential genes is simultaneously inhibited (Harth et 
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al., 2000). While the efficacy of gene silencing with mismatched PNAs may be 
reduced, it is reasonable to suggest that silencing of more than one essential 
gene will lead to lower MICs. En108 will bind to two off-target essential genes in 
K. pneumoniae, and one in S. Typhimurium, yet has a lower MIC in the later. 
This may be explained by mechanistic differences in the gene silencing itself 
(binding efficacy, Tm differences caused by mismatches, and location of the off-
target relative to TIR) or differences in the stringency of requirement for the 
target and off-target genes, i.e. a small reduction in the mRNA pool of the two 
off-targets in K. pneumoniae may be better tolerated than that of the off-targets 
in S. Typhimurium (Goh et al., 2009).  Differences in the susceptibility of the 
three species to En108 may also be explained by uptake efficiency: The 
transporter protein SbmA has recently been identified as required for peptide-
PNA uptake in E. coli (A, Ghosal, J.E.M. Stach, A. Vitali and P.E. Nielsen, 
submitted for publication). Mutations in the sbmA gene affect uptake kinetics, 
and as E. coli shares 86% and 92% similarity to its orthologues in K. 
pneumoniae and S. Typhimurium respectively, the observed difference in 
sensitivity to En108 in these three species may be explained by differences in 
SbmA-mediated uptake. 
The finding that PNA Ec1000, designed to silence the murA gene of E. coli, was 
antibacterial to S. Typhimurium was unexpected. The parameters described for 
the design of species-selective PNAs (see Materials & Methods) should 
theoretically prevent binding of PNAs to the TIRs of essential genes in non-
target species. A study by Dryselius et al. (Dryselius et al., 2003) demonstrated 
that the TIR of a gene is most sensitive to antisense PNA gene silencing. 
However, some PNAs that bind intragenically were shown to significantly 
elevate gene expression. Furthermore, PNAs can repress co-transcribed genes; 
a PNA binding to the TIR of a nonessential gene, may affect the transcription of 
an essential downstream gene to a varying degree depending on transcript 
stability (Dryselius et al., 2006b). Thus, the unexpected antibacterial activity of 
Ec1000 in S. Typhimurium may be due to such events. An analysis of the 
binding sites (allowing for 1 bp mismatch) for Ec1000 in S. Typhimurium shows 
that it binds intragenically to a number of essential genes (alaS, fusA, hemE 
and rplF) that are reported to be toxic upon overproduction (Kitagawa et al., 
2005b). Also, Ec1000 binds (1 bp mismatch) in the intergenic region of rpsN 
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and rplE, genes that are located in a ribosomal protein operon. Thus, it is 
possible that translation of the transcript rplNXE-rpsNH-rplFR-rpsE-rpmD-rplO-
secY-rpmJ could be repressed for genes downstream of rpsE. The predicted 
ribosomal binding site for rpsN is 25 bp upstream of the start codon, with the 
Ec1000 binding site 12 bp upstream, explaining why it was missed in the initial 
screen for undesirable off-target binding sites. In S. Typhimurium, Ec1000 can 
form a duplex in the TIRs of six genes: pipC, a pathogenicity island-encoded 
protein; pepP, a metallopeptidase; mrcA, a murein 
transglycosylase/transpeptidase; STM1127, a putative transcriptional regulator; 
STM3527, a hypothetical protein and STM4051, a putative outer membrane 
protein. None of these genes are reported to be essential in S. Typhimurium or 
the other species used in this study. It is also possible that the Ec1000 PNA 
may bind to a non-coding RNA. Non-coding RNAs are well documented as 
regulatory elements in S. Typhimurium (Vogel, 2009), and while we could 
identify no potential binding between Ec1000 and known non-coding RNAs in S. 
Typhimurium (Pfeiffer et al., 2007) there may be as yet unidentified non-coding 
RNAs that are transcribed from, or interact with, intergenic Ec1000 binding 
sites; disruption of a RNA antitoxin is one possible mechanism that would lead 
to bactericide (Faridani et al., 2006). It is unlikely that small elevations in 
essential gene expression, partial silencing of non-essential genes, or disruption 
of non-coding RNAs could be effective alone, but in combination they may be 
growth inhibitory. The elucidation of the mechanism responsible for Ec1000-
induced growth inhibition in S. Typhimurium is required for the continued 
development of species-selective antibacterial PNAs; understanding of the 
mechanism will enable the design parameters of peptide-PNAs to be modified 
to exclude likely off-target effects and/or identification of new targets for gene-
silencing antimicrobials. Comparative genomics between sensitive and resistant 
species, qRT-PCR  (Goh et al., 2009) and the introduction of point mutations 
within putative targets could be applied to identify the cause of the off-target 
selectivity in S. Typhimurium. While the unexpected activity of Ec1000 
prevented its use as an E. coli species-selective peptide-PNA, our in-silico 
analysis, and the identification of E. coli-specific TIRs (Table S6) suggest that 
finding targets that are amenable for discriminating E. coli from closely related 
species is readily achievable. There are 46 targets, in the -5 to +5 TIR region of 
essential genes in E. coli, that have >2 bp mismatches with orthologs in S. 
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Typhimurium (Table S5). The in silico approach was applied in the successful 
design of Se0002, and thus a peptide-PNA raised to the same target in E. coli, 
will likely discriminate E. coli for S. Typhimurium. Furthermore, the number of 
potential species-selective targets between these two strains is likely an 
underestimate as we confined our search to a single target region (-5 to +5 of 
the TIR) and peptide-PNAs with gene silencing activity have been described 
based on a target region at least twice this size (Dryselius et al., 2003).  
As the peptide-PNA mediated growth inhibition is dependent on the silencing of 
an essential gene or genes, a better understanding of which genes are 
essential in the specific pathogen, in a relevant (i.e. in host) environment, will 
facilitate in the design of peptide-PNAs. For example, the silencing of genes 
that are essential for survival or virulence in the host (Fields et al., 1986) or 
antimicrobial resistance factors, as peptide-PNAs silencing of such genes can 
reestablish the antimicrobial sensitive phenotype in resistant strains (Good and 
Nielsen, 1998; Jeon and Zhang, 2009b). Discovery of synthetically lethal gene 
combinations in bacteria (Typas et al., 2008) will also broaden the number of 
targets available for the design of species-selective peptide-PNAs.  
As peptide-PNAs are used within environments of increasing species diversity, 
it is clear that there will be a higher the likelihood of non-target species activity, 
as a consequence of identical target regions or off-target binding (as is likely the 
case for Ec1000 in S. Typhimurium). Nevertheless, relative to currently used 
antibiotics, PNAs provide greater opportunity for the design of narrow-spectrum 
antimicrobials where the primary target is dictated by the nucleic acid sequence. 
The availability of in-depth microbiome sequencing will enable the assessment 
(in terms of spectrum of activity) of PNA-based antimicrobial therapy in an 
animal model to be assessed; aid in the determination of conditions where such 
strategies may provide alternative or complementary therapy (Knight, 2010), 
and in the design of species-selective PNAs through exhaustive prediction of 
binding sites in all species of the microbiome.    
While examples of bacterial resistance to peptide-PNAs have not been 
published, it is reasonable to assume that it may arise through point mutation of 
the PNA binding site. In this case, activity would be restored by simple 
modification of the PNA sequence, whereas point mutations that lead to 
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structural changes in the binding site of proteins and ribosomes require 
chemical modification of the antimicrobial based on structure activity 
relationships that are not straightforward to predict. Resistance due to 
prevention of uptake (as above), degradation of the peptide carrier, or efflux 
remain possible, and as such, characterization of peptide-PNA resistance 
mutants and the evaluation of alternative PNA carriers, remain priority areas for 
the development of antimicrobial PNAs.  
Narrow-spectrum antimicrobial therapy has likely been hindered by the need to 
treat infections quickly without waiting for identification of the pathogen. 
However, with the advent of cheap sequencing and rapid diagnostics, the 
benefits of species-selective or narrow spectrum antimicrobials may improve 
patient outcome and ameliorate the development of antimicrobial resistance. 
Antimicrobials that act at the gene sequence level, such as PNAs, have great 
potential in the development of what Casadevall has termed them ‘Third-Age 
antimicrobials’ (Casadevall, 2006). 
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 FIG. 1. Species-selective antibacterial peptide-PNAs in two-species mixed 
culture. E. coli (dark grey), K. pneumoniae (white) and S. Typhimurium (light 
grey). All cultures were incubated for 16 hrs. A) axenic cultures of the species 
were treated with E. coli- specific Ec1000 at 3.2 M,  K. pneumoniae-specific 
Kp0001 at 3.2 M and S. Typhimurium-specific Se0001 at 2.0 M. Asterisks 
indicate species-selective growth inhibition of E. coli, K. pneumoniae and S. 
Typhimurium respectively. B) Two-species mixed cultures treated with peptide-
PNAs as above. The control cultures show the relative proportion of the two 
species without treatment, the two treatments to the left of the control represent 
the same mixed culture treated with a peptide-PNA. Black arrows indicate non 
species-selective growth inhibition of S. Typhimurium by Ec1000.  
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FIG. 2. Species-selective antibacterial peptide-PNAs in three-species mixed 
culture. B. subtilis (dark grey), K. pneumoniae (white) and S. Typhimurium (light 
grey) in mixed culture were separately treated with Ec108 at 3.5 M, Kp0001 or 
Se0001 at 4.5 M or by combined treatment of Kp0001 and Se0001 both at 4.5 
M. All cultures were incubated for 16 hrs. Selective inhibition of either K. 
pneumoniae or S. Typhimurium individually or together, achieved with the 
peptide-PNAs, could not theoretically be achieved with any combination of the 
twenty known antimicrobial compounds tested in this study. 
 
 
 
FIG. 3. S. Typhimurium-selective growth inhibition. Peptide-PNA Se0002 was 
designed to target the -5 to +5 region of the translational initiation region (TIR) 
of ftsZ in S. Typhimurium. Se0002 has 2 base pair mismatches in the TIR of 
ftsZ in E. coli. (A) Growth curve analysis of Se0002 in pure culture. E. coli 
growth in the presence of 1.25 M Se0002 (solid line) was identical to that of 
untreated controls (not shown). S. Typhimurium growth was inhibited in the 
presence of 1.25 M of Se0002 (dotted line) relative to the untreated control 
(dashed line). Growth in the treated samples after 10 hrs was not due to 
resistance (see text for details). (B) Mixed cultures of GFP-labeled S. 
Typhimurium AC02 and DsRed-labeled E. coli AC01 were treated with 1.25 M 
Se0002; and imaged by fluorescence microscopy after 6 hrs of incubation. The 
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filamentous growth phenotype was only observed in S. Typhimurium AC02 and 
is consistent with silencing of ftsZ expression.  
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Table 1. Bacterial strains used in this study. a American Type Culture Collection b Salmonella Genetic Stock Center 
 
 
 
 
 
  
Strain Source Genotype Characteristic 
Bacillus subtilis susp subtilis 168 
ATCCa 
23857 
trpC2 
Genome sequenced 
strain 
Escherichia coli DH10B Invitroge
n 
F- endA1, recA1, galE15, 
galK16, nupG, rpsL, ΔlacX74, 
Φ80lacZΔM15, araD139, 
Δ(ara,leu)7697, mcrA, Δ(mrr-
hsdRMS-mcrBC), λ- 
Genome sequenced 
strain, parent of E. coli 
AC01 
E. coli AC01 This 
study 
As above, pDsRed-Express2  Expression of DsRed 
fluorescent protein 
Klebsiella pneumoniae subsp. 
pneumoniae 
 
ATCC 
700721 
n/a Genome sequenced 
strain 
Salmonella enterica serovar 
Typhimurium LT2 
 
SGSCb 
1412 
n/a Genome sequenced 
strain 
S. Typhimurium LT2 substr 
JR501 
SGSC 
1593 
hsdSA29, hsdSB121, hsdL6, 
metA22, metE55,1 trpC2, ilv-
452, H1-b, H2-e,n,x (cured of 
Fels 2), fla-66, nml, rpsL120, 
xyl-404, galE719 
Restriction-deficient, 
modification-proficient 
cloning strain of S. 
Typhimurium LT2, 
parent of S. 
Typhimurium AC02 
S. Typhimurium AC02 This 
study 
As above, pGFPuv Expression of green 
fluorescent protein 
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Table 2. Properties of peptide-PNAs used in this study. 
 
a 
Code refers to predicted species-specificity Bs =B. subtilis, Ec = E. coli, En = Enterobacteriaceae, Kp = K. pneumonia, Se = S. enterica 
Typhimurium 
b
 Indicates if specificity based on bioinformatic prediction was observed. 
c
 Target is shown as positions of nucleotides relative to the start codon.  
d
 Thermal stability of PNA/DNA duplex. 
e 
Ec1000 lacked predicted specificity, see text for details. 
  
Name
a
 
Targ
et  
Sequence 
Minimum Inhibitory Concentration (µM)  
Expected 
specificit
y
b
 
Target 
site 
Tm
d
 
Reference B. 
subtilis 
E. 
coli 
K. 
pneumonia 
S. 
Typhimurium 
Bs000
1 
ftsZ  
(KFF) 3K-eg-
caacatgcta 
4.0 >10 >10 >10 yes -4 to +6 
53.
5 
This study 
En108 acpP 
(KFF) 3K-eg-
ctcatactct 
>10 1.2 0.4 0.3 yes -5 to +5 
41.
5 
Goh et al. 
2009 
Ec100
0 
murA 
(KFF) 3K-eg-
ccatttagtt 
>10 2.4 >10 3.2 no
e
 -6 to +4 
44.
0 
This study 
Kp000
1 
murA 
(KFF) 3K-eg-
tccattgatt 
>10 >10 2.5 >10 yes -5 to +5 
46.
8 
This study 
Se000
1 
murA  
(KFF) 3K-eg-
tccattattg 
>10 >10 >10 1.2 yes -5 to +5 
43.
5 
This study 
Se000
2 
ftsZ 
(KFF) 3K-eg-
aacataatct 
>10 >10 >10 2.5 yes -5 to +5 
46.
1 
This study 
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Table 3. PNA binding site analysis in target species. 
Species PNA 
No. off 
targets
a
 
Off Targets within TIR
b
 of gene 
No. essential (gene)
c
 No. non-essential (gene) 
E. coli En108 128 0  11 (araH, arpB, cadB, gpp, ssuE, ugpQ, upp, yagW, yhjG, yodC, yqjF) 
K. pneumoniae En108 143 2  (mukF
d,e
, ribH
d,f
) 5 (gppA, kpn_00790, kpn_01124, kpn_04794, nlpA) 
S. Typhimurium En108 138 1  (yhhM
d
) 14 (dps, hycE, pmgI, STM0566, STM0762, STM1698, STM2137,  
      STM2481, STM3085, STM4218, thiJ, upp, ydcY, ygaC) 
E. coli Ec1000 201 2  (lnt
d,f
, rpsN
d,f
) 11 (elaD, hypF, mrcA, ppsR, rhsD, ybfD, ydcC, yfbM, yhaJ, yhhI,  
      yjgH) 
S. Typhimurium  Se0001 320 5  (aspC
f
, hemK
d,e,f
,  8 (fucA, ppiC, sodA, STM2343, STM2903, yajB, ybdF, yebB) 
   
 
 
 
lnt
d,f
, nuoI
f
, purD
f
,   
  rluA
d,f
)   
S. Typhimurium  Se0002 311 0  11 (celC, t0363, t0453, t1718, t2652, t4467, tdcE, umuC, yacK, yadI,  
      ybaB) 
K. pneumoniae Kp0001 157 3 ispA
d,f
, rpsN
d,f
,  3 (KPN_02027, KPN_04368, rhaT) 
    topB
e
   
B. subtilis Bs0001 104 
0  
4 (yabQ, yeeG, yruI, yvyE) 
 
a includes sites with  1base-pair mismatch with PNA 
b Translation Initiation Region 
c identified by BLAST searching of the Database of Essential Genes 
d essential in E. coli  
e essential in S. Typhimurium 
f essential in other prokaryotes 
ND Not determine 
